TABLE 6-1Emergency HotlinesNeedAgencyPhone numberTo obtain information regarding the treatment of a known or suspected poisoning/toxicosis case.ASPCA Animal Poison Control888--426--4435Center (\$50 fee for service may apply)To report known or suspected adverse drug *(not vaccine)* reactions.Food & Drug Administration (FDA)888--332--8387 (voice messages accepted)Center for Veterinary Medicine (CVM)To report shortages of medically necessary veterinary drugs.Food & Drug Administration (FDA)301--827--4570Center for Veterinary Medicine (CVM)or888--463--6332To report known or suspected adverse vaccine reactions.US Dept of Agriculture (USDA)800--752--6255Center for Veterinary Biologics (Also, contact vaccine manufacturer directly. NOTE: this is for reporting purposes *only*; adverse event information on a specific product is usually not provided.)For inquiries on transfusion medicine (no charge).Animal Blood Bank HOTLINE800--243--5759 (24-hour)For inquiries on transfusion medicine and purchase of blood and blood components.Eastern Veterinary Blood Bank800--949--3822 (24-hour)For inquiries on access to blood and blood products for all species.Midwest Animal Blood Services517--851--8244 (24 hour)For inquiries on transfusion medicine---a full-service, nonprofit blood bank and educational network for animalsHEMOPET714--891--2022 (24-hour)Access to a commercial blood bank and purchase of blood and blood components.Veterinarians\'Blood Bank812--358--8500For inquiries on pesticides, pesticide products, poisonings and toxicities.National Pesticide Information Center800--858--7378 <npic@ace.orst.edu>For inquiries on pet shipping regulations and regulations for shipping pets on airlinesUS Dept of Agriculture (USDA) (voice response service)800--545--8732To contact the Office of Diversion Control of the DEADrug Enforcement Agency800--882--9539

TABLE 6-2Dog Breeds Recognized by the American Kennel Club (AKC)The American Kennel Club (AKC) currently recognizes 150 dog breeds, each of which is assigned to one of 7 breed groups. The AKC maintains an excellent website offering considerable information on individual breeds (see <http://www.akc.org/breeds/index.cfm>)Sporting groupAmerican Water SpanielBrittany SpanielChesapeake Bay RetrieverClumber SpanielCocker SpanielCurly-Coated RetrieverEnglish Cocker SpanielEnglish SetterEnglish Springer SpanielField SpanielFlat-Coated RetrieverGerman Shorthaired PointerGerman Wirehaired PointerGolden RetrieverGordon SetterIrish SetterIrish Water SpanielLabrador RetrieverNova Scotia Duck Tolling RetrieverPointerSpinone ItalianoSussex SpanielVizslaWeimaranerWelsh Springer SpanielWirehaired Pointing GriffonHound groupAfghan HoundAmerican FoxhoundBasenjiBasset HoundBeagleBlack and Tan CoonhoundBloodhoundBorzoiDachshundEnglish FoxhoundGreyhoundHarrierIbizan HoundIrish WolfhoundNorwegian ElkhoundOtterhoundPetit Basset Griffon VendèenPharaoh HoundRhodesian RidgebackSalukiScottish DeerhoundWhippetWorking groupAkitaAlaskan MalamuteAnatolian Shepherd DogBernese Mountain DogBlack Russian TerrierBoxerBullmastiffDoberman PinscherGerman PinscherGiant SchnauzerGreat DaneGreat PyreneesGreater Swiss Mountain DogKomondorKuvaszMastiffNeapolitan MastiffNewfoundlandPortuguese Water DogRottweilerSaint BernardSamoyedSiberian HuskyStandard SchnauzerTerrier groupAiredale TerrierAmerican Staffordshire TerrierAustralian TerrierBedlington TerrierBorder TerrierBull TerrierCairn TerrierDandie Dinmont TerrierIrish TerrierKerry Blue TerrierLakeland TerrierManchester Terrier (Standard)Miniature Bull TerrierMiniature SchnauzerNorfolk TerrierNorwich TerrierParson Russell TerrierScottish TerrierSealyham TerrierSkye TerrierSmooth Fox TerrierSoft Coated Wheaten TerrierStaffordshire Bull TerrierWelsh TerrierWest Highland White TerrierWire Fox TerrierToy groupAffenpinscherBrussels GriffonCavalier King Charles SpanielChihuahuaChinese CrestedEnglish Toy SpanielHavaneseItalian GreyhoundJapanese ChinMalteseManchester Terrier (Toy)Miniature PinscherPapillonPekingesePomeranianPugShih TzuSilky TerrierToy Fox TerrierYorkshire TerrierNon-sporting groupAmerican Eskimo DogBichon FriseBoston TerrierBulldogChinese Shar-peiChow ChowDalmatianFinnish SpitzFrench BulldogKeeshondLhasa ApsoLöwchenPoodleSchipperkeShiba InuTibetan SpanielTibetan TerrierHerding groupAustralian Cattle DogAustralian ShepherdBearded CollieBelgian MalinoisBelgian SheepdogBelgian TervurenBorder CollieBouvier des FlandresBriardCanaan DogCardigan Welsh CorgiCollieGerman Shepherd DogOld English SheepdogPembroke Welsh CorgiPolish Lowland SheepdogPuliShetland SheepdogMiscellaneous classBeauceronGlen of Imaal TerrierPlottRedbone Coonhound

TABLE 6-3Cat Breeds Recognized by the Cat Fanciers' Association (CFA)The Cat Fanciers' Association (CFA) presently recognizes 37 pedigreed breeds for showing in the Championship Class, and 4 breeds as Miscellaneous. For additional information on individual breeds on the CFA website, see <http://www.cfainc.org/breeds.html>.Championship classAbyssinianAmerican CurlAmerican ShorthairAmerican WirehairBalineseBirmanBombayBritish ShorthairBurmeseChartreuxColorpoint ShorthairCornish RexDevon RexEgyptian MauEuropean BurmeseExoticHavana BrownJapanese BobtailJavaneseKoratMaine CoonManxNorwegian Forest CatOcicatOrientalPersianRagdollRussian BlueScottish FoldSelkirk RexSiameseSingapuraSomaliSphynxTonkineseTurkish AngoraTurkish VanMiscellaneousAmerican BobtailLaPermRagaMuffinSiberian

TABLE 6-4Useful Information for Rodents and RabbitsHamsterRabbitMouseRatGerbilGuinea pigWeight at birth2 g100 g1.5 g5.5 g3 g100 gPuberty(F) 28--31 days4--9 mo35 days50--60 days(F) 3--5 mo(F) 20--30 days(M) 45 days(M) 10--12 wk(M) 70 days(best to breed 70 days)Duration of estrous cycle[\*](#cetablefn1){ref-type="table-fn"}4 daysOvulation not spontaneous; stimulated by copulation; doe ovulates 10--13 hr after4 days4 days4 days16 daysGestation (days)1628--3619--2121--232462--72Separation of adults during parturition and weaningYesYesNoNoNo (mates for life)NoNumber per liter4--107108--101--121--4Eyes open15 days10 days11--14 days14--17 days16--20 daysPrior to birthWean at25 days42--56 days21 days21 days21 days14--21 days or 160 gPostpartum estrusWithin 24 hr14 daysWithin 24--48 hrWithin 24--48 hrWithin 24--72 hrWithin 24 hrBreeding life11--18 mo1--3 years (max.6 yr)12--18 mo14 mo15--20 mo3--4 yrAdult weight(F) 120 g(F) 4.0 kg(F) 30 g(F) 300 g(F) 75 g(F) 850 g(M) 108 g(M) 4.3 kg(M) 39 g(M) 500 g(M) 85 g(M) 1000 gLife span (yr)2--35--73.0--3.5344--5Body temperature97° --101 °F101° --103.2 °F96.4° --100 °F99.5° --100.6 °F100.8 °F100.4° --102.5 °F(36.1° --38.3 °C)(38.3° --39.5 °C)(35.8° --37.7 °C)(37.5° --38.1 °C)(32.8 °C)(38--39.2 °C)Daily adult water consumption8--12 mL/day80 mL/kg body weight3--3.5 mL/day20--30 mL/day4 mL/day10 mL/100 g body weightDaily adult food consumption (varies with age and condition)7--12 g/day100--150 g/day2.5--4.0 g/day20--40 g/day10--15 g/day30--35 g/dayDietCommercial rat, mouse, or hamster chow supplemented with kale,[†](#cetablefn2){ref-type="table-fn"} cabbage,[†](#cetablefn2){ref-type="table-fn"} apples, milkCommercial rabbit pellets, greens in moderationCommercial mouse chowCommercial rat or mouse chowCommercial mouse or rat chow (lowest fat possible); sunflower seedsCommercial guinea pig chow, good-quality hay, kale, cabbage, fruits (cannot rely on vitamin C levels of commercial ration)Room temperature65° --75 °F62° --68 °F70° --80 °F76° --18 °F65° --80 °F65° --75 °F(18.3° --24 °C)(17° --20 °C)(21° --27 °C)(24.5° --25.5 °C)(18.3° --26.6 °C)(18.3° --24 °C)Humidity (%)50505050\<5050[^1][^2]From Schuchman SM: Individual care and treatment of rabbits, mice, rats, guinea pigs, hamsters, and gerbils. *In* Kirk RW, ed: Current Veterinary Therapy X.Philadelphia, WB Saunders, 1989, p 739.

TABLE 6-5Determination of the Sex of Mature and Immature Rodents and Rabbits**Mature hamsters, mice, rats, guinea pigs, and gerbils**MaleFemale1.Anogenital distance longer in the male2.Manipulate "genital papilla"(prepuce) to protrude penis.3.Palpate for testicles either in a scrotal sac (if present) or subcutaneous in inguinal region.4.Males have only two external openings in the inguinal area:a.Anusb.Urethral orifice at tip of penis.In very fat males there may be a depression between the penis and anus. This depression can be obliterated by manipulating the skin in this area.1.Anogenital distance shorter in the female.2.Look for the three external openings in the inguinal area:a.Anus (most caudal opening).b.Vaginal orifice (middle opening) -- look carefully.c.Urethral orifice at tip of urethral papilla (most anterior opening).In these animals the urethral papilla is located outside the vagina (unlike dogs and cats).In very fat females or young females, the vaginal orifice may be either hidden by folds of skin (the former) or sealed (latter). Gentle manipulation of the skin in this area will divulge the orifice.**Mature rabbitsMaleFemale**1.Protrude penis by manipulating skin of prepuce.2.Palpate for testicles.3.Anogenital distance is longer.1.There is a common orifice for both the vagina and urethra (like dogs and cats).2.No. structure like a "penis" can be protruded from the urogenital orifice.3.Anogenital distance is shorterFrom Schuchman SM: Individual care and treatment of rabbits, mice, rats, guinea pigs, hamsters, and gerbils. *In* Kirk RW, ed: Current Veterinary Therapy X. Philadelphia, WB Saunders, 1989, p 740.

TABLE 6-6Blood Values and Serum Chemical Constituents for Rodents and RabbitsLaboratory testRatsMiceHamstersGuinea pigsRabbitsMangolian gerbilsAST (Sigma-Frankel units)25--4232--4122--3610--2514--27--Alkaline phosphatase (Bodansky units)4.1--8.62.4--4.02.0--3.51.5--8.12.1--3.2--BUN (mg/dL)10--208--3010--408--205--3018--24Sodium (mEq/L)144114--154106--185120--155100--145144--158Potassium (mEq/L)5.93.0--9.62.3--9.86.5--8.23.0--7.03.8--5.2Bilirubin, total (mg/dL)0.420.18--0.540.3--0.40.24--0.300.15--0.20--Blood glucose (mg/dL)50--115108--19232.6--118.460--12550--14069--119RBCs (10^6^ cells/mm^3^)7.2--9.69.3--10.54.0--9.34.5--7.03.2--7.58.3--9.3Hemoglobin (g/dL)14.812--14.99.7--16.811--1510--1510--16Hematocrit (%)40--5035--5040--5235--5035--4535--45WBCs (10^3^ cells/mm^3^)8--148--147--155--128--109--14Segmented (%)302616--284230--5010--20Nonsegmented (%)008000Lymphocytes (%)65--7755--8064--7845--8130--5070--89Eosinophils (%)131511Monocytes (%)452890Basophils (%)000200[^3][^4]Modified from Schuchman SM: Individual care and treatment of rabbits, mice, rats, guinea pigs, hamsters, and gerbils. *In* Kirk RW, ed: Current Veterinary Therapy X. Philadelphia, WB Saunders,1989, p 746.

TABLE 6-7Ferrets---Physiologic, Anatomic, and Reproductive DataDataRange or value***Physiologic data***Life span5--9 yr (average 5--7)Commercial breeding life2--5 yrBody temperature101 --104 F (38 -40 C)Respiratory rate32--36 breaths/minHeart rate220--250 bpm (average 240)Water consumption75--100 mL/dayChromosome number2n = 40***Anatomical data***Dental formula2 (I3/3, C1/1, P3/4, M1/2)Vertebral formulaC-7, T-14, L-6, S-3, Cd-14--Cd-18***Reproductive data***Gestation39--46 days (average 42)Litter size2--17 kits (average 8)False pregnancy40--42 daysPlacentationZonalImplantation time12--31 daysWeaning5--6 wkOvulation30--40 hr post coitusFrom Randolph RW: Medical and surgical care of the pet ferret. *In* Kirk RW, ed: Current Veterinary Therapy X. Philadelphia, WB Saunders, 1989, p 766.

TABLE 6-8Hematologic Values for Normal Ferrets[\*](#cetablefn3){ref-type="table-fn"}Laboratory testMeanRangeHematocrit (%)52.342--61Hemoglobin (g/dL)17.015--18RBCs (10^6^ cells/mm^3^)9.176.8--12.2WBCs (10^3^ cells/mm^3^)10.14.0--19WBCsLymphocytes (%)34.512--54Neutrophils (%)58.311--84Monocytes (%)4.40--9.0Eosinophils (%)2.50--7.0Basophils (%)0.10--2.0Reticulocytes (%)4.61--14Platelets (10^3^ cells/mm^3^)499297--910Total protein (g/dL)6.05.1--7.4[^5]From Ryland L, Bernard S, Gorham J: A clinical guide to the pet ferret. Compend Contin Educ Pract Vet 5:25 1983, which was adapted from Thornton, et al: Lab Anim 13:119, 1979.© 20062006Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

TABLE 6-9Serum Chemistry Values for Normal Ferrets[\*](#cetablefn4){ref-type="table-fn"}AnalyteUnitMeanRangeGlucosemg/dL13694--207BUNmg/dL2210--45Albuminmg/dL3.22.3--3.8Alkaline phosphataseIU/L239--84ASTIU/L6528--120Total bilirubinmg/dL\<1.0Cholesterolmg/dL16564--296Creatininemg/dL0.60.4--0.9SodiummEq/L148137--162PotassiummEq/L5.94.5--7.7ChloridemEq/L116106--125Calciummg/dL9.28.0--11.8Phosphorusmg/dL5.94.0--9.1[^6][^7]From Ryland L, Bernard S, Gorham J:A clinical guide to the pet ferret. Compend Contin Educ Pract Vet 5:25 1983, which was adapted from Thornton, et al: Lab Anim 13:119 1979.© 20062006Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

TABLE 6-10Electrocardiographic Data for Normal Ferrets[\*](#cetablefn5){ref-type="table-fn"}ParameterMeanRange***Rate rhythm***224 ± 51150--340Normal sinus rhythmSinus arrhythmia*Measurements*P waveWidth0.03 ± 0.0090.015--0.04 sHeight0.106 ± 0.030.05--0.20 mVP--R intervalWidth0.05 ± 0.010.04--0.08 sQRS complexQ waveUsually noneRwaveWidth0.049 ± 0.0080.04--0.06 sHeight1.59 ± 0.630.6--3.15 mVS waveHeight0.166 ± 0.1010.1--0.25 mVS--T segmentWidth0.030 ± 0.0160.01--0.06 sQ--T intervalWidth0.13 ± 0.0270.10--0.18 sT waveWidth0.06 ± 0.01 0.03--0.1 sHeight0.24 ± 0.120.10--0.45 mV***Mean electrical axis (frontal plane)***+65--100 degrees[^8]

TABLE 6-11Conversion of Body Weight in Kilograms to Body Surface Area in Meters Squared for DogsKgM^2^KgM^2^0.500.0626.000.881.000.1027.000.902.000.1528.000.923.000.2029.000.944.000.2530.000.965.000.2931.000.996.000.3332.001.017.000.3633.001.038.000.4034.001.059.000.4335.001.0710.000.4636.001.0911.000.4937.001.1112.000.5238.001.1313.000.5539.001.1514.000.5840.001.1715.000.6041.001.1916.000.6342.001.2117.000.6643.001.2318.000.6944.001.2519.000.7145.001.2620.000.7446.001.2821.000.7647.001.3022.000.7848.001.3223.000.8149.001.3424.000.8350.001.3625.000.85

TABLE 6-12Conversion of Body Weight in Kilograms to Body Surface Area in Meters Squared for CatsKgM^2^0.500.061.000.101.500.122.000.152.500.173.000.203.500.224.000.244.500.265.000.285.500.296.000.316.500.337.000.347.500.368.000.388.500.399.000.419.500.4210.000.44

TABLE 6-13French Scale Conversion TableThe standard French, or Charrière, scale (abbreviated F or Fr) is generally used in the size calibration of catheters and other tubular instruments. It is based on the metric system, with each unit being approximately 0.33 mm, with a difference of 0.33 mm in diameter between consecutive sizes. Example: 27F indicates a diameter of 9 mm; 30F, a diameter of 10 mm.A convenient conversion table from the French scale to the English and American scales that is sometimes used for certain instruments is given below.

TABLE 6-14International System of Units (SI) Conversion Guide[\*](#cetablefn6){ref-type="table-fn"}Conversion FactorAnalyteFluidTraditional unitsMultiply (×)→SI units←Divide (÷)ACTH (adrenocorticotropin; corticotropin)Plasmapg/mL0.2202pmol/LALT (alanine aminotransferase; SGPT)Serummg/dL1U/LAlbuminSerumg/dl10g/LAldosteroneSerumng/dL27.74pmol/LAmmonia (NH~3~)Plasmaμg/dL0.5872μmol/LAmmonium (NH~4~^+^)Plasmaμg/dL0.5543μmol/LAmylaseSerumunits/L1U/LAntibodiesSerumHighest possible dilution1Highest possible dilutionAST (aspartate aminotransferase; SGOT)Serumunits/L1U/LBile acids (total)Serumμg/mL2.547μmol/LBilirubin (total)Serummg/dL17.1μmol/LBlood gases:Arterial bloodPCO~2~mm Hg0.1333kP~a~pHpH units1pH unitsPO~2~mm Hg0.1333kP~a~BUN (blood urea nitrogen)Serummg/dL0.357mmol/L of ureaCalciumSerummg/dL0.250mmol/LCalcium, ionized (iCa)Serum, plasmamEq/L0.500mmol/L**CBC (complete blood count):**Whole bloodHematocrit%0.01as a fraction of 1Hemoglobing/dL10g/LMCH (mean corpuscular hemoglobin)pg1pgMCHC (mean corpuscular hemoglobin concentration)g/dL10g/L**MCV (mean corpuscular volume)**um^2^1fLPlatelet count10^3^/mm^3^110^9^/LReticulocyte countNo. per 1000 RBCs0.001as a fraction of 1Reticulocyte countAs a%0.01as a fraction of 1**Differential cell count**Neutrophils (segmented)cells/mm^3^ (μL)110^6^ cells/LNeutrophils (band)cells/mm^3^1Lymphocytescells/mm^3^1Monocytescells/mm^3^1Eosinophilscells/mm^3^1Basophilscells/mm^3^1Cholesterol (total)Serummg/dL0.02586mmol/LCK (creatine kinase)SerumUnits/L1U/LCortisolSerum, plasmaμg/dL 27.59nmol/LCortisol (free)Urineμg/24 hours2.759nmol/dayCreatinineSerummg/dL88.4mol/LElectrolytesChlorideSerummEq/L1mmol/LCO~2~ (bicarbonate)Whole bloodmEq/L1mmol/LPotassiumSerummEq/L1mmol/LSodiumSerummEq/L1mmol/LFibrinogen (coagulation factor I)Plasmag/dL29.41mol/L*or*0.01g/Lmg/dLFibrin (fibrin degradation products)Serumμg/mL1mg/LGGT (gamma glutamyl transferase)SerumUnits/L1U/LGlucoseSerummg/dL0.05551mmol/LInsulinSerumμU/ml 7.175pmol/LmU/L7.175pmol/Lμg/L172.2pmol/LLeadPlasmag/dL0.04826μmol/Lmg/dL48.26μmol/LLipaseSerumunits/L1U/LMagnesiumSerummg/dL0.4114mmol/LmEq/L0.500mmol/LPhosphorusSerummg/dL0.3229mmol/LPlasminogenPlasma%0.01as a fraction of 1Protein (total)Serumg/dL10g/LProtein (spinal fluid)CSFmg/dL0.01g/LPT (prothrombin time)Plasmaseconds1secondsPTT (partial thromboplastin time)Plasmaseconds1secondsThyroid tests:TSH (thyroid-stimulating hormone)SerumμU/mL 1 mU/LT~4~ (thyroxine)Serumμg/dL 12.87 nmol/LThyroxine, free T^4^Serumng/dL12.87pmol/LT~3~ (triiodothyronine)Serumng/dL0.01536nmol/L[^9]

TABLE 6-15Units of Length, Volume, and Mass in the Metric SystemPrefixMultiply byFactormilli-0.001 (1/1000)×10^−3^centi-0.01 (1/100)×10^−2^deci-0.1 (1/10)×10^−1^deka-10×10hecto-100×10^2^kilo-1000×10^3^**ParameterUnitAbbreviations**The standard unit of **volume** in the metric system is the liter.1 milliliter = 0.001 liter1 milliliter = 1 mL = 1 cc[1](#cetablefn7){ref-type="table-fn"}1 centiliter = 0.01 liter1 centiliter = 1 cL1 deciliter = 0.1 liter1 deciliter = 1 dL1 liter1 liter = 1 L1 kiloliter = 1000 liters1 kiloliter = 1 kLThe standard unit of **mass** in the metric system is the gram.1 milligram = 0.001 gram1 milligram = 1 mg1 centigram = 0.01 gram1 centigram = 1 cg1 decigram = 0.1 gram1 decigram = 1 dg1 gram1 gram = 1 g1 kilogram = 1000 grams1 kilogram = 1 kgThe standard unit of **length** in the metric system is the meter.1 millimeter = 0.001 meter1 millimeter = 1 mm1 centimeter = 0.01 meter1 centimeter = 1 cm1 meter1 meter = 1 m1 decimeter = 0.1 meter1 decimeter = 1 dm1 kilometer = 1000 meters1 kilometer = 1 km[^10]

ANNUALIZED VACCINATION PROTOCOLS AND CRITERIA DEFINING RISK FOR THE DOG AND CAT {#cesec11}
===============================================================================

The fact that the canine and feline criteria recommend triennial vaccination for certain vaccines in no way stipulates that adult dogs and cats should *only* be vaccinated every 3 years. In fact, annual vaccination does represent a high standard of medical care, *as long as the vaccination appointment incorporates a thorough health/wellness examination*. Considering the large population of pet dogs and cats and the remarkable spectrum of risk factors for exposure to infectious pathogens, it is quite unreasonable to assume that a single vaccination protocol would be applicable in all patients seen in practice. Two of the most important variables to consider when assessing risk are the *age* of the patient and the patient\'s *"lifestyle."* In implementing a vaccination protocol in clinical practice, it is critical that the clinician consider these factors when recommending core, or non-core, vaccines for an individual patient.

The following tables exemplify *annualized* vaccination protocols for dogs and cats at *moderate risk* (applies to most), *high risk*, and *low risk* of exposure to infectious agents while also taking into consideration the recommendations set forth in the canine and feline criteria.

Additional Reading {#cesec12}
==================

Richards J, Rodan I, Elston T, et al: 2000 Report of the American Association of Feline Practitioners and Academy of Feline Medicine Advisory Panel on Feline Vaccines, Nashville, Tenn.

Report of the American Animal Hospital Association (AAHA) Canine Vaccine Task Force: 2003 Canine and Recommendations. *J Am Anim Hosp Assoc* 39:119-131, 2003. (The complete report, including supporting literature, is available to AAHA members at [www.aahanet.org](http://www.aahanet.org){#interref4}.)

Ford RB (ed): Veterinary Clinics of North America: Small Animal Practice. WB Saunders, Philadelphia, May 2001.

TABLE 6-16Types of Vaccines Licensed for Use in Dogs in the United StatesVaccine typeCore vs. non-coreRecommended vaccination interval for administration of booster inoculations*Minimum* duration of immunityDistemper: modified live (parenteral)Core3 years5+ to 7+ years (depending on strain)Recombinant distemper (parenteral)Core3 years3 years+Distemper-measles: modified live (parenteral)Non-coreNot indicatedNot applicableParvovirus: modified live (parenteral)Core3 years7+ yearsParvovirus: killed (parenteral)Non-coreAnnual1 year (studies are not available)Coronavirus: modified live (parenteral)NRNot indicatedCannot be determinedCoronavirus: killed (parenteral)NRNot indicatedCannot be determinedCanine adenovirus-2: modified live (parenteral)Core3 years7+ yearsCanine adenovirus-2: modified live (topical)Core3 years7+ yearsCanine adenovirus-2: killed (parenteral)Non-coreAnnualUnknownCanine adenovirus-1: modified live & killed (parenteral)NRDO NOT USEUnknownParainfluenza virus: modified live (parenteral)Non-core3 years5 + yearsParainfluenza virus: modified live (topical)Non-core3 years5 + years (preferred)*Bordetella bronchiseptica*: killed (parenteral)Non-coreAnnual∼12 months*Bordetella bronchiseptica*: avirulent live (topical)Non-coreAnnual∼12 months*Bordetella bronchiseptica*: antigen extract (parenteral)Non-coreAnnual1 yearLeptospira *var. canicola*Non-coreAnnualNot definitively established (antibodyLeptospira *var. icterhemorrhagiae*Non-coreAnnualtiters persist for approximatelyLeptospira *var. pomona*Non-coreAnnual3 months in dogs that seroconvertLeptospira *var. grippotyphosa*Non-coreAnnualfollowing an initial vaccination series)Recombinant Lyme (parenteral)Non-coreAnnual1 yearLyme: killed (parenteral)Non-coreAnnual1 year*Crotalus atrox* (Rattlesnake vaccine)Non-coreAnnual or as recommended by manufacturer based on riskUnknown (license is conditional at this writing---challenge studies in dogs have not been performed)*Giardia lamblia*: killed (parenteral)NRNot applicableIs not known to prevent infectionRabies,1-year: killed (parenteral)CoreAs defined by local/state law3+ yearsRabies,3-year: killed (parenteral)CoreAs defined by local/state law3+ years[^11]

TABLE 6-17Types of Vaccines Licensed for Use in Cats in the United StatesVaccine typeAdjuvanted vs. non-adjuvantedCore vs. non-coreRecommended vaccination interval for administration of booster inoculationsMinimum duration of immunityPanleukopenia: modified live (parenteral)Non-adjuvantedCore3 years7+ yearsPanleukopenia: killed (parenteral)AdjuvantedNon-coreAnnual5+ yearsPanleukopenia: modified live (topical)Non-adjuvantNon-core3 yearsNot known to be more than 1 year...but is likelyHerpesvirus-calicivirus: modified live (parenteral)Non-adjuvantedCore3 years5+ yearsHerpesvirus-calicivirus: killed (parenteral)AdjuvantedNon-coreAnnual5+ yearsHerpesvirus-calicivirus: modified live (topical)Non-adjuvantedNon-coreAnnual (3 year duration of immunity is likely)Not known...but expected to be at least 2 years*Chlamydophilia felis*: killedAdjuvantedNon-coreAnnual1 year (maximum)*Chlamydophilia felis*: live, avirulentNon-adjuvantedNon-coreAnnualRecombinant feline leukemiaNon-adjuvantNon-core[\*](#cetablefn8){ref-type="table-fn"}Annual1 yearFeline leukemia virus: killedAdjuvantedNon-core[\*](#cetablefn8){ref-type="table-fn"}Annual1 yearFeline immunodeficiency virus: killedAdjuvantedNon-core[†](#cetablefn9){ref-type="table-fn"}Annual1 yearFeline infectious peritonitis: modified live (topical)Non-adjuvantedNRNot applicableDoes not confer protective immunity*Bordetella bronchiseptica*: modified live (topical)Non-adjuvantedNon-coreAnnual1 year*Giardia lamblia*: killed (parenteral)AdjuvantedNRNot applicableIs not known to prevent infection*Microsporum canis:* killedAdjuvantedVaccine has been discontinuedRecombinant rabies (parenteral)Non-adjuvantedCoreAnnual3 yearsRabies,1-year: killed (parenteral)AdjuvantedCoreAnnual3+ yearsRabies,3-year: killed (parenteral)AdjuvantedCore3 years (as required by law)3+ years[^12][^13]

TABLE 6-18Annualized Vaccination Protocol for Dogs at Moderate Risk[\*](#cetablefn10){ref-type="table-fn"}Age at vaccinationVaccine6--8 weeksDistemper (MLV or recombinant)ParvovirusAdenovirus-2*Optional*:+Parainfluenza virus10--12 weeksDistemper (MLV or recombinant)ParvovirusAdenovirus-2Rabies (1 dose at 12,14, or 16 weeks)[†](#cetablefn11){ref-type="table-fn"}*Optional*:+Parainfluenza virus+*B. bronchiseptica* (killed parenteral,2 doses required,3--4 weeks apart)[‡](#cetablefn12){ref-type="table-fn"}+Leptospirosis (serovars as indicated at 12 weeks or older)14--16 weeksDistemper (MLV or recombinant)ParvovirusAdenovirus-2Rabies (now or at 12 weeks)*Optional*:+Parainfluenza virus+*B. bronchiseptica* (Live-intranasal,1 dose or the 2nd killed-parenteral dose)+Leptospirosis (serovars as indicated)+1 yearDistemper (MLV or recombinant)ParvovirusAdenovirus-2Rabies (booster required)*Optional*:+*B. bronchiseptica* (intranasal or parenteral)+Parainfluenza+Leptospirosis (serovars as indicated)+2 years*Optional*:+*B. bronchiseptica* (intranasal or parenteral)+Leptospirosis (serovars as indicated)+3 years*Optional*:+*B. bronchiseptica* (intranasal or parenteral)+Leptospirosis (serovars as indicated)+4 yearsDistemper (MLV or recombinant)ParvovirusAdenovirus-2Rabies*Optional*:+*B. bronchiseptica* (parenteral)+Parainfluenza+Leptospirosis (serovars as indicated)+5 years*Optional*:+*B. bronchiseptica* (parenteral)+Leptospirosis (serovars as indicated)+6 years*Optional*:+*B. bronchiseptica* (parenteral)+Leptospirosis (serovars as indicated)+7 yearsDistemper (MLV or recombinant)ParvovirusAdenovirus-2Rabies*Optional*:+*B. bronchiseptica* (parenteral)+Parainfluenza+Leptospirosis (serovars as indicated)Beyond 7 yearsCycle repeats as indicated***Defining criteria for MODERATE RISK-canine (applies to most dogs)***1.*B. bronchiseptica* vaccination is indicated if:•Dog is ever boarded in a commercial kennel, or•Dog requires occasional grooming, or•Dog regularly has supervised walks/runs outside with likelihood of contact with other dogs.2.Parainfluenza vaccination is indicated if:•Dog is ever boarded in a commercial kennel, or•Dog requires occasional grooming, or•Dog regularly has supervised walks/runs outside with likelihood of contact with other dogs.•NOTE: Parainfluenza vaccine is combined with all intranasal *B. bronchiseptica vaccines.*3.*Leptospira* vaccination is indicated if:•The dog is 12 weeks of age or older, and•Dog has opportunities for unsupervised outdoor activities, or•Cases of leptospirosis are known to have been confirmed in the area, or•Dog has access (supervised or otherwise) to areas inhabited by "reservoir" hosts (eg: opossum, skunk, raccoon, vole) or other domestic animals such as cattle or pigs (horses).•NOTE: risk of exposure is *not* limited to rural areas.4.Lyme borreliosis vaccination is not indicated unless:•Dog will travel to known endemic areas (Northeastern US or upper Midwest) and will spend time outside, or•Lyme borreliosis cases have been diagnosed (via IDEXX Snap 3Dx or Western Blot analysis) in the community, or•Dog is not receiving any form of topical tick preventative (eg, fipronil).[^14][^15][^16][^17]

TABLE 6-19Annualized Vaccination Protocol for Dogs at Low Risk[\*](#cetablefn13){ref-type="table-fn"}Age at vaccinationVaccine6--8 weeksDistemper (MLV or recombinant)ParvovirusAdenovirus-2*Optional*:+Parainfluenza virus10--12 weeksDistemper (MLV or recombinant)ParvovirusAdenovirus-2Rabies (1 dose at 12,14, or 16 weeks)[†](#cetablefn14){ref-type="table-fn"}*Optional*:+Parainfluenza virus14--16 weeksDistemper (MLV or recombinant)ParvovirusAdenovirus-2Rabies (now or at 12 weeks)[‡](#cetablefn15){ref-type="table-fn"}*Optional*:+Parainfluenza virus+1 yearDistemper (MLV or recombinant)ParvovirusAdenovirus-2Rabies (required in most states)*Optional*:+Parainfluenza+2 yearsHealth examinationNon-core vaccines considered if risk assessment changesHealth examination+3 yearsNon-core vaccines considered if risk assessment changes+4 yearsDistemper (MLV or recombinant)ParvovirusAdenovirus-2Rabies (required in most states)*Optional:*+Parainfluenza+5 yearsHealth examinationNon-core vaccines considered if risk assessment changes+6 yearsHealth examinationNon-core vaccines considered if risk assessment changes+7 yearsDistemperParvovirusAdenovirus-2Rabies (required in most states)*Optional*:+ParainfluenzaBeyond 7 yearsCycle repeats as indicated***Defining criteria for LOW RISK-canine (only CORE vaccines need be administered)***1.*B. bronchiseptica* is NOT indicated because:•Dog is never boarded in a commercial kennel.•Grooming is not an issue.•Dog lives exclusively indoors.•Dog has no exposure to other dogs (does occur...but is rare)2.Parainfluenza vaccination is indicated if:•Dog is ever boarded in a commercial kennel, or•Dog requires occasional grooming, or•Dog regularly has supervised walks/runs outside with likelihood of contact with other dogs.•NOTE: Parainfluenza vaccine is combined with all intranasal *B. bronchiseptica vaccines.*3.*Leptospira canicola, L. icterohemorrhagiae, L. pomona, and L. grippotyphosa* are NOT indicated because:•There is NO exposure to other dogs.•There is NO opportunity for unsupervised outdoor activities.•The dog lives exclusively indoors.•Leptospirosis is not known to occur in the area.**3. Lyme borreliosis is NOT indicated because**:•Dog does not reside in a known Lyme borreliosis endemic area.•Dog does not travel to known endemic areas.•Dog neither lives in or travels into a known tick-vector area.•Dog is reliably treated with topical flea/tick preparation.•Dog has never known a tick and never will.[^18][^19][^20][^21]

TABLE 6-20Annualized Vaccination Protocol for Dogs at High Risk[\*](#cetablefn16){ref-type="table-fn"}Age at vaccinationVaccine6--8 weeksDistemper (recombinant)ParvovirusAdenovirus-2Parainfluenza*B. bronchiseptica* \[intranasal recommended\][†](#cetablefn17){ref-type="table-fn"}10--12 weeksDistemper (recombinant)ParvovirusAdenovirus-2ParainfluenzaRabies (at 12,14, or 16 weeks)[‡](#cetablefn18){ref-type="table-fn"}*B. bronchiseptica* \[*intranasal* recommended\]*Optional*:+Leptospirosis+Lyme borreliosis (recombinant)14--16 weeksDistemper (recombinant)ParvovirusAdenovirus-2Parainfluenza*B. bronchiseptica* \[intranasal recommended\]Rabies (now or at 12 weeks)*Optional*:+Leptospirosis+Lyme borreliosis (recombinant)+1 yearDistemper (MLV or recombinant)ParvovirusAdenovirus-2Parainfluenza*B. bronchiseptica* (intranasal or parenteral)Rabies (required)*Optional*:+Leptospirosis+Lyme borreliosis (recombinant)+2 years*B. bronchiseptica* (intranasal or parenteral)*Optional*:+Leptospirosis+Lyme borreliosis (recombinant)+3 years*B. bronchiseptica* (intranasal or parenteral)*Optional*:+Leptospirosis+Lyme borreliosis (recombinant)+4 yearsDistemper (MLV or recombinant)ParvovirusAdenovirus-2Parainfluenza*B. bronchiseptica* (intranasal or parenteral)Rabies (required)*Optional*:+Leptospirosis+Lyme borreliosis (recombinant)+5 years*B. bronchiseptica* (intranasal or parenteral)*Optional*:+Leptospirosis+Lyme borreliosis (recombinant)+6 years*B. bronchiseptica* (intranasal or parenteral)*Optional*:+Leptospirosis+Lyme borreliosis (recombinant)+7 yearsDistemper (MLV or recombinant)ParvovirusAdenovirus-2Parainfluenza*B. bronchiseptica* (intranasal or parenteral)Rabies (required)*Optional*:+Leptospirosis+Lyme borreliosis (recombinant)Beyond 7 yearsCycle repeats as indicated***Defining criteria for HIGH RISK-canine*1. *B. bronchiseptica* booster is indicated because:** •Dog is regularly boarded in a commercial kennel.•Dog is routinely groomed at a facility where other dogs are maintained.•Dog is regularly allowed outdoors and is unsupervised.•Dog has regular exposure to other, unknown dogs.•Dog is on a first-name basis with animal control officers.**2. Annual *Leptospira* spp booster is indicated if:** •Dog lives outside and is not constrained to a gated kennel.•Dog lives on a farm and has ample outdoor activity.•Dog is regularly allowed to roam freely.•Dog is exclusively outdoors.•Dog is used for hunting or other extended outdoor activity.•Cases of leptospirosis are known to have been confirmed in the area.•Dog has access (supervised or otherwise) to areas inhabited by "reservior" hosts (e.g., opossum, skunk, raccoon, vole) or other domestic animals such as cattle or pigs (horses?).**3. Annual Lyme borreliosis booster is indicated if:** •Dog resides in a known Lyme borreliosis endemic area (eg: Northeastern US or Upper Midwest).•Dog resides outside most or all of the time and does have tick exposure.•Dog regularly travels to known endemic areas.•Cases of Lyme borreliosis have been identified by serologic testing (IDEXX Snap 3Dx orWestern Blot) among dogs in the patient population.•Dog is inconsistently treated with topical flea/tick preparation.•Dog is only treated with OTC tick preparations.•Ticks are known to be constant companions for this dog.[^22][^23][^24]

TABLE 6-21Annualized Vaccination Protocol for Cats at Moderate Risk[\*](#cetablefn19){ref-type="table-fn"}Age at vaccinationVaccine9--10 weeksPanleukopenia (MLV)Herpesvirus-1 and calicivirus (MLV)*Optional*:+FeLV (recombinant, transdermal)12--14 weeksPanleukopenia (MLV)Herpesvirus-1 and calicivirus (MLV)+Rabies (recombinant)[†](#cetablefn20){ref-type="table-fn"}*Optional*:+FeLV (recombinant, transdermal)+1 yearPanleukopenia (MLV)Herpesvirus-1 and calicivirus (MLV)+ Rabies (recombinant)*Optional*:+ FeLV (recombinant, transdermal)+2 years+ Rabies (recombinant, transdermal)+3 years+ Rabies (recombinant)Panleukopenia (MLV)+4 yearsHerpesvirus-1 and calicivirus (MLV)+ Rabies (recombinant)+5 years+ Rabies (recombinant)+6 years+ Rabies (recombinant)Panleukopenia (MLV)+7 yearsHerpesvirus-1 and calicivirus (MLV)+ Rabies (recombinant)+8 years+ Rabies (recombinant)+9 years+ Rabies (recombinant)+10 yearsPanleukopenia (MLV)Herpesvirus-1 and calicivirus (MLV)+ Rabies (recombinant)Beyond 10 yearsCycle repeats as indicated***Defining criteria for MODERATE RISK-feline (applies to most cats)*1. FeLV vaccine is indicated if:** •The cat lives indoors predominantly, but *not* exclusively ... *and*•The cat is less than 6 months of age ... *and*•The cat is known to occasionally have contact with other cats of unknown health status ... *or*•Other cats in the household are known to be FeLV infected•Other cats live in the household but are of unknown FeLV status ... *or*•Other cats in the household are known to roam at will, or•Owner may bring stray cats into the houshold.**2. *Bordetella bronchiseptica* and *Chlamydophila felis* vaccines are not indicated because:** •The cat is an adult (current literature suggests that clinical *B. bronchiseptica* infections are most likely to occur in kittens), *... and*•The cat does not have exposure to other cats, *... and*•Any other cats in the household are known to be strictly indoor cats *... and*•Owner is unlikely to bring stray cats into the household.**3. Rabies vaccination in cats** •Is NOT required by many states and municipalities;however, in accordance with the Feline Vaccination Guidelines, rabies is a CORE vaccine and is highly recommended for all cats.[^25][^26][^27]

TABLE 6-22Annualized Vaccination Protocol for Cats at Low Risk[\*](#cetablefn21){ref-type="table-fn"}Age at vaccinationVaccine9--10 weeksPanleukopenia (MLV)Herpesvirus-1 and calicivirus (MLV)12--14 weeksPanleukopenia (MLV)Herpesvirus and calicivirus (MLV)+ Rabies (recombinant)[†](#cetablefn22){ref-type="table-fn"}+ 1 yearPanleukopenia (MLV)Herpesvirus-1 and calicivirus (MLV)+ Rabies (recombinant)+ 2 years+ Rabies (recombinant)+ 3 years+ Rabies (recombinant)+ 4 yearsPanleukopenia (MLV)Herpesvirus-1 and calicivirus (MLV)+ Rabies (recombinant)+ 5 years+ Rabies (recombinant)+ 6 years+ Rabies (recombinant)+ 7 yearsPanleukopenia (MLV)Herpesvirus-1 and calicivirus (MLV)+ Rabies (recombinant)+ 8 years+ Rabies (recombinant)+ 9 years+ Rabies (recombinant)+ 10 yearsPanleukopenia (MLV)Herpesvirus-1 and calicivirus (MLV)+ Rabies (recombinant)Beyond 10 yearsCycle repeats as indicated***Defining criteria for low risk-feline (protocol centers around CORE vaccines)*1. FeLV and FIV vaccines are not indicated because:** •Cat is known to be a strictly indoor cat, *and*•Any other cats in the household are known to be both FeLV and FIV-free and were tested within the last 12 months, *and*•Other cats in the household are known to be strictly indoor cats.•Owner does not bring stray cats into the household.**2. *Bordetella bronchiseptica* and *Chlamydophila felis* vaccines are not indicated because:** •The cat is an adult (current literature suggests that clinical *B. bronchiseptica* infections are most likely to occur in kittens), *and*•The cat does not have exposure to other cats, *and*•Any other cats in the household are known to be strictly indoor cats.•Owner does not bring stray cats into the household.**3. Rabies vaccination in cats** •Is NOT required by many states and municipalities; however, in accordance with the Feline Vaccination Guidelines, rabies is a CORE vaccine and is highly recommended for all cats.[^28][^29][^30]

TABLE 6-23Annualized Vaccination Protocol for Cats at High Risk[\*](#cetablefn23){ref-type="table-fn"}Age at vaccinationVaccine9--10 weeksPanleukopenia (MLV)Herpesvirus-1 and calicivirus (MLV)*Optional*:MOPEPOΩΣ+ FeLV (recombinant, transdermal)+ *B. bronchiseptica*+ *Chlamydophila* (non-adjuvanted)[†](#cetablefn24){ref-type="table-fn"}+ FIV12--14 weeksPanleukopenia (MLV)Herpesvirus-1 and calicivirus (MLV)+ Rabies (recombinant)[‡](#cetablefn25){ref-type="table-fn"}*Optional*:+ FeLV (non-adjuvanted)+ *B. bronchiseptica*+ *Chlamydophila* (non-adjuvanted)+ FIV+ 1 yearPanleukopenia (MLV)Herpesvirus-1 and calicivirus (MLV)+ Rabies (recombinant)*Optional*:+ FeLV (recombinant, transdermal)+ *B. bronchiseptica*+ *Chlamydophila* (non-adjuvanted)+ FIV+ 2 years+ Rabies (recombinant)*Optional*:+ FeLV (recombinant, transdermal)+ *B. bronchiseptica*+ *Chlamydophila* (non-adjuvanted)+ FIV+ 3 years+ Rabies (recombinant)*Optional*:+ FeLV (recombinant, transdermal)+ *B. bronchiseptica*+ *Chlamydophila* (non-adjuvanted)+ FIV+ 4 yearsPanleukopenia (MLV)Herpesvirus-1 and calicivirus (MLV)+ Rabies (recombinant)*Optional*:+ FeLV (recombinant, transdermal)+ *B. bronchiseptica*+ *Chlamydophila* (non-adjuvanted)+ FIV+ 5 years+ Rabies (recombinant)*Optional*:+ FeLV (recombinant, transdermal)+ *B. bronchiseptica*+ *Chlamydophila* (non-adjuvanted)+ FIV+ 6 years+ Rabies (recombinant)*Optional*:+ FeLV (recombinant, transdermal)+ *B. bronchiseptica*+ *Chlamydophila* (non-adjuvanted)+ FIV+ 7 yearsPanleukopenia (MLV)Herpesvirus-1 and calicivirus (MLV)+ Rabies (recombinant)*Optional*:+ FeLV (recombinant, transdermal)+ *B. bronchiseptica*+ *Chlamydophila* (non-adjuvanted)+ FIV+ 8 years+ Rabies (recombinant)*Optional*:+ FeLV (recombinant, transdermal)+ *B. bronchiseptica*+ *Chlamydophila* (non-adjuvanted)+ FIV+ 9 years+ Rabies (recombinant)*Optional*:+ FeLV (recombinant, transdermal)+ *B. bronchiseptica*+ *Chlamydophila* (non-adjuvanted)+ FIV+ 10 yearsPanleukopenia (MLV)Herpesvirus-1 and calicivirus (MLV)+ Rabies (recombinant)*Optional*:+ FeLV (recombinant, transdermal)+ *B. bronchiseptica*+ *Chlamydophila* (non-adjuvanted)+ FIVBeyond 10 yearsCycle repeats as indicated***Defining criteria for HIGH RISK-feline*1. Both FeLV and FIV vaccines are indicated because:** •Cat is known to roam at will and engage in fighting (risk of FIV in male cats is 4X greater than in female cats), *or*•There is likely exposure to other cats with unknown health status, or•There are other cats in the household that are known to roam at will and engage in fighting...*or*•Owner regularly adopts (or hoards) cats.**2. *Bordetella bronchiseptica* and *Chlamydophila felis* vaccines are indicated because:** •The cat is a kitten and resides within a cluster household (current literature suggests that clinical *B. bronchiseptica* infections are most likely to occur in kittens), *or*•The cat has regular exposure to other cats of unknown health status, *or*•There are other cats in the household known to roam at will and have contact with other cats ... *or*•Owner regularly adopts (or hoards) cats.**3. Rabies vaccination in cats:** •Is NOT required by many states and municipalities; however, in accordance with the Feline Vaccination Guidelines, rabies is a CORE vaccine and is highly recommended for all cats.[^31][^32][^33][^34]

TABLE 6-24Compendium of Animal Rabies Prevention and Control, 2005\*\*The material in this report originated at the National Center for Infectious Diseases (Anne Schuchat, MD, Acting Director), and the Division of Viral and Rickettsial Diseases (James W. LeDuc, PhD, Director)., National Association of State Public Health Veterinarians, Inc. (NASPHV)††The NASPHV Committee: Suzanne R. Jenkins, VMD, MPH, Co-Chair; Mira J. Leslie, DVM, MPH, Co-Chair; Michael Auslander, DVM, MSPH; Lisa Conti, DVM, MPH; Paul Ettestad, DVM, MS; Faye E. Sorhage, VMD, MPH; and Ben Sun, DVM, MPVM.Consultants to the Committee: Donna M. Gatewood, DVM, MS, Center for Veterinary Biologics, U.S. Department of Agriculture (USDA); Ellen Mangione, MD, MPH, Council of State and Territorial Epidemiologists (CSTE); Lorraine Moule, National Animal Control Association (NACA); Greg Pruitt, Animal Health Institute; Charles E. Rupprecht, VMD, MS, PhD, CDC; John Schiltz, DVM, American Veterinary Medical Association (AVMA); Charles V. Trimarchi, MS, New York State Health Department; and Dennis Slate, PhD, Wildlife Services, USDA.This compendium has been endorsed by AVMA, CDC, CSTE, and NACA. Corresponding author: Mira J. Leslie, DVM, MPH, Washington Department of Health, Communicable Disease Epidemiology, 1610 NE 150th Street, MS K17-9, Shoreline, WA 98155-9701.Rabies is a fatal viral zoonosis and a serious public health problem.[@bib1] The recommendations in this compendium serve as the basis for animal rabies prevention and control programs throughout the United States and facilitate standardization of procedures among jurisdictions, thereby contributing to an effective national rabies-control program. This document is reviewed annually and revised as necessary. Principles of rabies prevention and control are detailed in Part I; Part II contains recommendations for parenteral vaccination procedures. All animal rabies vaccines licensed by the United States Department of Agriculture (USDA) and marketed in the United States are listed in Part III.Part I: Rabies prevention and controlA.*Principles of rabies prevention and control* 1.**Rabies exposure.** Rabies is transmitted only when the virus is introduced into bite wounds, open cuts in skin, or onto mucous membranes from saliva or other potentially infectious material such as neural tissue.[@bib2] Questions about possible exposures should be directed to state or local health authorities.2.**Human rabies prevention.** Rabies in humans can be prevented either by eliminating exposures to rabid animals or by providing exposed persons with prompt local treatment of wounds combined with the administration of human rabies immune globulin and vaccine. The rationale for recommending preexposure and postexposure rabies prophylaxis and details of their administration can be found in the current recommendations of the Advisory Committee on Immunization Practices (ACIP).[@bib2] These recommendations, along with information concerning the current local and regional epidemiology of animal rabies and the availability of human rabies biologics, are available from state health departments.3.**Domestic animals.** Local governments should initiate and maintain effective programs to ensure vaccination of all dogs, cats, and ferrets and to remove strays and unwanted animals. Such procedures in the United States have reduced laboratory-confirmed cases of rabies in dogs from 6949 in 1947 to 117 in 2003.[@bib3] Because more rabies cases are reported annually involving cats (321 in 2003) than dogs, vaccination of cats should be required. Animal shelters and animal control authorities should establish policies to ensure that adopted animals are vaccinated against rabies. The recommended vaccination procedures and the licensed animal vaccines are specified in Parts II and III of the compendium.4.**Rabies in vaccinated animals.** Rabies is rare in vaccinated animals.[@bib4] If such an event is suspected, it should be reported to state public health officials; the vaccine manufacturer; and USDA, Animal and Plant Health Inspection Service, Center for Veterinary Biologics (Internet: <http://www.aphis.usda.gov/vs/cvb/ic/adverseeventreport.htm>, telephone: 800-752-6255, or e-mail: <CVB@usda.gov>). The laboratory diagnosis should be confirmed and the virus characterized by a rabies reference laboratory. A thorough epidemiologic investigation should be conducted.5.**Rabies in wildlife.** The control of rabies among wildlife reservoirs is difficult.[@bib5] Vaccination of free-ranging wildlife or selective population reduction might be useful in some situations, but the success of such procedures depends on the circumstances surrounding each rabies outbreak (see Part I. C. Control Methods in Wildlife). Because of the risk of rabies in wild animals (especially raccoons, skunks, coyotes, foxes, and bats), AVMA, NASPHV, and CSTE strongly recommend the enactment and enforcement of state laws prohibiting their importation, distribution, and relocation.6.**Rabies surveillance.** Laboratory-based rabies surveillance is an essential component of rabies control and prevention programs. Accurate and timely information is necessary to guide human postexposure prophylaxis decisions, determine the management of potentially exposed animals, aid in emerging pathogen discovery, describe the epidemiology of the disease, and assess the need for and effectiveness of oral vaccination programs for wildlife.7.**Rabies diagnosis.** Rabies testing should be performed by a qualified laboratory that has been designated by the local or state health department[@bib6] in accordance with the established national standardized protocol for rabies testing (<http://www.cdc.gov/ncidod/dvrd/rabies/Professional/publications/DFA_diagnosis/DFA_protocol-b.htm>). Euthanasia[@bib7] should be accomplished in such a way as to maintain the integrity of the brain so that the laboratory can recognize the anatomic parts. Except in the case of very small animals, such as bats, only the head or brain (including brainstem) should be submitted to the laboratory. Any animal or animal specimen being submitted for testing should be kept under refrigeration (not frozen or chemically fixed) during storage and shipping.8.**Rabies serology.** Some "rabies-free" jurisdictions may require evidence of vaccination and rabies antibodies for importation purposes. Rabies antibody titers are indicative of an animal\'s response to vaccine or infection. Titers do not directly correlate with protection because other immunologic factors also play a role in preventing rabies, and our abilities to measure and interpret those other factors are not well developed. Therefore, evidence of circulating rabies virus antibodies should not be used as a substitute for current vaccination in managing rabies exposures or determining the need for booster vaccinations in animals.[@bib8]B.*Prevention and control methods in domestic and confined animals* 1.**Preexposure vaccination and management.** Parenteral animal rabies vaccines should be administered only by or under the direct supervision of a veterinarian. Rabies vaccinations may also be administered under the supervision of a veterinarian to animals held in animal control shelters prior to release. Any veterinarian signing a rabies certificate must ensure that the person administering vaccine is identified on the certificate and is appropriately trained in vaccine storage, handling, and administration and in the management of adverse events. This practice ensures that a qualified and responsible person can be held accountable to ensure that the animal has been properly vaccinated.Within 28 days after primary vaccination, a peak rabies antibody titer is reached and the animal can be considered immunized. An animal is currently vaccinated and is considered immunized if the primary vaccination was administered at least 28 days previously and vaccinations have been administered in accordance with this compendium.Regardless of the age of the animal at initial vaccination, a booster vaccination should be administered 1 year later (see Parts II and III for vaccines and procedures). No laboratory or epidemiologic data exist to support the annual or biennial administration of 3-year vaccines following the initial series. Because a rapid anamnestic response is expected, an animal is considered currently vaccinated immediately after a booster vaccination.a.**Dogs, cats, and ferrets.** All dogs, cats, and ferrets should be vaccinated against rabies and revaccinated in accordance with Part III of this compendium. If a previously vaccinated animal is overdue for a booster, it should be revaccinated. Immediately following the booster, the animal is considered currently vaccinated and should be placed on an annual or triennial schedule depending on the type of vaccine used.b.**Livestock.** Consideration should be given to vaccinating livestock that are particularly valuable or that might have frequent contact with humans (e.g., in petting zoos, fairs, and other public exhibitions).[@bib9], [@bib10] Horses traveling interstate should be currently vaccinated against rabies.c.**Confined animals.** 1)**Wild.** No parenteral rabies vaccines are licensed for use in wild animals or hybrids (the offspring of wild animals crossbred to domestic animals). Wild animals or hybrids should not be kept as pets.[@bib11], [@bib12], [@bib13], [@bib14]2)**Maintained in exhibits and in zoological parks.** Captive mammals that are not completely excluded from all contact with rabies vectors can become infected. Moreover, wild animals might be incubating rabies when initially captured; therefore, wild-caught animals susceptible to rabies should be quarantined for a minimum of 6 months before being exhibited. Employees who work with animals at such facilities should receive preexposure rabies vaccination. The use of pre- or postexposure rabies vaccinations for employees who work with animals at such facilities might reduce the need for euthanasia of captive animals. Carnivores and bats should be housed in a manner that precludes direct contact with the public.3)**Stray animals.** Stray dogs, cats, and ferrets should be removed from the community. Local health departments and animal control officials can enforce the removal of strays more effectively if owned animals have identification and are confined or kept on leash. Strays should be impounded for at least 3 business days to determine if human exposure has occurred and to give owners sufficient time to reclaim animals.2.**Importation and interstate movement of animals.** a.**International.** The CDC regulates the importation of dogs and cats into the United States. Importers of dogs must comply with rabies vaccination requirements (42 CFR, Part 71.51\[c\] \[<http://www.cdc.gov/ncidod/dq/animal.htm>\]) and complete CDC form 75.37 (<http://www.cdc.gov/ncidod/dq/pdf/cdc7537-05-24-04.pdf>). The appropriate health official of the state of destination should be notified within 72 hours of the arrival into his or her jurisdiction of any imported dog required to be placed in confinement under the CDC regulation. Failure to comply with these requirements should be promptly reported to the Division of Global Migration and Quarantine, CDC (telephone: 404-498-1670).Federal regulations alone are insufficient to prevent the introduction of rabid animals into the country.[@bib15], [@bib16] All imported dogs and cats are subject to state and local laws governing rabies and should be currently vaccinated against rabies in accordance with this compendium. Failure to comply with state or local requirements should be referred to the appropriate state or local official.b.**Interstate.** Before interstate (including commonwealths and territories) movement, dogs, cats, ferrets, and horses should be currently vaccinated against rabies in accordance with the compendium\'s recommendations (see Part I. B.1. Preexposure Vaccination and Management). Animals in transit should be accompanied by a currently valid NASPHV Form 51, Rabies Vaccination Certificate (<http://www.nasphv.org/83416/106001.html>). When an interstate health certificate or certificate of veterinary inspection is required, it should contain the same rabies vaccination information as Form 51.c.**Areas with dog-to-dog rabies transmission.** The movement of dogs from areas with dog-to-dog rabies transmission for the purpose of adoption or sale should be eliminated. Rabid dogs have been introduced into the United States from areas with dog-to-dog rabies transmission.[@bib15], [@bib16] This practice poses the risk of introducing canine-transmitted rabies to areas where it does not currently exist.3.**Adjunct procedures.** Methods or procedures which enhance rabies control include the following:a.**Identification.** Dogs, cats, and ferrets should be identified (e.g., metal or plastic tags or microchips) to allow for verification of rabies vaccination status.b.**Licensure.** Registration or licensure of all dogs, cats, and ferrets may be used to aid in rabies control. A fee is frequently charged for such licensure, and revenues collected are used to maintain rabies- or animal-control programs. Evidence of current vaccination is an essential prerequisite to licensure.c.**Canvassing.** House-to-house canvassing by animal control officials facilitates enforcement of vaccination and licensure requirements.d.**Citations.** Citations are legal summonses issued to owners for violations, including the failure to vaccinate or license their animals. The authority for officers to issue citations should be an integral part of each animal-control program.e.**Animal control.** All communities should incorporate stray animal control, leash laws, and training of personnel in their programs.4.**Postexposure management.** Any animal potentially exposed to rabies virus (see Part I. A.1. Rabies Exposure) by a wild, carnivorous mammal or a bat that is not available for testing should be regarded as having been exposed to rabies.a.**Dogs, cats, and ferrets.** Unvaccinated dogs, cats, and ferrets exposed to a rabid animal should be euthanized immediately. If the owner is unwilling to have this done, the animal should be placed in strict isolation for 6 months. Rabies vaccine should be administered upon entry into isolation or 1 month prior to release to comply with preexposure vaccination recommendations (see Part I.B.1.a.). Protocols for the postexposure vaccination of previously unvaccinated domestic animals have not been validated, and evidence exists that the use of vaccine alone will not prevent the disease.[@bib17] Animals with expired vaccinations need to be evaluated on a case-by-case basis. Dogs, cats, and ferrets that are currently vaccinated should be revaccinated immediately, kept under the owner\'s control, and observed for 45 days. Any illness in an isolated or confined animal should be reported immediately to the local health department.b.**Livestock.** All species of livestock are susceptible to rabies; cattle and horses are among the most frequently infected. Livestock exposed to a rabid animal and currently vaccinated with a vaccine approved by USDA for that species should be revaccinated immediately and observed for 45 days. Unvaccinated livestock should be slaughtered immediately. If the owner is unwilling to have this done, the animal should be kept under close observation for 6 months. Any illness in an animal under observation should be reported immediately to the local health department.The following are recommendations for owners of livestock exposed to rabid animals:1)If the animal is slaughtered within 7 days of being bitten, its tissues may be eaten without risk of infection, provided that liberal portions of the exposed area are discarded. Federal guidelines for meat inspectors require that any animal known to have been exposed to rabies within 8 months be rejected for slaughter.2)Neither tissues nor milk from a rabid animal should be used for human or animal consumption.[@bib18] Pasteurization temperatures will inactivate rabies virus; therefore, drinking pasteurized milk or eating cooked meat does not constitute a rabies exposure.3)Having more than one rabid animal in a herd or having herbivore-to-herbivore transmission is uncommon; therefore, restricting the rest of the herd if a single animal has been exposed to or infected by rabies might not be necessary.c.**Other animals.** Other mammals bitten by a rabid animal should be euthanized immediately. Animals maintained in USDA-licensed research facilities or accredited zoological parks should be evaluated on a case-by-case basis.5.**Management of animals that bite humans** a.**Dogs, cats, and ferrets.** Rabies virus may be excreted in the saliva of infected dogs, cats, and ferrets during illness and/or for only a few days prior to illness or death.[@bib19], [@bib20], [@bib21] A healthy dog, cat, or ferret that bites a person should be confined and observed daily for 10 days[@bib22]; administration of rabies vaccine to the animal is not recommended during the observation period to avoid confusing signs of rabies with possible side effects of vaccine administration.Such animals should be evaluated by a veterinarian at the first sign of illness during confinement. Any illness in the animal should be reported immediately to the local health department. If signs suggestive of rabies develop, the animal should be euthanized and the head shipped for testing as described in Part I.A.7. Any stray or unwanted dog, cat, or ferret that bites a person may be euthanized immediately and the head submitted for rabies examination.b.**Other biting animals.** Other biting animals that might have exposed a person to rabies should be reported immediately to the local health department. Management of animals other than dogs, cats, and ferrets depends on the species, the circumstances of the bite, the epidemiology of rabies in the area, and the biting animal\'s history, current health status, and potential for exposure to rabies. Prior vaccination of these animals may not preclude the necessity for euthanasia and testing.C.*Prevention and control methods related to wildlife*The public should be warned not to handle or feed wild mammals. Wild mammals and hybrids that bite or otherwise expose persons, pets, or livestock should be considered for euthanasia and rabies examination. A person bitten by any wild mammal should immediately report the incident to a physician who can evaluate the need for antirabies treatment (see current rabies prophylaxis recommendations of the ACIP[@bib2]). State-regulated wildlife rehabilitators may play a role in a comprehensive rabies control program. Minimum standards for persons who rehabilitate wild mammals should include rabies vaccination, appropriate training, and continuing education. Translocation of infected wildlife has contributed to the spread of rabies[@bib23], [@bib24]; therefore, the translocation of known terrestrial rabies reservoir species should be prohibited.1.**Terrestrial mammals.** The use of licensed oral vaccines for the mass vaccination of free-ranging wildlife should be considered in selected situations, with the approval of the state agency responsible for animal rabies control.[@bib5] The distribution of oral rabies vaccine should be based on scientific assessments of the target species and followed by timely and appropriate analysis of surveillance data; such results should be provided to all stakeholders. In addition, parenteral vaccination (trap-vaccinate-release) of wildlife rabies reservoirs may be integrated into coordinated oral rabies vaccination programs to enhance their effectiveness. Continuous and persistent programs for trapping or poisoning wildlife are not effective in reducing wildlife rabies reservoirs on a statewide basis. However, limited population control in high-contact areas (e.g., picnic grounds, camps, suburban areas) may be indicated for the removal of selected high-risk species of wildlife.[@bib5] State agriculture, public health, and wildlife agencies should be consulted for planning, coordination, and evaluation of vaccination or population-reduction programs.2.**Bats.** Indigenous rabid bats have been reported from every state except Hawaii and have caused rabies in at least 40 humans in the United States.[@bib25], [@bib26], [@bib27], [@bib28], [@bib29] Bats should be excluded from houses, public buildings, and adjacent structures to prevent direct association with humans.[@bib30], [@bib31] Such structures should then be made bat-proof by sealing entrances used by bats. Controlling rabies in bats through programs designed to reduce bat populations is neither feasible nor desirable.Part II: Recommendations for parenteral rabies vaccination proceduresA.*Vaccine administration*All animal rabies vaccines should be restricted to use by, or under the direct supervision of a veterinarian[@bib32] except as recommended in Part I.B.1. All vaccines must be administered in accordance with the specifications of the product label or package insert.B.*Vaccine selection*Part III lists all vaccines licensed by USDA and marketed in the United States at the time of publication. New vaccine approvals or changes in label specifications made subsequent to publication should be considered as part of this list. Any of the listed vaccines can be used for revaccination, even if the product is not the same brand previously administered. Vaccines used in state and local rabies control programs should have a 3-year duration of immunity. This constitutes the most effective method of increasing the proportion of immunized dogs and cats in any population.[@bib33] No laboratory or epidemiologic data exist to support the annual or biennial administration of 3-year vaccines following the initial series.C.*Adverse events*Currently, no epidemiologic association exists between a particular licensed vaccine product and adverse events, including vaccine failure.[@bib34], [@bib35] Adverse events should be reported to the vaccine manufacturer and to USDA, Animal and Plant Health Inspection Service, Center for Veterinary Biologics (Internet: <http://www.aphis.usda.gov/vs/cvb/ic/adverseeventreport.htm>; telephone: 800-752-6255; or e-mail: <CVB@usda.gov>).D.*Wildlife and hybrid animal vaccination*The safety and efficacy of parenteral rabies vaccination of wildlife and hybrids have not been established, and no rabies vaccines are licensed for these animals. Parenteral vaccination (trap-vaccinate-release) of wildlife rabies reservoirs may be integrated into coordinated oral rabies vaccination programs as described in Part I. C.1. to enhance their effectiveness. Zoos or research institutions may establish vaccination programs, which attempt to protect valuable animals, but these should not replace appropriate public health activities that protect humans.[@bib9]E.*Accidental human exposure to vaccine*Human exposure to parenteral animal rabies vaccines listed in Part III does not constitute a risk for rabies infection. However, human exposure to vaccinia-vectored oral rabies vaccines should be reported to state health officials.[@bib36]F.*Rabies certificate*All agencies and veterinarians should use NASPHV Form 51, Rabies Vaccination Certificate, which can be obtained from vaccine manufacturers or from NASPHV(<http://www.nasphv.org>). It is also available from CDC (<http://www.cdc.gov/ncidod/dvrd/rabies/professional/professi.htm>). The form must be completed in full and signed by the administering or supervising veterinarian. Computer-generated forms containing the same information are also acceptable.***Rabies vaccines licensed and marketed in the United States, 2005*Product nameProduced byMarketed byFor use inDosage (mL)Age at primary vaccination**[\*](#cetablefn26){ref-type="table-fn"}**Booster recommendedRoute of inoculation*MONOVALENT (inactivated)***Defensor 1Pfizer, Inc.Pfizer, Inc.Dogs13 mos[†](#cetablefn27){ref-type="table-fn"}AnnuallyIM[‡](#cetablefn28){ref-type="table-fn"} or SC[§](#cetablefn29){ref-type="table-fn"}License No.189Cats13 mosAnnuallySCDefensor 3Pfizer, Inc.Pfizer, Inc.Dogs13 mos1 year later and trienniallyIM or SCLicense No.189Cats13 mos1 year later and trienniallySCSheep23 mosAnnuallyIMCattle23 mosAnnuallyIMRabdomunPfizer, Inc.Schering-PloughDogs13 mos1 year later and trienniallyIM or SCLicense No.189Cats13 mos1 year later and trienniallySCSheep23 mosAnnuallyIMCattle23 mosAnnuallyIMRabdomun 1Pfizer, Inc.Schering-PloughDogs13 mosAnnuallyIM or SCLicense No.189Cats13 mosAnnuallySCRabvac 1Fort DodgeFort DodgeDogs13 mosAnnuallyIM or SCAnimal HealthAnimal HealthCats13 mosAnnuallySCLicence No.112Rabvac 3Fort DodgeFort DodgeDogs13 mos1 year later and trienniallyIM or SCAnimal HealthAnimal HealthCats13 mos1 year later and trienniallyIM or SCLicense No.112Horses23 mosAnnuallyIMRabvac 3 TFFort DodgeFort DodgeDogs13 mos1 year later and trienniallyIM or SCAnimal HealthAnimal HealthCats13 mos1 year later and trienniallyIM or SCLicense No.112Horses23 mosAnnuallyIMProrab-1I ntervet, Inc.Intervet, IncDogs13 mosAnnuallyIM or SCLicense No.286Cats13 mosAnnuallyIM or SCSheep23 mosAnnuallyIMProrab-3FIntervet, Inc.Intervet, Inc.Cats13 mos1 year later and trienniallyIM or SCLicense No.286Imrab 3Merial, Inc.Merial, Inc.Dogs13 mos1 year later and trienniallyIM or SCLicense No.298Cats13 mos1 year later and trienniallyIM or SCSheep23 mos1 year later and trienniallyIM or SCCattle23 mosAnnuallyIM or SCHorses23 mosAnnuallyIM or SCFerrets13 mosAnnuallySCImrab 3 TFMerial, Inc.Merial, Inc.Dogs13 mos1 year later or trienniallyIM or SCLicense No.298Cats13 mos1 year later or trienniallyIM or SCFerrets13 mosAnnuallySCImrab LargeMerial, Inc.Merial, Inc.Cattle23 mosAnnuallyIM or SCAnimalLicence No.298Horses23 mosAnnuallyIM or SCSheep23 mos1 year later or trienniallyIM or SCImrab 1Merial, Inc.Merial, Inc.Dogs13 mosAnnuallySCLicense No.298Cats13 mosAnnuallySC***Monovalent (Rabies glycoprotein, live canary pox vector)***Purevax felineMerial, Inc.Merial, Inc.Cats18 wksAnnuallySCRabiesLicence No.298***Combination (Inactivated rabies)***Equine PotomavacMerial, Inc.Merial, Inc.Horses13 mosAnnuallyIM+ ImrabLicense No.298Mystique 11Intervet, Inc.Intervet, Inc.Horses13 mosAnnuallyIMPotomavac +License No.286***Combination (Rabies glycoprotein, live canary pox vector)***Purevax felineMerial, Inc.Cats18 wksAnnuallySC3/RabiesLicense No.298Purevax FelineMerial, Inc.Merial, Inc.Cat18 wksAnnuallySC4/RabiesLicence No.298***Oral (Rabies glycoprotein, live vaccinia vector)- RESTRICTED TO USE IN STATE AND FEDERAL RABIES-CONTROL PROGRAMS***Raboral V-RGMerial, Inc.Merial, Inc.RacoonsN/AN/AAG determined by local authoritiesOralLicence No.298Goyotes[^35][^36][^37][^38]

TABLE 6-25Prescription Writing Reference ... Do\'s & Don'tsVeterinarian informationOwner information***Always include:***Prescribing veterinarian\'s namePatient\'s name (in "quotes")Practice addressPatient\'s age or date of birthPractice telephone numberOwner\'s name (or that of an owner representative)DEA \# (if written for a controlled substance)Owner\'s addressCurrent dateOwner\'s phone numberRx•**Drug Name:** (Print FULL brand name or generic name...NEVER abbreviate)•**Dosage Form:** (specify tablet, capsule, suspension, other)•**Strength:** (mg, g, μ g, etc.) or concentration (mg/ml)...use metric units•**Total Quantity:** (\# 10 \[for 10 tablets\]; 60 ml)•**Sig:** *Include the following:* Dose (individual); route; frequency; duration; indication or use•**Number of Refills:** define the number permitted•**Designate:** whether or not generic substitution is permissible•**Signature:*Common prescription writing errors***•Always use metric units: e.g., **g** (gram) for solids; **ml** or **mL** (milliliter) for liquids.•Use **per** instead of a slash **(/)**, which can be interpreted as the number **1**.•Use **units** instead of the abbreviation **u**, which can be interpreted as **0** or **4** or **μ**.•Use **once daily** instead of **sid**, which has been interpreted as **5/d** or **5 per day!** (NOTE:"sid" is *not* a conventional prescription abbreviation.)•Use **three times daily** insteadof **tid,** and **four times daily** insteadof **qid.**•Use **every other day** instead of **qod**.•REMEMBER---abbreviations like **qd**, **qid,** and **qod** are easily confused with each other•When writing numbers:•Use a **leading zero** with decimals: e.g., use **0.5 ml** rather than **.5 ml**.•Avoid using a **trailing zero:** e.g., use **3** rather than **3.0**.•And FINALLY---**When in doubt ...spell it out.**

TABLE 6-26Common Drug Indications and Dosages[†](#cetablefn31){ref-type="table-fn"}DrugProprietary namesAction/*Use*FormulationRecommended dosageAcepromazineMany generic productsTranquilizer and antiemetic5-,10-, and 25-mg tablets and 10-mg/mL injectionDog: 0.56--1.13 mg/kg IM, SC, IV;0.56--2.25 mg/kg PO q6--8hCat: 1.13--2.25 mg/kg IM, SC, IVAcetaminophenTylenol and other generic brandsNSAID/*analgesia*120-,160-,325-, and 500-mg tabletsDog: 15 mg/kg PO q8hCat: DO NOT USEAcetaminophen with codeineTylenol with codeine; other generic productsNSAID + opioid/*analgesia*Oral solution and tablets. Many forms (e.g.,300 mg acetaminophen plus either 15,30, or 60 mg codeine)Follow dosing recommendations for codeineDog: (analgesia) 0.5--1 mg/kg PO q4--6hCat: DO NOT USEAcetazolamideDiamoxDiuretic/*management of glaucoma*125-and 250-mg tabletsGlaucoma: 5--10 mg/kg PO q8--12hDiuretic: 4--8 mg/kg PO q8--12h![](fx2.gif) AcetylcysteineMucomystAntidote/*acetamin-ophen toxicosis in cats*20% solution (200 mg/mL)Cat: (*acetaminophen toxicosis*) 140 mg/kg (initial loading dose; then 70 mg/kg PO or IV q4h for 5 dosesACTH Gel*See* CorticotropinActivated charcoal*See* Charcoal, activatedAlbendazoleValbazenAntiparasitic/*especially respiratory parasites and Giardia* spp.113.6-mg/mL suspension and 300 mg/mL paste*General antiparasitic:* 25--50 mg/kg PO q12h for 3 days *Respiratory parasites:* 50 mg/kg, q24h PO for 10--14 days *Giardia:* 25 mg/kg q12h for 2 days; 2 to 5 puffs four times dailyAlbuterolProventil; VentolinBronchodilator2-,4-, and 5-mg tablets; 2 mg/5 mL syrup; aerosol (metered inhaler @ 90 mcg/dose)20--50 μg/kg four times/day; up to maximum of 100 μg/kg four times/dayAllopurinolLopurin; ZyloprimAntiinflammatory/*adjunct therapy for Leishmaniasis; urolith prevention*100-and 300-mg tabletsUrolith prevention: 10 mg/kg q8h; then reduce to 10 mg/kg q24hLeishmaniasis: 10 mg/kg, q12h PO for 4 months or more.Aluminum carbonate gelBasalgelAntacid/*GI phosphate binder (uncommonly used today)*Capsules (equivalent to 500 mg aluminum hydroxide)10--30 mg/kg PO q8h (with meals)Aluminum hydroxide gelAmphogelAntacid/*GI phosphate binder (uncommonly used today)*64 mg/mL oral suspension; 600-mg tablet10--30 mg/kg PO q8h (with meals)AmikacinAmiglyde-V (veterinary); Amikin (human)Antibacterial50-and 250-mg/mL injectionDog and cat: 6.5 mg/kg IV, IM, SC q8h or 20 mg/kg IV, IM, SC q24hAminophyllineMany generic brandsBronchodilator/*chronic bronchitis and asthma*100-and 200-mg tablets; 25 mg/mL injectionDog: 10 mg/kg PO, IM, IV q8hCat: 6.6 mg/kg PO q12hDog: 10--15 mg/kg, PO, q12h, up to 1 wk; then 5--7.5 mg/kg PO q12h for 2 wk; then 7.5 mg/kg q24h as maintenance![](fx2.gif) AmiodaroneCordaroneAntiarrhythmic/*life-threatening arrhythmias*200 mg tables and 50 mg/mL injectionCat: no dosage recommendationAmitrazMitabanAntiparasitic/*especially ectoparasites: Demodex and Sarcoptes*10.6 mL concentrated dip (19.9%)10.6 mL per 7.5 L water (0.025% solution); apply three to six topical treatments every 2 weeks for refractory cases, this dose has been exceeded to produce increased efficacy. Doses that have been used include 0.025%,0.05%, and 0.1% concentration applied twice a week and 0.125% solution applied to one-half body every day for 4 weeks to 5 months.AmitriptylineElavilBehavior modifier/*separation anxiety and (in cats) chronic idiopathic cystitis*10-,25-,50-,75-, 100-, and 150-mg tablets; 10 mg/mL injectionDog: 1--2 mg/kg PO q12--24h (range: 0.25--4 mg/kg q12--24h)Cat: 2 mg/kg or approx 5--10 mg per cat per day POAmlodipineNorvascCalcium channel blocker/*vasodilator for systemic hypertension*2.5-,5-, and 10-mg tabletsDog: 2.5 mg/dog or 0.1 mg/kg PO once dailyCat: 0.625 mg/cat/day PO initially; then increase if needed to 1.25 mg/cat/day (average is 0.18 mg/kg once daily)Ammonium chlorideGenericUrinary acidifier/*acidify urine and treat metabolic alkalosis*Available as crystalsDog: 100 mg/kg PO q12hCat: 800 mg/cat (approximately ⅓ to ¼ tsp) mixed with food dailyAmoxicillin trihydrateAmoxi-Tabs;Broad-spectrum antibacterial50-,100-,200-, and 400-mg tablets; 50 mg/mL oral suspension6--20 mg/kg PO q8--12hAmoxi-drops; Amoxil; othersAmoxicillin/clavulanateClavamoxBroad-spectrum antibacterial62.5-,125-,250-, and 375-mg tablets; 62.5 mg/mL suspensionDog: 12.5--15 mg/kg PO q12hCat: 62.5 mg/cat PO q12h; consider administering these doses q8h for gram-negative infectionsAmphotericin BAmBisome (new formulation; less toxic but expensive)Antifungal (liposomal formulation)/*deep, systemic fungal infection* & *leishmaniasis*50-mg injectable vial3--5 mg/kg/day IV administered over 60--120 minFungizone (traditional formulation)Antifungal/*deep systemic fungal infection* & *leishmaniasis*50-mg injectable vial0.5 mg//kg IV (slow infusion) q48h; cumulative dose is 4--8 mg/kgCAUTION: Monitor renal functionAmpicillinOmnipen; Principen; othersBroad-spectrum antibacterial250-and 500-mg capsules; 125-, 250-, and 500-mg vials of ampicillin sodium10--20 mg/kg IV, IM, SC q6--8h (ampicillin sodium); 20--40 mg/kg PO q8h![](fx2.gif) Ampicillin + sulbactamUnasynBroad-spectrum antibacterial1.5-and 3-g vials in 2:1 combination for injection10--20 mg/kg IV, IM q8hAmpicillin trihydratePolyflexBroad-spectrum antibacterial10-and 25-mg vials for injection6.5--10 mg/kg IM, SC q12hAmproliumAmprol, CoridThiamine analog/*treatment of coccidia*9.6% (9.6 g/dL) oral solution; soluble powder1.25 g of 20% amprolium powder to daily feed, or 30 mL of 9.6% amprolium solution to 3.8 L of drinking water for 7 days![](fx2.gif)Antiserum, snakebiteAntiveninAntivenin/*concentrated serum globulin from horses immunized with multiple types of venom*10-mL vialsDose varies from 10 to 50 mL (1 to 5 vials) initially; additional doses may be administered 2 h following initial treatmentApomorphine hydrochlorideGenericEmetic (potent)6-mg tablet0.02--0.04 mg/kg IV, IM,0.1 mg/kg SC, or instill 0.25 mg in conjunctiva of eye (dissolve 6-mg tablet in 1--2 mL of saline)Ascorbic acidVitamin CVitamin supplementVarious forms100--500 mg/animal/day (diet supplement) or 100 mg/animal q8h (urine acidification)L-AsparaginaseElsparAntineoplastic/*lymphoid malignancies*10,000 U per vial for injectionDog: 10,000 to 20,000 IU/m^2^ IV once weeklyCat: 400 U/kg SC or IM (as part of a protocol)*Pretreatment* with antihistamine (diphenhydramine),2 mg/kg (dog) and 1 mg/kg (cat) 30 minutes earlier is recommendedAspirinMany generic and brand name products (e. g., Bufferin, Ascriptin)NSAID; anticoagulant81-and 325-mg tabletsDog: *Mild analgesia*: 10 mg/kg q12h *Antiinflammatory:* 20--25 mg/kg q12h *Antiplatelet:* 5--10 mg/kg q24--48hCat: 10--20 mg/kg q48h*Antiplatelet*: 80 mg q48hAtenololTenorminBeta-blocker/*hypertension and tachyarrhythmias*25-,50-, and 100-mg tablets; 25 mg/mL oral suspension; and 0.5 mg/mL ampule for injectionDog: 6.25--12.5 mg/dog q12h (or 0.25--1.0 mg/kg q12--24h) Cat: 6.25--12.5 mg/cat q12h (approx.3 mg/kg)AtracuriumTracriumNeuromuscular blocking agent/*adjunct to general anesthesia for muscle relaxation*10-mg/mL injection0.2 mg/kg IV initially; then 0.15 mg/kg q30min (or IV infusion at 3--8 μg/kg/min)![](fx2.gif) AtropineMany generic productsAntimuscarinic-anticholinergic/*preanesthetic agent and treatment of some bradyarrhythmias*400-,500-, and 540 μg/mL injection; 15 mg/mL injection0.02--0.04 mg/kg IV, IM, SC q6--8h or0.2--0.5 mg/kg (as needed) for organophosphate and carbamate toxicosisAuranofin (triethylphosphine gold)RidauraGold compound/*immune-mediated skin disease*3-mg capsule0.1--0.2 mg/kg PO q12hAurothioglucoseSolganolGold compound/*immune-mediated skin disease*50 mg/mL injectionDog \<10 kg: 1 mg IM 1st wk,2 mg IM 2nd wk, and then 1 mg/kg/wk maintenance; \>10 kg: 5 mg IM 1st wk, 10 mg 2nd wk, and then 1 mg/kg/wk maintenanceAzathioprineImuranPurine antagonist/*immunosuppressive agent*50-mg tablet; 10 mg/mL injectionDog: 2 mg/kg PO q24h initially; then 0.5--1 mg/kg q48hCat (use cautiously): 1 mg/kg PO q48h *Monitoring patient CBC is indicated during therapy*AzithromycinZithromaxAntibacterial/*broad-spectrum activity with very long tissue half-life*250-mg capsule; 250-and 600-mg tablets; 20 mg/mL oral suspensionDog: 5--10 mg/kg PO once daily for 3--5 days (treatment may be extended for up to 10 days of consecutive treatment)Cat: 5--10 mg/kg PO daily for 3--5 days.BAL*See* Dimercaprol, LotensinBenazeprilACE inhibitor/*chronic heart failure, hypertension, first choice in treating protein-losing nephropathies*5-,10-,20-, and 40-mg tabletsDog: *Heart failure:* 0.25--0.5 mg/kg PO q24h*Hypertension:* 0.25 mg/kg PO q12hCat: *Heart failure:* 0.25--0.5 mg/kg PO once or twice daily*Hypertension:* 0.25--1.0 mg/kg PO once or twice dailyBetamethasoneCelestonePotent glucocorticoid/*antiinflammatory and immune-mediated disease*600-μg (0.6-mg) tablet; 3 mg/mL sodium phosphate injectionDog and cat:*Antiinflammatory:* 0.1--0.2 mg/kg PO q12--24h *Immunosuppressive*: 0.2--0.5 mg/kg once or twice dailyBethanecholUrecholineMuscarinic-cholinergic/*enhance urinary bladder contraction*5-,10-,25-, and 50-mg tablets; 5 mg/mL injectionDog: 5--15 mg/dog PO q8hCat: 1.25--5 mg/cat PO q8hBisacodylDulcolaxStimulant laxative5-mg tablet5 mg/animal PO q8--24hBismuth subsalicylatePepto-BismolGI protectant/*treatment of simple (uncomplicated) diarrhea*Oral suspension; 262 mg/15 mL or 525 mg/mL in extra strength formulation; 262-mg tablet1--3 mL/kg/day (in divided doses) POBleomycinBlenoxaneAntineoplastic/*used in multiple cancer protocols*15-U vials for injectionDog: 10 U/m^2^ IV or SC for 3 days; then 10 U/m^2^ weekly (maximum cumulative dose 200 U/m^2)^Bromide*See* Potassium bromide ParlodelBromocriptine mesylateDopamine agonist and prolactin inhibitor/*pregnancy termination or pseudopregnancy (pseudocyesis) in dogs*2.5-mg tablets and 5.0-mg capsules*Pseudocyesis*: 10 μg/kg PO for 10 days, or 30 μg/kg PO for 16 days *Pregnancy termination*: 50--100 μg/kg PO for 4--7 days; begin treatment from day 35--45 after LH surgeCAUTION: Vomiting is a common side effectBunamidine hydrochlorideScolabanAntiparasitic/*tape worms*400-mg tablet20--50 mg/kg PO per treatmentBupivacaineMarcaine; genericLocal anesthetic (parenteral)2.5-and 5-mg/mL solution injection1 mL of 0.5% solution/10 cm for an epiduralBuprenorphineBuprenexPartial opiate agonist *analgesic*0.3 mg/mL solutionDog: 0.005--0.02 mg/kg IV, IM, SC q6--12hCat: 0.005--0.01 mg/kg IV, IM q6--12h Buccal administration is well tolerated in cats and lasts ∼6 hoursBuspironeBuSparNon-benzodiazepine anxiolytic/*control urine spraying*5-and 10-mg tabletsCat: 2.5--5 mg/cat PO daily (may be increased to twice daily for some cats)BusulfanMyleranOral antineoplastic/*chronic granulocytic leukemia*2-mg tablet3--4 mg/m^2^ PO q24hButorphanolTorbutrol; TorbugesicOpioid analgesic/*perioperative analgesia*1-,5-, and 10-mg tablets; 0.5 or 10 mg/mL injectionDog: *Antitussive*: 0.055 mg/kg SC q6--12h or 0.55 mg/kg PO*Preanesthetic*: 0.2--0.4 mg/kg IV, IM, SC (with acepromazine)*Analgesic*: 0.2--0.4 mg/kg IV, IM, SC q2--4h or 0.55--1.1 mg/kg PO q6--12hCat: *Analgesic*: 0.2--0.8 mg/kg IV, SC q2--6h or 1.5 mg/kg PO q4--8hCalcitriolRocaltrol; CalcijexCalcium supplement/*increases calcium absorption in the GI tract; used in management of hypoparathyroidism*Available as injection (Calcijex) and capsules (Rocaltrol): 0.25-and 0.5-μg capsules; 1-or 2-μg/mL injectionDog: 0.25 to 0.5 μg/dog/day PO q24hCat: 0.25 μg/cat PO q48hCalcium carbonateGeneric and many brand name products (e.g., Tums)Calcium supplementMany tablets or oral suspension (e.g.,650-mg tablet contains 260 mg calcium ion)5--10 mL oral solution PO q4--6h*For phosphate binder:* 60--100 mg/kg/dayPO in divided doses![](fx2.gif) Calcium chlorideGenericCalcium supplement10% (100 mg/ml) solution0.1--0.3 mL/kg IV (slowly)Calcium citrate (OTC)CitricalCalcium supplement950-mg tablet (contains 200 mg calcium ion)Dog: 20 mg/kg/day PO (with meals)Cat: 10--30 mg/kg q8h PO (with meals)![](fx2.gif) Calcium gluconateKalcinate and genericCalcium supplement10% (100 mg/mL) injection0.5--1.5 mL/kg IV (slowly)Calcium lactate (OTC)GenericCalcium supplementAvailable as a powder and various-sized tabletsDog: 0.5--2.0 g/dog/day PO (in divided doses)Cat: 0.2--0.5 g/cat/day PO (in divided doses)CaptoprilCapotenACE inhibitor (vasodilator)/*hypertension and congestive heart failure*25-mg tabletDog: 0.5--2 mg/kg PO q8--12hCat: 3.12--6.25 mg/cat PO q8hCarbenicillinGeopen; PyopenAntibacterial1-,2-,5-,10-, and 30-g vials for injection40--50 mg/kg and up to 100 mg/kg IV, IM, SC q6--8hCarbenicillin indanyl sodiumGeocillinAntibacterial500-mg tablet10 mg/kg PO q8hCarboplatinParaplatinAntineoplastic/*multiple tumor types*50-and 150-mg vials for injectionDog: 300 mg/m^2^ IV q3--4 wkCat: 200 mg/m^2^ IV q4wk![](fx2.gif) CarprofenRimadylNSAID25-,75-, and 100-mg tabletsDog: 2.2 mg/kg PO q12h50 mg/mL in 20-mL vials for injectionCat: Not approved for use in catsCascara sagrada (OTC)Many brand name productsLaxative100-and 325-mg tabletsDog: 1--5 mg/kg/day POCat: 1--2 mg/cat/dayCastor oil (OTC)GenericLaxativeOral liquid (100%)Dog: 8--30 mL/day POCat: 4--10 mL/day POCefaclorCeclorAntibacterial250-and 500-mg capsules and 25 mg/mL oral suspension4--20 mg/kg PO q8h![](fx2.gif) CefadroxilCefa-Tabs; Cefa-DropsAntibacterial50 mg/mL oral suspension; 50-, 100-,200-, and 1000-mg tabletsDog: 22--30 mg/kg PO q12hCat: 22 mg/kg PO q24hCefepimeMaxipimeAntibacterial500-mg,1-g, and 2-g vials for injection40 mg/kg IV q6hCefiximeSupraxAntibacterial20 mg/mL oral suspension; 200-and 400-mg tablets10 mg/kg PO q12h*For cystitis*: 5 mg/kg PO q12--24hCefotaximeClaforanAntibacterial500-mg and 1-,2-, and 10-g vials for injectionDog: 50 mg/kg IV, IM, SC q12hCat: 20--80 mg/kg IV, IM q6hCefotetanCefotanAntibacterial1-,2-, and 10-g vials for injection30 mg/kg IV, SC q8h![](fx2.gif) Cefoxitin sodiumMefoxinAntibacterial1-,2-, and 10-g vials for injection30 mg/kg IV q6--8hCeftazidimeFortaz; Ceptaz; TazicefAntibacterial0.5-,1-,2-, and 6-g vials reconstituted to 280 mg/mLDog and cat: 30 mg/kg IV, IM q6h*CRI*: Loading dose 4.4 mg/kg; then 4.1 mg/kg/h with IV fluidsCeftiofurNaxcel (ceftiofur sodium); Excenel (ceftiofur HCl)Antibacterial50 mg/mL injectionDog: 30 mg/kg, SC, q4--6h 2.2--4.4 mg/kg SC q24h (for urinary tract infections)![](fx2.gif) CephalexinKeflex; genericAntibacterial/*especially skin, urinary, respiratory tract infections*250-and 500-mg capsules; 250-and 500-mg tablets; 100 mg/mL or 125 and 250 mg/5 mL oral suspension10--30 mg/kg PO q6--12h*Pyoderma*: 22--35 mg/kg PO q12hCephalothin sodiumKeflinAntibacterial1-and 2-g vials for injection10--30 mg/kg IV, IM q4--8hCephapirinCefadylAntibacterial500-mg and 1-,2-, and 4-g vials for injection10--30 mg/kg IV, IM q4--8h![](fx2.gif) Charcoal, activatedActaChar; Charcodote; Toxiban; genericGI adsorbentOral suspension1--4 g/kg PO (granules)6--12 mg/kg (suspension)ChlorambucilLeukeranAntineoplastic/*has also been used to treat eosinophilic granuloma complex in cats*2-mg tabletDog: 2--6 mg/m^2^ q24h initially; then q48h POCat: 0.1--0.2 mg/kg q24h initially; then q48h POChloramphenicol and chloramphenicol palmitateChloromycetin; genericAntibacterial30 mg/mL oral suspension (palmitate); 250-mg capsule; and 100-,250-, and 500-mg tabletsDog: 40--50 mg/kg PO q8hCat: 12.5--20 mg/kg PO q12hChloramphenicol sodium succinateChloromycetin; genericAntibacterial100 mg/mL injectionDog: 40--50 mg/kg IV, IM q6--8hCat: 12.5--20 mg/cat IV, IM q12hChlorothiazideDiurilDiuretic/*also used as an* antihypertensive250-and 500-mg tablets;50 mg/mL oral suspension and injection20--40 mg/kg PO q12hChlorpheniramine maleate (OTC)Chlor-Trimeton; Phenetron; othersAntihistamine (H~1~-blocker)/*weak antipruritic agent in allergic animals*4-and 8-mg tabletsDog: 4--8 mg/dog PO q12h (up to maximum of 0.5 mg/kg q12h)Cat: 2 mg/cat PO q12hChlorpromazineThorazineTranquilizer/*antiemetic*25-mg/mL injection solution0.5 mg/kg IM, SC q6--8h *Before cancer chemotherapy*: 2 mg/kg SC q3hChlortetracyclineGenericAntibacterialPowdered feed additive25 mg/kg PO q6--8hChorionic gonadotropin*See* GonadotropinCimetidineTagametAntihistamine (H~2~ blocker)/*treatment and prevention of gastric ulcer*100-,150-,200-, and 300-mg tablets; 60 mg/mL injection10 mg/kg IV, IM, PO q6--8h *In renal failure:* 2.5--5 mg/kg IV, PO q12hCiprofloxacinCiproAntibacterial250-,500-, and 750-mg tablets, 2 mg/mL injection5--15 mg/kg PO, IV q12hCisapridePropulsidProkinetic/*stimulates GI tract motility*10-mg tabletDog: 0.1--0.5 mg/kg PO q8--12h (doses as high as 0.5--1.0 mg/kg have been used in some dogs)Cat: 2.5--5 mg/cat PO q8--12h (doses as high as 1 mg/kg q8h have been used in cats)CisplatinPlatinolAntineoplastic/*multiple tumor types*1-mg/mL injection; 50-mg vialsDog: 60--70 mg/m^2^ IV q3--4wk (administer fluid for diuresis with therapy)Cat: DO NOT USE.ClemastineTavist; Contac 12 Hour; genericAntihistamine (H~1~-blocker)/*antipruritic in allergic dogs*1.34-mg tablet (OTC); 2.64-mg tablet (Rx); 0.134 mg/mL syrupDog: 0.05--0.1 mg/kg PO q12h![](fx2.gif) ClindamycinAntirobe; CleocinAntibacterial/*especially gram-positive infections*. *Recommended for toxoplasmosis (controversial).*25 mg/mL oral liquid; 25-,75-, and 150-mg capsule; and 150-mg/mL injection (Cleocin)Dog: 11 mg/kg PO q12h or 22 mg/kg PO q24hCat: 5.5 mg/kg q12h, or 11 mg/kg q24h (staphylococcal infections); 11 mg/kg q12h or 22 mg/kg q24h (anaerobic infections) PO *Toxoplasmosis*: 12.5 mg/kg PO q12h for 4 wkClofazimineLampreneAntibacterial50-and 100-mg capsulesCat: 1 mg/kg PO up to maximum of 4 mg/kg/dayClomipramineAnafranil (human);Tricyclic antidepressant/*behavior modification*10-,25-, and 50-mg tablets (human); 5-,20-, and 80-mg tablets (veterinary)Dog: 1--2 mg/kg PO q12h up to maximum of 3 mg/kg PO q12hClomicalm (veterinary)Cat: 1--5 mg/cat PO q12--24hClonazepamKlonopinAnticonvulsant/*also used to manage certain types of behavior disorders*0.5-,1-, and 2-mg tablets0.5 mg/kg PO q8--12hClorazepateTranxeneAnticonvulsant/*also used to manage certain types of behavior disorders*3.75-,7.5-,11.25-,15-, and 22.5-mg tablets2 mg/kg PO q12hClotrimazole (CTL)Many generic products, including lotrimazole topical solution, USP 1%Antifungal (topical only)/*nasal aspergillosis*1% topical solution in 30 mL*For nasal aspergillosis in dogs:* Infuse 1% solution in each nasal cavity for 1 h in anesthetized dog.*NOTE: patient preparation is required*CloxacillinCloxapen; Orbenin; TegopenAntibacterial250-and 500-mg capsules; 25 mg/mL oral solution20--40 mg/kg PO q8hCodeineGenericOpioid analgesic15-,30-, and 60-mg tablets; 5 mg/mL syrup; 3 mg/mL oral solution*Analgesia*: 0.5--1 mg/kg PO q4--6h*Antitussive*: 0.1--0.3 mg/kg PO q4--6hColchicineGenericAntiinflammatory/*hepatic failure*500-and 600-μg tablets; 500 μg/mL ampule injection0.01--0.3 mg/kg PO q24hColony-stimulating factorNeupogenHormone/*stimulate granulocyte production in bone marrow*300 μg/mL injection2.5 μg/kg SC q12h![](fx2.gif) Corticotropin (ACTH Gel)H.P. Acthar Gel (*expensive*)Hormone/*diagnostic test drug for the diagnosis of hyper-and hypoadrenocorticism*5 mL (multiple dose) 80 USP units/mL*Response test*: Collect pre-ACTH sample and inject 2.2 IU/kg IM;Dog: Collect post-ACTH sample in 2 hCat: Collect post-ACTH samples at 1 and 2 h![](fx2.gif) CosyntropinCortrosynHormone/*diagnostic test drug for the diagnosis of hyper-and hypoadrenocorticism*250 μg per vial (can be stored in freezer for 6 months)*Response test*:Dog: Collect pre-sample and inject 5 μg/kg IVCat: Collect pre-sample and inject 0.125 mg IVDog and cat: Collect post sample 1 h post-administration.Cyanocobalamin*See* Vitamin B~12~CyclophosphamideCytoxan; NeosarAntineoplastic/*multiple tumor types and adjunctive in immune-mediated disorders*25 mg/mL injections; 25-nd 50-mg tablets*Anticancer*: 50 mg/m^2^ PO once daily 4 days/wk or 150--300 mg/m^2^ IV and repeat in 21 days*Immunosuppressive therapy*: 50 mg/m^2^ (approx 2.2 mg/kg) PO q48h or 2.2 mg/kg once daily for 4 days/wkCat: 6.25--12.5 mg/cat once daily 4 days/wkCyclosporine (cyclosporin A)Neoral, Sandimmune; Optimmune (ophthalmic)Immunosuppressant (CMI)/*multiple uses ranging from atopic dermatitis to hemolytic anemia to perianal fistulas Consult additional references before prescribing*Neoral: 25-mg and 100-mg microemulsion capsules; 100-mg/mL oral solution (for microemulsion) Sandimmune: 100-mg/mL oral solution; 25-and 100-mg capsulesDog: 3--7 mg/kg, PO, q12--24h (adjust dose based on condition being treated and by monitoring blood levels)*Hemolytic anemia*: Up to 10 mg/kg PO q12h (as adjunctive therapy)Cat: 4--6 mg/kg PO q12h*NOTE: multiple products are available but all are NOT bioequivalent*Optimmune: 0.2% ointmentCyproheptadinePeriactinAntihistamine/*appetite stimulant in cats*4-mg tablet; 2 mg/5 mL syrup*Antihistamine*: 1.1 mg/kg PO q8--12h*Appetite stimulant*: 2 mg/cat POCytarabine (cytosine arabinoside)Cytosar-UAntineoplastic/*lymphoma and leukemia*100-mg vialDog (lymphoma): 100 mg/m^2^ IV, SC once daily or twice daily for 4 daysCat: 100 mg/m^2^ once daily for 2 daysDacarbazineDTICAntineoplastic/*lymphoreticular neoplasms and soft tissue sarcomas*200-mg vial for injection200 mg/m^2^ IV for 5 days q3wks; or 800--1000 mg/m^2^ IV q3wks![](fx2.gif) DalteparinFragminLow molecular weight heparin/*management of thromboembolic disease*Multiple injectable preparations*Prophylaxis*: 70 IU/kg q24h SC*Treatment*: 200 IU/kg q24h SCDanazolDanocrineAnabolic steroid/*adjunctive therapy for immune-mediated disease*50-,100-, and 200-mg capsules5--10 mg/kg PO q12hDantroleneDantriumMuscle relaxant/*urethral obstruction and prevention of malignant hyperthermia*100-mg capsules; 0.33 mg/mL injection*Malignant hyperthermia*: 2--3 mg/kg IV*Muscle relaxation*:Dog: 1--5 mg/kg PO q8hCat: 0.5--2 mg/kg PO q12hDapsoneGenericAntibacterial/*Mycobacterium* spp.25-and 100-mg tablets1.1 mg/kg PO q8--12h![](fx2.gif) DeferoxamineDesferalAntidote/*iron toxicosis*500-mg vial for injection10 mg/kg IV, IM q2h for two doses; then 10 mg/kg q8h for 24 hDeprenyl (L-deprenyl)*See* Selegiline (Anipryl)![](fx2.gif) Desmopressin acetateDDAVPHormone/*used in the clinical management of patients with diabetes insipidus and patients with von Willebrand\'s disease*100 μg/mL injection and desmopressin acetate nasal solution (0.01% metered spray); 0.1-and 0.2-mg tabletsDiabetes insipidus: 2--4 drops (2 μg) q12--24h intranasally or in eye; animal oral dose not established, but dose extrapolated from humans is 0.05 mg/animal q12h PO with increase to 0.1 or 0.2 mg/animal as needed. *von Willebrand\'s disease*: 1 μg/mL (0.01 mL/kg) SC, IV diluted in 20 mL saline administered over 10 minDesoxycorticosterone pivalatePercorten-V; DOCP; DOCA pivalateMineralocorticoid/*hypoadrenocorticism*25 mg/mL suspension for injection1.5--2.2 mg/kg IM q25days![](fx2.gif) Dexamethasone (dexamethasone solution and dexamethasone sodium phosphate)Azium solution in poly-ethylene glycol; sodium phosphate forms include Dexaject SP, Dexavet, and Dexasone; tablets include Decadron and genericGlucocorticoid/*multiple uses as antiinflammatory and immunosuppressive agent; also used in the diagnosis of hyperadrenocorticism*Azium solution,2 mg/mL; sodium phosphate forms are 3.33 mg/mL; 0.25-,0.5-, 1-,1.5-,2-,4-, and 6-mg tablets.Antiinflammatory: 0.07--0.15 mg/kg IV, IM, PO q12--24h *For shock, spinal injury*: 2.2--4.4 mg/kg IV (of sodium phosphate form) *Diagnostic testing use*: See Dexamethasone Suppression in Section 5.![](fx2.gif) DextranDextran 70; Gentran-70Replacement fluidInjectable solution: 250, 500, and 1000 mL10--20 mL/kg IV to effectDextromethorphanBenylin and othersAntitussive/*weak cough suppressant*Available in syrup, capsule, and tablet; many OTC products0.5--2 mg/kg PO q6--8h![](fx2.gif) Dextrose solution 5% in waterD5WReplacement fluidFluid solution for IV administration40--50 mL/kg IV q24h![](fx2.gif) DiazepamValium; genericAnticonvulsant/*multiple neurotropic effects ranging from behavior disorders to seizure control*2-and 5-mg tablets;*Preanesthetic*: 0.5 mg/kg IV5 mg/mL solution for injection*Status epilepticus*: 0.5 mg/kg IV, 1.0 mg/kg rectal; repeat if necessary *Appetite stimulant* (cat): 0.2 mg/kg IV**\<fiugre\>** DichlorphenamideDaranideDiuretic/*management of glaucoma*50-mg tablet3--5 mg/kg PO q8--12hDichlorvosTaskAntiparasitic/*roundworms, hookworms, whipworms*10-and 25-mg tabletsDog: 26.4--33 mg/kg POCat: 11 mg/kg PODicloxacillinDynapenAntibacterial125-,250-, and 500-mg capsules; 12.5 mg/mL oral suspension25 mg/kg IM q6h Oral doses not absorbedDiethylcarbamazine (DEC)Caricide; FilaribitsAntiparasitic/*prevention of heartworm disease in dogs; treatment of ascarids in cats*Chewable tablets; 50-, 60-,180-,200-, and 400-mg tablets*Heartworm prophylaxis*: 6.6 mg/kg PO q24hCat: (for ascarids) 55--110 mg/kg PO onceDiethylstilbestrol (DES)Limited availability; compounding requiredHormone/*estrogen replacement and urinary incontinence; induce abortion in dogs*Tablets (prepared through compounding pharmacies)Dog: 0.1--1.0 mg/dog PO q24hCat: 0.05--0.1 mg/cat PO q24hDifloxacinDicuralAntibacterial11.4-,45.4-, and 136-mg tablets5--10 mg/kg/day PODigitoxinCrystodiginCardiac inotrope/*congestive heart failure and management of various* tachyarrhythmias0.05-and 0.1-mg tablets0.02--0.03 mg/kg PO q8hDigoxinLanoxin; CardoxinCardiac inotrope/*congestive heart failure and management of various tachyarrhythmias*0.0625-,0.125-,0.25-mg tablets; 0,05 and 0.15 mg/mL elixir[\*](#cetablefn30){ref-type="table-fn"}Dog: \<20 kg,0.01 mg/kg q12h; \>20 kg, 0.22 mg/m^2^ PO q12h (subtract 10% for elixir)Dog (rapid digitalization): 0.0055--0.011 mg/kg IV q1h to effectCat: 0.08--0.01 mg/kg PO q48h (approximately ¼ of a 0.125-mg tablet/cat)Dihydrotachysterol (DHT)*See* Vitamin D analog![](fx2.gif) DiltiazemCardizem; DilacorCalcium channel blocker/*hypertension; also supraventricular tachycardia and hypertrophic cardiomyopathy*30-,60-,90-, and 120-mg tablets; 50 mg/mL injectionDog: 0.5--1.5 mg/kg PO q8h; 0.25 mg/kg over 2 min IV (repeat if necessary)Cat: 1.75--2.4 mg/kg PO q8h; for *Dilacor XR or Cardizem CD*, dose is 10 mg/kg PO once daily![](fx2.gif) DimenhydrinateDramamineAntihistamine/*prevention of motion sickness*50-mg tablets; 50 mg/mL injectionDog: 4--8 mg/kg PO, IM, IV q8hCat: 12.5 mg/cat IV, IM, PO q8hDimercaprol (BAL)BAL in OilChelating agent/*bind heavy metals (lead, mercury) and arsenicals*100 injection4 mg/kg IM q4hDinoprost tromethamine*See* Prostaglandin F~2a~Dioctyl calcium sulfosuccinate*See* Docusate calciumDioctyl sodium sulfosuccinate*See* Docusate sodium![](fx2.gif) DiphenhydramineBenadrylAntihistamine/*weak sedative, prevents motion sickness*Available OTC: 2.5 mg/mL elixir; 25-and 50-mg capsules and tablets; 50 mg/mL injection2--4 mg/kg PO q6--8h or 1 mg/kg IM, IV (for dogs, administer 25--50 mg/dog IV, IM, PO q8h)DiphenoxylateLomotilMeperidine congener/*treatment of diarrhea*2.5 mg tabletsDog: 0.1--0.2 mg/kg PO q8--12hCat: 0.05--0.1 mg/kg PO q12hDiphenylhydantoin*See* PhenytoinDiphosphonate disodium etidronate*See* Etidronate disodiumDipyridamolePersantineAnticoagulant/*prevention of thromboembolism*25-,50-,75-mg tablets; 5 mg/mL injection4--10 mg/kg PO q24hDisopyramideNorpaceAntiarrhythmic in dogs/*oral treatment or prevention of ventricular arrhythmias (dog only)*100-and 150-mg capsulesDog: 6--15 mg/kg, PO, q8hDivalproex sodiumSee Valproic acid![](fx2.gif) DobutamineDobutrexRapid acting cardiac inotrope (beta-agonist)/*short-term treatment of heart failure*250 mg/20 mL vial for injection (12.5 mg/mL)Dog: 5--20 g/kg/min IV infusionCat: 0.5--2 g/kg/min IV infusionWARNING: may induce arrhythmias, facial twitching, or seizure (cats)Docusate calciumSurfak; DoxidanStool softener60-mg tablet (and many others)Dog: 50--100 mg/dog PO q12--24hCat: 50 mg/cat PO q12--24hDocusate sodiumColace; Doxan; Doss; many OTC productsStool softener50-and 100-mg capsules; 10 mg/mL liquidDog: 50--200 mg/dog PO q8--12hCat: 50 mg/cat PO q12--24h![](fx2.gif) DolasetronAnzemet5-HT~3~ receptor antagonist/*antiemetic*50-and 100-mg tablets; 20 mg/mL injection*Prevention:* 0.6 mg/kg, PO or IV q24h*Treatment:* 1 mg/kg, PO or IV q24h![](fx2.gif) DopamineIntropinCardiac inotrope (beta-agonist)/*vasodilation (lower doses); adjunctive treatment of acute heart failure and oliguric renal failure*40-,80-, or 160-mg/mL2--10 μg/kg/min by IV infusion; treatment limited to the critical care setting.![](fx2.gif) DoxapramDopramCNS stimulant/*stimulate respiration, especially in neonates*20-mg/mL injection5--10 mg/kg IVNeonate: 1--5 mg SC, sublingual, or via umbilical veinDoxepinSinequanTricyclic antidepressant/*psychogenic dermatoses*Various capsules; 10 mg/mL oral solution0.5--1.0 mg/kg PO q12h *(especially lick granuloma)*DoxorubicinAdriamycinAntineoplastic (antibiotic)/*used in treatment protocols for multiple tumor types*2 mg/mL injection30 mg/m^2^ IV q 21 days; or \>20 kg,30 mg/m^2^; \<20 kg,1 mg/kgCat: 1 mg/kg IV q3wkDoxycyclineVibramycin; genericAntibacterial10 mg/mL oral suspension;3--5 mg/kg PO, IV q12h; or 10 mg/kg PO q24h100-mg tablet; 100-mg injection vial*For Rickettsia* in dogs: 5 mg/kg q12h![](fx2.gif) EDTA (edetate calcium disodium)Calcium disodium versenateChelates heavy metals/*treatment of lead or zinc toxicosis*20 mg/mL injection25 mg/kg SC, IM, IV q6h for 2--5 daysEdrophoniumTensilon; othersShort-acting cholinergic/*administered as a test agent for myasthenia gravis*10 mg/mL injectionDog: 0.11--0.22 mg/kg IVCat: 2.5 mg/cat IVEnalaprilEnacardACE inhibitor/*vasodilator used in the treatment of heart failure and/or hypertension; also used in the treatment of patients with protein-losing nephropathies and chronic renal failure*2.5-,5-,10-, and 20-mg tabletsDog: 0.5 mg/kg PO q12--24hCat: 0.25--0.5 mg/kg PO q12--24hEnfluraneEthaneInhalation anestheticAvailable as solution for inhalation*Induction*: 2--3%EnilconazoleImaverol; ClinaFarm-ECAntifungal (topical only)/*infusion for treatment of nasal aspergillosis and topical uses in certain dermatophytoses*10% or 13.8% emulsifiable concentrate*Nasal aspergillosis*: 10 mg/kg q12h instilled into nasal sinus via surgically implanted tubes for 14 days (10% solution diluted 50/50 with water)...this is nasty!NOTE: generally replaced by clotrimazole soak (see Clotrimazole).*Dermatophytes*: dilute 10% solution to 0.2% and wash lesion with solution four times at 3-to 4-day intervals![](fx2.gif) EnoxaparinLovenoxLow molecular weight heparin/*thromboembolic disease*Multiple preparations*Prevention*: 0.5 mg/kg SC q24h*Treatment*: 1--2 mg/kg SC q12h![](fx2.gif) EnrofloxacinBaytrilAntibacterial68-,22.7-mg, and 5.7-mg tablets; Taste Tabs are 22.7 and 68 mg; 22.7 mg/mL injection5--10 mg/kg/once daily (or divided twice daily) PO or IM; Parenteral solution for IM use has been administered by the IV route...administer slowly if indicated.WARNING: Doses of 10 mg/kg and higher are not recommended in cats because of risk of drug-induced retinal damage and blindness![](fx2.gif) EphedrineEphedrin sulfateSympathomimetic/*primarily for urinary incontinence EMERGENCY USE: Hypotension associated with anesthesia*25-mg capsules and 50 mg/mL in 1-mL ampules for injectionUrinary incontinence:Dog: 4 mg/kg, or 12.5--50 mg/dog (total) PO q8--12h;Also,1.2 mg/kg PO q8h, or 5 to 15 mg/dog (total) q8hCat: 2--4 mg/kg, PO q8--12h*Hypotension:* 0.03--0.1 mg/kg IV bolusNOTE: dilute 5 mg in 10 mL saline; give the lower dose first; may repeat in 5 minutes after first dose if hypotension does not improve![](fx2.gif) EpinephrineAdrenalin; generic products (adrenaline)Alpha-and beta-adrenergic agonist/*anaphylaxis and cardiac arrest*1 mg/mL (1:1000) injection solution*Cardiac arrest:* 10--20 g/kg IV or 200 g/kg intratracheal (may be diluted in saline)*Anaphylaxis:* 2.5--5 g/kg IV or 50 g/kg intratracheal (may be diluted in saline)EpsiprantelCestexOral cesticide/*tapeworms*Coated tabletDog: 5.5 mg/kg PO given onceCat: 2.75 mg/kg PO given onceErgocalciferol*See* Vitamin D~2~ErythromycinMany brand name and generic productsAntibacterial/also used as a prokinetic (increases gastric emptying in dogs and cats)250-mg capsule or tablet*Antibacterial dose:* 10--20 mg/kg PO q8--12h*Prokinetic dose:* 0.5--1.0 mg/kg PO q8hErythropoietin, human recombinant (rHuEPO)Epogen; Epoetin alfa; ProcritHormone/*induction of erythropoiesis in anemia associated with chronic renal failure*Various preparation as U/mL in single-dose and multidose vials for injectionDoses range from 35 or 50 U/kg three times/wk to 400 U/kg/wk IV, SC (adjust dose to hematocrit of 0.30--0.34)EsmololBreviblocUltrashort-acting beta-1 blocker/*short-term treatment of cardiac arrhythmias, especially supraventricular tachycardia*10 mg/mL injection500 g/kg IV, which may be given as0.05--0.1 mg/kg slowly every 5 minutes or 50--200 g/kg/min infusionEstradiol cypionateECP; Depo-Estradiol; genericHormone/*previously used to prevent pregnancy following an unplanned breeding*2 mg/mL injection*Pregnancy Avoidance:WARNING: NOT recommended for use as an abortifacient in dogs or cats*Dog: 22--44 g/kg IM (total dose not to exceed 1.0 mg)Cat: 250 g/cat IM between 40 h and 5 days of matingWARNING: may cause bone marrow suppression; in some cases, may cause aplastic anemia.Etidronate disodiumDidronelBisphosphonate/*reduced calcium resorption from bone in hypercalcemic patients*200-and 400-mg tablets; 50 mg/mL injectionDog: 5 mg/kg/day POCat: 10 mg/kg/day POEtodolacEtogesicOral NSAID/*pain* management in dogs150-and 300-mg tabletsDog: 10--15 mg/kg PO once daily![](fx2.gif) FamotidinePepcidH~2~-receptor antagonist/*reduces gastric acid production; used to treat or prevent gastric ulcer*10-mg tablet; 10 mg/mL injection0.5 mg/kg IM, SC, IV, orPO q12--24hWARNING: may cause intravascular hemolysis when given IV to catsFelbamateFelbatolDicarbamate anticonvulsant/*management of seizures in dog only*400-and 600-mg tablets; 120 mg/mL oral flavored suspensionDog: Start with 15 mg/kg PO q8h and increase gradually to maximum of 65 mg/kg q8hFenbendazoleSafe-Guard; PanacurAnthelminthic/*effective against a variety of internal parasites*Panacur granules 22.2% (222 mg/kg); 100 mg/mL liquid25 to 50 mg/kg/day PO for 3 days (NOTE: for some parasites, recommended treatment duration may be longer)![](fx2.gif) FentanylSublimaze; genericAnalgesic (opiate)/*parenteral pain control*250 mg/5 mL injection0.02--0.04 mg/kg IV, IM, SC q2h; or 0.01 mg/kg IV, IM, SC (with acetylpromazine or diazepam)*For analgesia:* 0.01 mg/kg IV, IM, SC q2hFentanyl transdermalDuragesicAnalgesic (opiate)/*transdermal pain control*25-,50-,75-, and 100-μg/h patch Cat: 25 g/h patch every 3 daysDog: 10--20 kg,50 g/h patch q72hNOTE: when administering fentanyl by the transdermal route, dosing regimens can vary among patients; consult individual sources to match patient size with patch size and patch placement. Do not cut the patch to achieve lower doses.Ferrous sulfate (OTC)GenericOral iron supplement/*iron deficiency anemia*Many oral preparations availableDog: 100--300 mg/dog PO q24hCat: 50--100 mg/cat PO q24hFinasterideProscar5-alpha-reductase inhibitor/*benign prostatic hyperplasia in dogs*5-mg tabletsDog: 0.1 mg/kg PO q24h or5 mg/10--50 kg dog PO q24hFipronilFrontlineGABA-regulated chloride channel inhibitor/*topical* control of ticks and fleasTopical solution onlyApplied topically once each month as recommended by the manufacturer; approved for use in both dogs and catsFirocoxibPrevicoxNSAID/*for management of inflammation and pain associated with osteoarthritis in dogs.*57 mg and 227 mg chewable tabletsDogs only: 5 mg/kg, PO, once daily.FlorfenicolNuflorAntibacterial (primarily used in cattle)300 mg/mL (available only as a cattle preparation)Dog: 25--50 mg/kg q8h SC or IMCat: 25--50 mg/kg q12h SC or IMFluconazoleDiflucanAntifungal/*oral (dog and cat) or parenteral (dog only) treatment for systemic deep mycoses or nasal fungal infection*50-,100-,150-, and 200-mg tablets; 10 or 40 mg/mL oral suspension; 2 mg/mL IV injectionDog: 2.5--5.0 mg/kg once daily PO or IVCat: 2.5--10 mg/cat PO q12h; or 25 mg/cat/day POFlucytosineAncobonAntifungal/*treatment of systemic mycoses*250-mg capsule; 75 mg/mL oral suspension25--50 mg/kg PO q6--8h (up to a maximum dose of 100 mg/kg PO q12h)FludrocortisoneFlorinefMineralocorticoid/*treatment of hypoadrenocorticism*100-μg (0.1-mg) tabletDog: 0.2--0.8 mg/dog or 0.02 mg/kgPO q24h (13--23 μg/kg)Cat: 0.1--0.2 mg/cat PO q24h![](fx2.gif) FlumazenilRomaziconBenzodiazepine antagonist/*antidote: reverse therapeutic effects or overdose*100 μg/mL (0.1 mg/mL) injection0.01 -0.02 mg (total dose) IV as neededCAUTION: may cause significant hypotensionFlumethasoneFlucortOral glucocorticoid/*antiinflammatory*0.5 mg/mL injectionDog: 0.0625--0.25 mg/day in divided doses IV, IM, SCCat: 0.03--0.125 mg/day IV, IM, SCFlunixin meglumineBanamineNSAID/*pain management*250-mg packet granules; 10 and 50 mg/mL injectionIntra-articular: 0.166 to 1.0 mg total dose mg/kg IV, IM, SC once or 1.1 mg/kg/dayPO 3 days/wkOphthalmic: 0.5 mg/kg IV once5-Fluorouracil (5-FU)FluorouracilAntineoplastic/*used in treatment protocols for multiple tumor types*50-mg/mL vialDog: 150 mg/m^2^ IV once/weekCat: DO NOT USEFluoxetineProzacSelective-serotonin reuptake inhibitor (SSRI)/*treatment of behavior disorders*10-and 20-mg capsules; 4 mg/mL oral solutionDog: 0.5 mg/kg day initially PO; then increase to 1 mg/kg/day PO (10--20 mg/dog)Cat: 0.5--4 mg/cat PO q24hFluvoxamineLuvoxSelective serotonin reuptake inhibitor (SSRI)/*treatment and diagnosis of behavior disorders*25-,50-, and 100-mg tablesDog: 0.5--2.0 mg/kg, PO, bidCat: 0.25--0.5 mg/kg PO once daily![](fx2.gif) Fomepizole (4-Methylpyrazole; 4-MP)Antizol-VetAntidote/*ethylene glycol poisoning*1.5-mL single-use vials; reconstitute in 30 mL of0.9% NaCl for a 5% solution (50 mg/mL)20 mg/kg IV initially within 8 h of ingestion; then 15 mg/kg IV at 12-and 24-h intervals; then 5 mg/kg IV at 36 hFurazolidoneFuroxoneAntibacterial and antiprotozoal/*generally a second-choice drug*100-mg tablet4 mg/kg PO q12h for 7--10 daysFurosemideLasix, genericDiuretic/*multiple uses; commonly used to treat congestive heart failure and pulmonary edema*12.5-,20-, and 50-mg tablets; 10 mg/mL oral solution; 50 mg/mL injectionDog: 2--6 mg/kg IV, IM, SC, PO q8--12h (or as needed); 0.6--1.0 mg/kg/h IVCat: 1--4 mg/kg IV, IM, SC, PO q8--24hGemfibrozilLopidAntilipemic/*treatment of hypertriglyceridemia in patients that do not respond to dietary fat restriction*300-mg capsules; 600-mg tablets7.5 mg/kg PO q12hGentamicinGentocinAntibacterial (aminoglycoside)50 and 100 mg/mL solution for injectionDog: 2--4 mg/kg q6--8h or 6--10 mg/kg IV, IM, SC q24hCat: 3 mg/kg q8h or 9 mg/kg IV, IM, SC q24hWARNING: Do NOT administer to patients that are dehydrated or acidotic; can cause acute renal failureGlipizideGlucotrolOral hypoglycemic/*variably effective control* of type 2 diabetes in cats5-and 10-mg tablets2.5--7.5 mg/cat PO q12h; usual dose is 2.5 mg/cat initially; then increase to 5 mg/cat q12hGlucosamine + chondroitin sulfateCosequin and other brandsNeutraceutical/*adjunctive treatment of nonseptic arthritis; may be useful in treating cats with lower urinary tract disease (FLUTD)*Regular (RS) and double-strength (DS) capsulesDog: 1--2 RS capsules per day (2--4 capsules of DS for large dogs)Cat: 1 RS capsule dailyGlyburideDiabeta; Micronase; GlynaseOral hypoglycemic/*variably effective control of type 2 diabetes in cats*1.25-,2.5-, and 5-mg tablets0.625 mg per cat once daily (represents one half of 1.25-mg tablet)Glycerin (OTC)GenericOral osmotic/*reduces intraocular (and CSF) pressure*Oral solution1--2 mL/kg PO q8hGlycopyrrolateRobinul-VAntimuscarinic/*multiple uses: pre-anesthetic medication, antidote*0.2 mg/mL injection0.005--0.011 mg/kg IV, IM, SCGold sodium thiomalateMyochrysineGold salt/*treatment of immune-mediated skin disorders*Injection1--5 mg IM 1st wk, then 2--10 mg IM 2nd wk, then 1 mg/kg IM once/wk maintenanceGold therapy*See* AurothioglucoseGoLYTELY*See* Polyethylene glycol electrolyte solutionGonadorelinFactrel; GnRH; LHRHHormone/*diagnosis and treatment of various reproductive disorders*50-μg/mL injectionTherapeutic doses:Dog: 50--100 μg/dog IM q24--48hCat: 25 μg/cat IM onceGonadotropin, human chorionic (hCG)Profasi; Pregnyl; APL; genericHormone/*induce luteinization*5000, 10,000 and 20,000 U injectionDog: 22 U/kg IM q24--48h or 44 U IM onceCat: 250 U/cat IM onceWARNING: Do NOT use in pregnant animalsGonadotropin-releasing hormone*See* GonadorelinGranisetronKytrilAntiemetic/*prevent emesis associated with chemotherapy*1 mg/mL injection; 1-mg tablet0.01 mg/kg (10 μg/kg) IVGriseofulvin (microsize)Fulvicin U/FAntifungal (fungistatic antibiotic)/*treatment of dermatophytes (especially M. canis)*125-,250-, and 500-mg tablets; 25 mg/mL oral suspension; 125 mg/mL oral syrup50 mg/kg PO q24h (up to a maximum dose of 110--132 mg/kg/day in divided treatments)Growth hormone (hGH)Humatrope; Nutropin; Protropin; Somatotropin; SomatremHormone/*replacement hormone in patients with confirmed deficiency.*5 and 10 mg/vial0.1 U/kg SC, IM three times per wk for 4--6 wkWARNING: Is diabetogenicHalothaneFluothaneInhalation anesthetic250 mL liquid*Induction*: 3%*Maintenance*: 0.5--1.5%Hemoglobin glutamerOxyglobinBlood substitute13 g/dL in 125 mg single-dose bags10--30 mL/kg, IV; or up to 10 mL/kg/hour.![](fx2.gif) Heparin sodiumLiquaeminAnticoagulant/*treat DIC and treatment and prevention of thromboembolic disease*1000 and 10,000 U/mL injection100--200 units/kg IV loading dose; then 100--300 units/kg SC q6--8h*Low-dose prophylaxis* (dog and cat): 70 U/kg SC q8--12h![](fx2.gif) Hydroxyethyl starch (HES)HetastarchVolume expander/*used when colloidal therapy is indicated*Injection10--20 mL/kg IV to effect, 20--30 mL/kg/day![](fx2.gif) HydralazineApresolineVasodilator/*hypertension and adjunctive treatment of heart failure*10-mg tablet; 20 mg/mL injectionDog: 0.5 mg/kg (initial dose); titrate to 0.5--2 mg/kg PO q12hCat: 2.5 mg/cat PO q12--24hHydrochlorothiazideHydroDIURIL; genericDiuretic/*hypertension, congestive heart failure, and nephrogenic (ADH-resistant) diabetes insipidus*10 and 100 mg/mL oral solution; 25-,50-, and 100-mg tablets2--4 mg/kg PO q12hHydrocodone bitartrateHycodan (contains atropine)Analgesic (opiate)/*pain management*5-mg tabletDog: 0.22 mg/kg PO q4--8hCat: no dose availableHydrocortisoneCortef; genericGlucorticoid/*antiinflammatory and replacement therapy in adrenal insufficient conditions*5-,10-, and 20-mg tablets*Replacement therapy*: 1--2 mg/kg PO q12h*Antiinflammatory*: 1.5--5 mg/kg PO q12h![](fx2.gif) Hydrocortisone sodium succinateSolu-CortefGlucorticoid/*antiinflammatory* and shock treatmentVarious size vials for injection*Shock*: 50--150 mg/kg IVAntiinflammatory: 5 mg/kg IV q12h![](fx2.gif) Hydromorphone DilaudidAnalgesic (opiate)/*pain management and restraint*Tablets, oral solution, and injectable (IM) forms availableDog: 0.22 mg/kg, IM, SC, q4--6h as needed for pain.HydroxyureaHydreaAntineoplastic/*polycythemia vera, mastocytoma, leukemias*500-mg capsuleDog: 50 mg/kg PO once daily,3 days/wkCat: 25 mg/kg PO once daily,3 days/wkHydroxyzineAtaraxAntihistamine/*antipruritic and sedative effects, especially in atopic patients*10-,25-, and 50-mg tablets; 2 mg/mL oral solutionDog: 1--2 mg/kg q6--8h IM, POCat: DO NOT USEIfosfamideIfexAntineoplastic/*lymphomas and other sarcomas*1 gram powder for IV infusion in single-dose vialsDogs and cats: Dose ranges from 300 to500 mg/m^2^ IVCAUTION: Consult treatment protocol before administeringImidaclopridAdvantageTopical flea treatment for dogs and catsTopical solutionApply topically once monthly as directed by the manufacturer for the treatment of fleasImidacloprid + permethrinK9 AdvantixTopical flea treatment and tick repellent for DOGS ONLYTopical solutionApply topically once monthly as directed by the manufacturer for the treatment of fleasCat: DO NOT USE; contains permethrinImipenem + cilastinPrimaxinAntibacterial250-or 500-mg vials for injection5--10 mg/kg IV, IM q6--8h; has been administered to dogs at 10 mg/kg q8h SCImidocarb dipropinateImizolAntiprotozoal/*treatment of babesia, ehrlichiosis (not regarded as effective), Cytauxzoon felis, and related infections*Parenteral solution for IM or SC injection; 120 mg/mL in 10-mL multi-dose vialsDog:5 mg/kg IM or SC once;repeat in 2 wk*For babesiosis*: 6.6 mg/kg IM or SC once; repeat in 2 wk)Cat: (cytauxzoonosis) 5 mg/kg IM q2wk as neededImipramineTofranilTricyclic antidepressant/*treatment of behavior disorders*10-,25-, and 50-mg tablets2--4 mg/kg PO q12--24hIndomethacinIndocinSafe dose has not been establishedInterferon (interferon alpha-2a, HulFN-alpha)RoferonCytokine/*immunomodulation in cats with FeLV and/or FIV infection (clinical value of treatment is not established)*3 million U/vialCat: 30 U/cat/day, PO; or 15--30 U/cat IM or SC once daily for 7 days and repeated every other wkIpecac syrup (OTC)IpecacOral emeticNO LONGER RECOMMENDED: can cause fatal arrhythmiasIpodateBilivist; OragrafinOrganic iodine/*treatment of hyperthyroidism (especially in cats)*500-mg capsules (should be formulated for cats as 50-mg ampules)Dog: 15 mg/kg, PO, q12hCat: 100--200 mg (total dose)/cat once daily; dose may be reduced if the 2-wk response is judged satisfactoryIron*See* Ferrous sulfate![](fx2.gif) IsofluraneIsoflurane; Forane; Aerrane; othersInhalation anesthetic100-mL bottleInduction: 5%Maintenance: 1.5--2.5%![](fx2.gif) IsoproterenolIsuprelBeta-agonist/*uncommonly used to treat acute bronchoconstriction and certain cardiac arrhythmias*0.2 mg/mL ampules for injection10 μg/kg IM, SC q6h; or dilute 1 mg in 500 mL of 5% dextrose or Ringer\'s solution and infuse IV 0.5--1 mL/min (1--2 μg/min) or to effect![](fx2.gif) Isosorbide dinitrateIsordil; Isorbid; SorbitrateVasodilator/*congestive heart failure*2.5-,5-,10-,20-,30-, and 40-mg tablets;40-mg capsules2.5--5 mg/animal PO q12h (or 0.22-1.1 mg/kg PO q12h)![](fx2.gif) Isosorbide mononitrateMonoketVasodilator/*congestive heart failure*10-and 20-mg tablets5 mg/dog PO, two doses/day 7 h apartIsotretinoinAccutaneSynthetic retinoid/*treatment of dermatologic diseases associated with epithelial cell proliferation (e.g., ichthyosis, cutaneous lymphoma)*10-,20-, and 40-mg capsules1--3 mg/kg/day (up to maximum recommended dose of 3--4 mg/kg/day PO)ItraconazoleSporanoxAntifungal/*treatment of systemic mycoses*100-mg capsulesDog: 2.5 mg/kg PO q12h or 5 mg/kg PO q24hCat: 1.5--3.0 mg/kg PO up to 5 mg/kg PO q24hIvermectinHeartgard; Ivomec; Eqvalan liquidAntiparasiticide/*multiple applications*1% (10 mg/mL) injectable solution; 10 mg/mL oral solution; 18.7 mg/mL oral paste; 68-,136-, and 272-μg tabletsHeartworm preventative:Dog: 6 μg/kg (range: 3 to 12 μg/kg) PO q30 daysCat: 24 μg/kg PO q30days*Microfilaricide*: 50 μg/kg PO 2 wk after adulticide therapy*Ectoparasite therapy* (dog and cat): 200--300-μg/kg IM, SC, PO*Endoparasites* (dog and cat): 200--400 μg/kg SC, PO weekly*Demodex therapy*: 600 μg/kg/day PO for 60--120 daysKanamycinKantrimAntibacterial200-and 500-mg/mL injection10 mg/kg IV, IM, SC q6--8hKaopectate (kaolin + pectin) (OTC)KaopectateGI adsorbent/*management of acute, simple diarrheal disorders, especially result of dietary indiscretion*12 oz oral suspension1--2 mL/kg PO q2--6h![](fx2.gif) KetamineKetalar; Ketavet; VetalarDissociative anesthetic100 mg/mL injection solutionDog: 5.5--22 mg/kg IV, IM (recommend adjunctive sedative or tranquilizer treatment)Cat:2--25 mg/kg IV, IM (recommend adjunctive sedative or tranquilizer treatment)KetoconazoleNizoralAntifungal/*systemic mycoses, Malassezia canis infection; limited application in the treatment of canine hyperadrenocorticism*200-mg tablet; 100 mg/mL oral suspension (only available in Canada)Dog: 10--15 mg/kg PO q8--12h*Malassezia canis:* 10 mg/kg PO q24h or 5 mg/kg PO q12h)Cat: 5--10 mg/kg PO q8--12h*Hyperadrenocorticism:*Dog: 15 mg/kg PO q12h![](fx2.gif) KetoprofenOrudis-KT (OTC); KetofenNSAID/*pain management*12.5-mg tablet (OTC); 100 mg/mL injectionDog and cat: 1 mg/kg PO q24h for up to5 days or 2.0 mg/kg IV, IM, SC for one doseKetorolac tromethamineToradolNSAID/*pain management*10-mg tablet; 15 and 30 mg/mL injection in 10% alcoholDog: 0.5 mg/kg PO, IM, IV q12h for not more than two dosesCat: DO NOT USEL-DopaSee Levodopa![](fx2.gif) Lactated Ringer\'s solutionGenericFluid replacement250-,500-, and 1000-mL bags*Maintenance:* 40--50 mL/kg/day IV*Shock therapy:*Dog: 90 mL/kg IVCat: 60--70 mL/kg IVLactuloseChonulac; genericDisaccharide laxative/*limit bowel absorption of protein and facilitate lowering of blood ammonia levels in patients with hepatic encephalopathy*10 g/15 mL*Constipation:* 1 mL/4.5 kg PO q8h (to effect)*Hepatic encephalopathy:*Dog: 0.5 mL/kg PO q8hCat: 2.5--5 mL/cat PO q8h![](fx2.gif) Leucovorin (folinic acid)Wellcovorin; genericAntidote/*folic acid antagonism; application in dogs and cats is not established*5-,10-,15-, and 25-mg tablets; 3 and 5 mg/mL injection*With methotrexate administration:* 3 mg/m^2^ IV, IM, PO*Antidote for pyrimethamine toxicosis:* 1 mg/kg PO q24hLevamisoleLevasole, Tramisol InjectableAntiparasitic/*treatment of nematode infection; also proposed to be a non-specific immunostimulant*0.184-g bolus;11.7-g/13-g packet; 50-mg tabletDog:*Hookworms:* 5--8 mg/kg PO once (up to10 mg/kg PO for 2 days)*Microfilaricide:* 10 mg/kg PO q24h for 6--10 days*Immunostimulant:* 0.5--2 mg/kg PO 3 times/wkCat: 4.4 mg/kg once PO (for *lungworms:* 20--40 mg/kg PO q48h for five treatments)LevodopaLarodopa; l-DopaDopamine agonist/hepatic encephalopathy100-, 250-, and 500-mg tablets or capsulesHepatic encephalopathy: 6.8 mg/kg initially; then 1.4 mg/kg q6hLevothyroxine sodium (T~4~)Soloxine; Thyro-Tabs; SynthoidHormone/*hypothyroidism*0.1-to 0.8-mg tablets (in 0.1-mg increments)Dog: 18--22 g/kg, PO, q12h (adjust dose via monitoring T~4~ levels)Cat: 10--20 g/kg/day, PO (adjust dose via monitoring T~4~ levels)![](fx2.gif) Lidocaine (without epinephrine)Xylocaine; genericAnesthetic and antiarrhythmic/*ventricular arrhythmias; also local and regional anesthetic; has been used systemically for pain*5-,10-,15-, and 20-mg/mL injectionDog *(antiarrhythmic):* 2--4 mg/kg IV (to a maximum dose of 8 mg/kg over 10-min period); 25--75 g/kg/min IV infusionCat *(antiarrhythmic):* 0.25--0.75 mg/kg IV slowly; for epidural (dog and cat): 4.4 mg/kg of 2% solutionLincomycinLincocinAntibacterial100-,200-, and 500-mg tablets15--25 mg/kg PO q12h*For pyoderma:* Doses as low as 10 mg/kg q12h have been usedLiothyronine (T~3~)CytomelHormone (active form of ^T^3^)/^*replacement therapy in patients with hypothyroidism that fail to respond to T~4~*60-μg tablet4.4 g/kg PO q8h*For T~3~ suppression test (cats):* Collect presample for T~4~ and T~3~; administer 25 g q8h for 7 doses; then collect post samples for T~3~ and T~4~ after last doseLisinoprilPrinivil; ZestrilACE inhibitor/*vasodilator for treatment of hypertension or heart failure*2.5-,5-,10-,20-, and 40-mg tabletsDog: 0.5 mg/kg PO q24hCat: No dose establishedLithium carbonateLithotabsNonspecific immunostimulant/*adjunctive treatment to increase neutrophil counts in patients with chemotherapy-induced neutropenia*150-,300-, and 600-mg capsules; 300-mg tablet; 300 mg/5 mL syrupDog: 10 mg/kg PO q12hCat: Not recommendedLoperamideImodium; genericAnalgesic (opiate)/*nonspecific* management of diarrhea2-mg tablet; 0.2 mg/mL oral liquidDog: 0.1 mg/kg PO q8--12hCat: 0.08--0.16 mg/kg PO q12hLufenuronProgramAntiparasitic/*flea control*45-,90-,135-,204.9-and 409.8-mg tablets; 135 and 270 mg suspension per unit packDog: 10/mg/kg PO q30daysCat: 30 mg/kg PO q30days; 10 mg/kg SC q6moLufenuron + milbemycin oximeSentinel tablets; Flavor TabsAntiparasitic/*flea control plus heartworm preventative effective against certain intestinal parasites*Milbemycin/lufenuron ratio is as follows: 2.3/46-mg Sentinel tablets; 5.75/115-,11.5/230-, and 23/460-mg Flavor TabsDog: Administer 1 tablet q30days as recommended by manufacturer (each tablet formulated for size of dog)Cat: DO NOT USELuteinizing hormone*See* Gonadorelinl-Lysine (OTC)l-Lysine (multiple preparations)Amino acid/*prevention of feline herpesvirus-1 recrudesence*250-500-mg capsulesCat (empiric dose): Mix 250 mg with food once dailyNOTE: Efficacy studies have not been performed; no known effect on feline calicivirus carrier cats![](fx2.gif) Magnesium chlorideGenericElemental salt/*ventricular dysrhythmias, refractory hypokalemia, and ventricular fibrillation*200 mg/mL in 50-mL vials for injection0.15--0.3 mEq/kg IV over 2--10 min; or0.75 mEq/kg/day IV by CRIMagnesium citrateCitroma; Citro-Nesia (Citro-Mag in Canada)LaxativeOral solution2--4 mL/kg POMagnesium hydroxide (OTC)Milk of MagnesiaLaxativeOral liquid*Antacid:* 5--10 mL/kg PO q4--6h*Cathartic:* Dog: 15--50 PO mL/kgCat: 2--6 mL/cat PO q24hMagnesium sulfate (OTC)Epsom saltsLaxative/*also used for oral magnesium supplementation*Crystals; many generic preparationsDog: 8--25 g/dog PO q24hCat: 2--5 g/cat PO q24h![](fx2.gif) MannitolOsmitrolDiuretic (osmotic)/*management of anuric and/or oliguric renal failure; applications in management of glaucoma* and cerebral edema5--25% solution for injection*Diuretic:* 1 g/kg 5--25% solution IV to maintain urine flow*Glaucoma or CNS edema:* 0.25--2 g/kg 15--25% solution IV over 30--60 min (repeat in 6 h if necessary)MarbofloxacinZeniquinAntibacterial25-,50-,100-,200-mg tabletsDog: 2.75--5.55 mg/kg PO q24hCat: dose not establishedMCT oilMCT oil (many sources)Medium-chain triglyceride/*lipid supplement used in patients with GI absorptive disorders*Oral liquid1--2 mL/kg/day in foodMebendazoleTelminticAntiparasitic/*multiple applications for treatment of endoparasites*40 mg/powder22 mg/kg (with food) q24h for 3 days![](fx2.gif) MeclizineAntivert; genericAntihistamine/*antiemetic, especially when nausea is associated with vertigo*12.5-,25-, and 50-mg tabletsDog: 25 mg PO q24h (for motion sickness, administer 1 h before traveling)Cat: 12.5 mg PO q24hMeclofenamateArquel; MeclomenNSAID/*pain management*50-and 100-mg capsulesDog: 1 mg/kg/day PO for up to 5 days![](fx2.gif) MedetomidineDomitorAnalgesic/*adjunct for anesthesia; restraint*1.0 mg/mL injection750 μg/m^2^ IV or 1000 g/m^2^ IMMedium-chain triglycerides*See* MCT oilMedroxyprogesterone acetateDepo-Provera (injection); Provera (tablets)Hormone/*management of certain dermatologic and behavior disorders, including urine spraying in cats; benign prostatic hyperplasia;*150 and 400 mg/mL suspension injection; 2.5-,5-, and 10-mg tablets1.1--2.2 mg/kg IM q7days*Behavior disorders:* 10--20 mg/kg SC*Prostatic hyperplasia:* 3--5 mg/kg SC, IMMegstrol acetateOvaban; MegaceHormone/*management of certain dermatologic and behavior disorders, including urine spraying in cats*5-mg tabletDog:*Proestrus:* 2 mg/kg PO q24h for 8 days*Anestrus:* 0.5 mg/kg PO q24h for 30 days*Behavior disorders:* 2--4 mg/kg q24h for 8 days (reduce dose for maintenance)Cat (NOTE: Any use in cats is EXTRA-LABEL):*Dermatologic therapy or urine spraying:* 2.5--5 mg/cat PO q24h for 1 wk; then reduce to 5 mg once or twice/wk*Estrus suppression:* 5 mg/cat/day for 3 days; then 2.5--5 mg once/wk for 10 wkMelarsomineImmiticideAntiparasitic (arsenical)/*treatment of canine heartworm disease*25 mg/mL injection; after reconstitution retains potency for 24 hAdminister via deep IM injectionClass 1--2 dogs: 2.5 mg/kg/day for 2 consecutive daysClass 3 dogs: 2.5 mg/kg once, then in 1 mo two additional doses 24 h apartCat: DO NOT USE![](fx2.gif) MeloxicamMetacamNSAID/*pain management*1.5 mg/mL oral solution0.2 mg/kg PO, initial loading dose; then0.1 mg/kg PO q12hMelphalanAlkeranAntineoplastic/*used in treatment protocols for multiple tumor types*2-mg tablet1.5 mg/m^2^ or 0.1--0.2 mg/kg PO q24h for7--10 days; repeat every 3 wkMeperidineDemerolAnalgesic (opiate)/*pain management*50-and 100-mg tablets;10 mg/mL syrup; 25,50,75, and 100 mg/mL injectionDog: 5--10 mg/kg IV, IM as often as q2--3h (or as needed)Cat: 3--5 mg/kg IV, IM q2--4h (or as needed)MepivicaineCarbocaine-VLocal anesthetic2% (20 mg/mL) injectionVariable dose for local infiltration*For epidural*,0.5 mg of 2% solution q30sec until reflexes are absent.6-MercaptopurinePurinetholAntineoplastic/*used in treatment protocols for multiple tumor types*50-mg tablet50 mg/m^2^ PO q24hCaution: Consult treatment protocol before administering.MeropenemMerremAntibacterial/*especially in treating resistant infections caused by Pseudomonas, E. coli,* and Klebsiella500 mg in 20-mL vial, or 1 g in 30-mL vial for injection20 mg/kg IV q8h*For meningitis*: 40 mg/kg IV q8hMesalamineAsacol; Mesasal; PentasaAntidiarrheal/*alternative use in patients unable to tolerate sulfasalazine in treatment of colitis*400-mg tablet; 250-mg capsuleVeterinary dose has not been established.The usual human dose is 400--500 mg q6--8h (also see Sulfasalazine, Olsalazine)MetaproterenolAlupent; MetaprelBeta-agonist/*bronchodilator therapy*10-and 20-mg tablets; 5 mg/mL syrup; inhalers0.325--0.65 mg/kg PO q4--6hMetaforminGlucophageOral hypoglycemic/*management of type 2 diabetes in cats*500-and 800-mg tabletsCats: 2 mg/kg PO q12hMethazolamideNeptazaneCarbonic anhydrase inhibitor/*treatment of open-angle glaucoma*25-and 50-mg tablets2--4 mg/kg (up to maximum dose of 4--6 mg/kg) PO q8--12hMethenamine hippurateHiprex; UrexUrinary antiseptic/*of questionable value*1-g tabletDog: 500 mg/dog PO q12hCat: 250 mg/cat PO q12hMethenamine mandelateMandelamine; genericUrinary antiseptic/*of questionable value*1-g tablet; granules for oral solution; 50 and 100 mg/mL oral suspension10--20 mg/kg PO q8--12hMethimazoleTapazoleAntithyroidal/*management of feline hyperthyroidism*5-and 10-mg tabletsCat: 2.5 mg/cat q12h PO for 7--14 days; then 5--10 mg/cat PO q12h and adjust by monitoring T~4~Methionine (DL)Uroeze; DL-methionine powderUrinary acidifier500-mg tablets and powders added to animal\'s food; 75 mg/5 mL pediatric oral solution; 200-mg capsuleDog: 150--300 mg/kg/day POCat: 1--1.5 g/cat PO (added to food each day)Methionine (*S*-adenosyl)*See* SAMe![](fx2.gif) MethocarbamolRobaxin-VMuscle relaxant/*adjunctive therapy for trauma, acute inflammation of skeletal muscle and/or tremorigenic* toxins500-and 750-mg tablets;44 mg/kg PO q8h on the first day; then100 mg/mL injection22--44 mg/kg PO q8hMethohexitalBrevitalUltra-short-acting barbiturate/*anesthetic induction*0.5-,2.5-, and 5-gram vials for injection3--6 mg/kg IV (give slowly to effect)MethotrexateMTX; Mexate; Folex; Rheumatrex; genericAntineoplastic/*used in treatment protocols for multiple tumor types, especially lymphomas*2.5-mg tablet; 2.5 or 25 mg/mL injection2.5--5 mg/m^2^ PO q48h (dose depends on specific protocol) or:Dog: 0.3--0.5 mg/kg IV once/wkCat: 0.8 mg/kg IV q2--3wk![](fx2.gif) MethoxamineVasoxylVasopressor/*used in critical care setting to increase blood pressure*20 mg/mL injection200--250 g/kg IM or 40--80 g/kg IVMethoxyfluraneMetofaneInhalation anesthetic/*uncommonly used today*4-oz bottle for inhalation*Induction:* 3%*Maintenance:* 0.5--1.5%![](fx2.gif) Methylene blue 0.1%Generic; also called new methylene blueAntidote/*emergency treatment of methemoglobinemia*1% solution (10 mg/mL)1.5 mg/kg IV slowly; use once.MethylprednisoloneMedrolGlucorticoid/*antiinflammatory and immunosuppressive*1-,2-,4-,8-,18-, and 32-mg tabletsIn cats, Use With Caution 0.22--0.44 mg/kg PO q12--24hNOTE: Methylprednisolone is 1.25 times more potent than prednisoloneMethylprednisolone acetateDepo-MedrolRepository glucocorticoid/*antiinflammatory (extended duration of activity)*20 and 40 mg/mL suspension for injectionDog: 1 mg/kg (or 20--40 mg/dog) IM q1--3wkCat: 10--20 mg/cat IM q1--3wkNOTE: Actual dose may vary, depending on use and effect![](fx2.gif) Methylpredni-solone sodium succinateSolu-MedrolGlucocorticoid/*adjunctive treatment for patients in shock or with spinal cord trauma/swelling*1-and 2-g and 125-and 500-mg vials for injection*For emergency* use: 30 mg/kg IV; repeat at 15 mg/kg IV in 2--6 hFor replacement therapy or antiinflammatory therapy; see also Prednisolone![](fx2.gif) 4-Methylpyrazole (4-MP)*See* FomepizoleMethyltestosteroneAndroid; genericHormone/*replacement therapy; also an anabolic agent used to induce erythropoiesis*10-and 25-mg tabletsDog: 5--25 mg/dog PO q24--48hCat: 2.5--5 mg/cat PO q24--48h![](fx2.gif) MetoclopramideReglan: Maxolon; othersAntiemetic/*especially in patients with vomiting associated with gastroparesis*5-and 10-mg tablets;0.2--0.5 mg/kg IV, IM, PO q6--8h; or1 mg/mL oral solution; 5 mg/mL injection1--2 mg/kg/day IV by CRI (approx 0.1--0.2 mg/kg/h)MetoprololLopressorBeta blocker/*management of tachycardia*50-and 100-mg tablets; 1 mg/mL injectionDog: 5--50 mg/dog (0.5--1.0 mg/kg) PO q8hCat: 2--15 mg/cat PO q8h![](fx2.gif) MetronidazoleFlagyl; genericAntiparasitic and antibacterial/*effective against anaerobic bacteria; somewhat effective against Giardia (fenbendazole is preferred)*250-and 500-mg tablets; 50 mg/mL suspension; 5 mg/mL injection*Anaerobic infection:*Dog: 15 mg/kg PO q12h or 12 mg/kg q8h;Cat: 10--25 mg/kg PO q24h*Giardia:* Dog: 12--15 mg/kg PO q12h for 8 days;Cat: 17 mg/kg (⅓ tablet per cat) q24h for 8 days![](fx2.gif) MexiletineMexitilAntiarrhythmic/*ventricular arrhythmias*150-,200-, and 250-mg capsulesDog: 5--8 mg/kg PO q8--12h (USE CAUTIOUSLY)Cat: No dose establishedMiboleroneCheque DropsHormone (androgenic)/*suppression of estrus and treatment of false pregnancy (pseudocyesis)*55 μg/mL oral solutionDog: 0.45--11.3 kg,30 μg; 11.8--22.7 kg,60 μg; 23--43.3 kg,120 μg; \>45.8 kg,180 μg; or approximately 2.6--5-μg/kg/day POCat: DO NOT USEWARNING: Multiple adverse effects are possible when used in prepubertal females![](fx2.gif) MidazolamVersedBenzodiazepine/*pre-anesthetic medication*5 mg/mL injection0.1--0.25 mg/kg IV, IM (or 0.1--0.3 mg/kg/h IV infusion)NOTE: May cause excitement in catsMilbemycin oximeInterceptor; Interceptor Flavor TabsGABA inhibitor/*prevention of canine heartworm disease, microfilaricide; also used to treat demodicosis*23-,11.5-,5.75-, and 2.3-mg tabletsDog:*Microfilaricide:* 0.5 mg/kg*Demodex:* 2 mg/kg PO q24h for 60--120 days*Heartworm prevention:* 0.5 mg/kg PO q30daysMilk of Magnesia (OTC)*See* Magnesium hydroxideMineral oil (OTC)GenericLaxative (lubricant)Oral liquidDog: 10--50 mL/dog PO q12hCat: 10--25 mL/cat PO q12hMinocyclineMinocinAntibacterial50-and 100-mg tablets;10 mg/mL oral suspension5--12.5 mg/kg PO q12h![](fx2.gif) MisoprostolCytotecProstaglandin E~1~ analog/*treatment of gastric ulcers, especially those associated with NSAID use*0.1-mg (100-μg) andDog: 2--5 μg/kg PO q6--8h0.2-mg (200-μg) tabletsCat: Dose not establishedMitotane (o, p¢-DDD)LysodrenCytotoxic agent/*treatment of hyperadrenocorticism associated with adrenal hyperplasia; less effective if treating adrenal gland neoplasia*500-mg tabletDog:*Pituitary-dependent hyperadrenocorticism:* 50 mg/kg/day (in divided doses) PO for 7--10 days; then 25 mg/kg/wk PO*Adrenal neoplasia:* 50--75 mg/kg/day for 10 days; then 75--100 mg/kg/wk POMitoxantroneNovantroneAntineoplastic/*used in treatment protocols for multiple tumor types*2 mg/mL injectionDog: 6 mg/m^2^ IV q21daysCat: 6.5 mg/m^2^ IV q21days![](fx2.gif) MorphineGenericAnalgesic (opiate)/*pain management*1 and 15 mg/mL injection; 30-and 60-mg delayed-release tabletsDog: 0.1--1 mg/kg IV, IM, SC (dose is escalated as needed for pain relief) q4--6h*Epidural*: 0.1 mg/kgCat: 0.1 mg/kg q3--6h IM, SC (or as needed)![](fx2.gif) NaloxoneNarcanOpiate antagonist/opiate reversal20 and 400 μg/mL injection0.01--0.04 mg/kg IV, IM, SC as needed to reverse opiateNaltrexoneTrexanOpiate antagonist/*management of certain behavioral disorders (e.g., tail chasing, self-mutilation)*50-mg tabletDog: 2.2 mg/kg PO q12hNandrolone decanoateDeca-DurabolinAnabolic steroid/*appetite stimulant; also used to stimulate erythropoiesis*50,100, and 200 mg/mL injectionDog: 1--1.5 mg/kg/wk IMCat: 1 mg/cat/wk IMNaproxenNaprosyn; Naxen; Aleve (naproxen sodium)NSAID/*pain management*220-mg tablet (OTC); 25-mg/mL suspension liquid; 250-,375-, and 500-mg tablets (Rx)Dog: 5 mg initially, then 2 mg/kg q48hNeomycinBiosolAntibacterial/*management of hepatic encephalopathy (gut "sterilization")*500-mg bolus; 200 mg/mL oral liquid10--20 mg/kg PO q6--12hNeostigmine bromide and neostigmine methylsulfateProstigmin; StiglynAnticholinesterase/*diagnosis of myasthenia gravis; antidote for anticholinergic intoxication and massive ivermectin overdose in cats*15-mg tablet (neostigmine bromide); 0.25 and 0.5 mg/mL injection (neostigmine methylsulfate)2 mg/kg/day PO (in divided doses, to effect)*Injection:* antimyasthenic: 10 μg/kg IM, SC, as needed; antidote for nondepolarizing neuromuscular block: 40μg/kg IM, SC; diagnostic aid for myasthenia gravis: 40 μg/kg IM or 20 μg/kg IVNitrofurantoinMacrodantin; Furalan; Furatoin; Furadantin; genericAntibacterial/*especially in susceptible urinary tract infectionsMacrodantin and generic:* 25-, 50-, and 100-mg capsules *Furalan, Furatoin, and generic:* 50-and 100-mg tablets *Furadantin:* 5 mg/mL oral suspension10 mg/kg/day divided into four daily treatments; then 1 mg/kg PO at night![](fx2.gif) Nitroglycerin ointmentNitrol; Nitro-Bid; NitrostatVenodilator/*management of congestive heart failure*0.5,0.8,1,5-, and 10 mg/mL injection; 2% ointment; transdermal (0.2 mg/h systems patch)Dog: 4--12 mg (up to 15 mg) topically q12hCat: 2--4 mg topically q12h (or ¼ inch of ointment per cat)![](fx2.gif) NitroprussideNitropressVascular and smooth muscle relaxant/*acute hypertension; acute heart failure secondary to mitral regurgitation*50-mg vial for injection1--5 mg, up to maximum of 10 μg/kg/min IV infusionNizatidineAxidH~2~ receptor antagonist/*reduce gastric acid production and prevention of gastric ulcers*150-and 300-mg capsules2.5--5.0 mg/kg, PO once dailyNorfloxacinNoroxinAntibacterial400-mg tablet22 mg/kg PO q12hOlsalazineDipentumAntidiarrheal/*alternative drug to sulfasalazine for management of colitis in dogs (expensive)*500-mg tabletDosage in animals is not establishedDog: 5--10 mg/kg, PO q8h is recommendedOmeprazolePrilosec (formerly Losec); Gastrogard (equine paste)Proton pump inhibitor/*gastric ulceration and erosion*20-mg capsuleDog: 20 mg/dog PO once daily (or 0.7 mg/kg q24h)Cat: DO NOT USE![](fx2.gif) OndansetronZofran5-HT~3~ receptor antagonist/*antiemetic for patients with severe vomiting*4-and 8-mg tablets; 2 mg/mL injection0.1--1.0 mg/kg PO 30 min before cancer chemotherapy*For intractable vomiting:* 0.11 to 0.176 mg/kg, IV slow pushOrbifloxacinOrbaxAntibacterial5.7-,22.7-, and 68-mg tablets2.5 to 7.5 mg/kg PO once dailyOrmetoprim + SulfadimethoxinePrimorAntibacterialCombination tablet: 120-,250-, 600-, and 1200-mg tablets.27 mg/kg on 1st day followed by 13.5 mg/kg PO q24hOxacillinProstaphlin; genericAntibacterial250-and 500-mg capsules; 50 mg/mL oral solution22--40 mg/kg PO q8hOxazepamSeraxBenzodiazepine/*appetite* stimulant15-mg tabletCat: appetite stimulant: 2.5 mg/cat POOxtriphyllineCholedyl-SABronchodilator/*chronic bronchitis (feline asthma?)*400-and 600-mg tablets (oral solutions and syrup available in Canada but not U.S.)Dog: 47 mg/kg (equivalent to 30 mg/kg theophyllline) PO q12hCat: Dose Not AvailableOxybutyninDitropanUrinary antispasmodic/*adjunctive treatment of detrusor hyperreflexia (includes FeLV-positive cats)*5-mg tabletDog: 0.2 mg/kg PO q8--12h (or 1.25 to 3.75 mg/dog q12h)Cat: 0.5--1.0 mg/kg PO q8--12hOxymetholoneAnadrolHormone (anabolic steroid)/*may stimulate erythropoiesis*50-mg tablet1--5 mg/kg/day POOxymorphoneNumorphanAnalgesic (opiate)/*pain management*1.5 and 1 mg/mL injection*Analgesia*: 0.1--0.2 mg/kg IV, SC, IM (as needed); redose with 0.05--0.1 mg/kg q1--2h. *Preanesthetic*: 0.025--0.05 mg/kg IM, SCOxytetracyclineTerramycinAntibacterial250-mg tablets; 100 and 200 mg/mL injection7.5--10 mg/kg IV q12h; 20 mg/kg PO q12hOxytocinPitocin; Syntocinon (nasal solution); genericHormone/*induction of labor or parturition*10 and 20 U/mL injection; 40 U/mL nasal solutionDog: 5--20 U/dog SC, IM (repeat every 30 min for primary inertia) Cat: 3--5 U/cat SC, IM (repeat every 30 min)2-PAM*See* Pralidoxime chloridePancreatic enzymeViokaseDigestive enzymes/*management of exocrine insufficiency*16,800 U lipase, 70,000 U protease, and 70,000 U amylase per 0.7 g; also capsules and tabletsMix 2 tsp powder with food/20 kg; or 1--3 tsp/0.45 kg of food 20 min before feedingPancuronium bromidePavulonNeuromuscular blocker/*muscle relaxation as an* adjunct to anesthesia1 and 2 mg/mL injection0.1 mg/kg IV, or start with 0.01 mg/kg and additional doses of 0.01 mg/kg q30minParegoricCorrective mixtureAntidiarrheal/*management of simple diarrhea*2 mg morphine per 5 mL of paregoric0.05--0.06 mg/kg PO q12hParomomycinHumatinAntiparasitic/*cryptosporidiosis in cats*250-mg capsulesCat: 125--165 mg/kg, PO, q12h for 7 days.WARNING: toxicity and renal damage have been reported at these dosesParoxetinePaxilSelective serotonin reuptake inhibitor (SSRI)/*management of behavior disorders*10-,20-,30-, and 40-mg tabletsDog and Cat: 2.5--5.0 mg (total dose)PO once dailyCat (alternative): ⅛ to ¼ of 10-mg tablet daily POD-PenicillamineCuprimine; DepenChelating agent/*treatment of lead poisoning; also for cystine urolithiasis*125-and 250-mg capsules and 250-mg tablets10--15 mg/kg PO q12hPenicillin G benzathineBenza-Pen; othersAntibacterial1,50,000 U/mL, combined with 1,50,000 U/mL procaine penicillin G24,000 U/kg IM q48hPenicillin G potassium; penicillin G sodiumMultipleAntibacterial5 million-- to 20 million--unit vials20,000--40,000 U/kg IV, IM q6--8hPenicillin G procaineGenericAntibacterial30,0000 U/mL suspension20,000--40,000 U/kg IV, IM q12--24hPenicillin VPen-VeeAntibacterial250-and 500-mg tablets10 mg/kg PO q8hPentazocineTalwin-VAnalgesic (opiate)/*pain management*30 mg/mL injectionDog: 1.65--3.3 mg/kg IM q4hCat: 2.2--3.3 mg/kg IV, IM, SC; 25--30 mg/kg![](fx2.gif) PentobarbitalNembutal; genericAnesthetic/*sedative or injectable anesthetic*50 mg/mLIV for anesthesiaNOTE: This formulation isNOT to be used for euthanasia.PentoxifyllineTrentalAntiinflammatory effects/*has been used to treat immune-mediated skin disorders (e.g., associated with vasculitis)* in dogs400-mg tabletDog: For use in canine dermatology and for vasculitis,10 mg/kg PO q12h![](fx2.gif) PhenobarbitalLuminal; genericBarbiturate/*sedation and anticonvulsant*15-,30-,60-, and 100-mg tablets; 30,60,65, and 130 mg/mL injection; 4 mg/mL oral elixir solutionDog: 2--8 mg/kg PO q12hCat: 2--4 mg kg PO q12hDog and cat: Adjust dose by monitoring plasma concentration*Status epilepticus*: Administer in increments of 10--20 mg/kg IV to effectPhenoxybenzamineDibenzylineAlpha-adrenergic blocker/*reduces internal urethral sphincter tone associated with detrusor areflexia; also hypertension associated with pheochromocytoma*10-mg capsuleDog:*Urinary*: 0.25 mg/kg PO q8--12h or 0.5 mg/kg q24h*Hypertension*: 0.2--1.5 mg/kg, PO bid for 10--14 days before surgeryCat: 2.5 mg/cat q8--12h or 0.5 mg/cat PO q12hNOTE: In cats, doses as high as 0.5 mg/kg IV have been used to relax urethal smooth musclePhentolamineRegitineVasodilator/*hypertension*5-mg vial for injection0.02--0.1 mg/kg IVPhenylbutazoneButazolidin; genericNSAID100-,200-,400-mg and 1-g tablets; 200 mg/mL injectionNOT recommended for use in dogs and cats (better drugs are available)![](fx2.gif) PhenylephrineNeo-SynephrineAlpha-adrenergic/*treatment of hypotension in the critical care setting; also used topically intranasally prior to rhinoscopy*10 mg/mL injection; 1% nasal solutionDog and Cat: 1--3 μg/kg/min CRI in 0.9% saline or D5W;0.1 mg/kg, IM, SC, q15min*Topical*: 3--5 drops intranasally to effect to induce local vasoconstrictionPhenylpropanol-amineDexatrim; Propagest; othersAdrenergic agonist/*urinary incontinence associated* with urethral sphincter hypotonus15-,25-,30-, and 50-mg tabletsDog: 12.5--50 mg (total) PO q8h or 1.5--2 mg/kg, PO, q12hCat: 12.5 mg (total) PO q8h or1.5 mg/kg, PO, q8hPhenytoinDilantinAnticonvulsant/*not generally recommended; limited application in digoxin-induced arrhythmias*30 and 1250 mg/mL oral suspension; 30-and 100-mg capsules; 50 mg/mL injection*Antiepileptic* (dog): 20--34 mg/kg q8h*Digoxin-induced antiarrhythmic*: 30 mg/kg PO q8h or 10 mg/kg IV over 5 min![](fx2.gif) Phenytoin + Pentobarbital sodiumBeuthanasia-D Special; EuthasolEuthanasia solution100-mL multiple dose vials1 mL/10 lb body weight IV. NOTE: Alternative routes (at the same dosage) can be used in profoundly debilitated patients (e.g., intraperitoneal, intracardiac)PhysostigmineAntiliriumCholinesterase inhibitor/*limited application; may be of use in promoting micturition in patients with urinary retention (postoperatively)*1 mg/mL injection0.02 mg/kg IV q12h![](fx2.gif) Phytomenadione*See* Vitamin K~1~![](fx2.gif) Phytonadione*See* Vitamin K~1~PiperacillinPipracilAntibacterial2-,3-,4-, and 40-g vials for injection40 mg/kg IV or IM q6hPiperazineManyAntiparasitic/*roundworms*860 mg powder; 140-mg capsule, 17,0340, and 800 mg/mL oral solution44--66 mg/kg PO administered oncePiroxicamFeldene; genericNSAID/*has antitumor effects (indirect) in patients with transitional cell carcinoma (palliative treatment)*10-mg capsulesDog: 0.3 mg/kg, PO, once daily Cat: 0.3 mg/kg PO, q24--72h (Administer with food)Pitressin (ADH)*See* Vasopressin and Desmopressin acetatePlicamycin (formerly mithramycin)MithracinAntineoplastic/*adjunctive treatment in carcinoma protocols; also used to decrease calcium levels in hypercalcemic cancer patients*2.5 mg/mL injectionDog:*Antineoplastic*: 25--30 μg/kg/day IV (slow infusion) for 8--10 days*Antihypercalcemic*: 25 μg/kg/day IV (slow infusion) over 4 hoursCat: NOT recommendedPolyethylene glycol electrolyte solutionGoLYTELYLaxativeOral solution25 mg/kg PO; repeat in 2--4 hours POPolysulfated glycosaminoglycan (PSGAG)Adequan CanineAntiarthritic/*long-term management of osteoarthritis*100 mg/mL injection in 5-mL vial (250 mg/mL vials for horses)4.4 mg/kg IM twice weekly for up to 4 weeksPotassium bromide (KBr)No commercial formulationAnticonvulsant/*long-term antiepileptic therapy*Usually prepared as oral solutionDog and Cat: 30--40 mg/kg PO q24hNOTE: If administered without phenobarbital, higher doses of up to 40--50 mg/kg may be needed; adjust doses by monitoring plasma concentrations; loading doses of 400 mg/kg divided over 3 days have been administered.![](fx2.gif) Potassium chloride (KCl)GenericPotassium salt/*replacement therapy*Various concentrations for injection (usually 2 mEq/mL); oral suspension and oral solution0.5 mEq potassium/kg/day; or supplement 10--40 mEq/500 mL of fluids, depending on serum potassiumPotassium citrateUrocit-K; genericPotassium salt/*replacement therapy*5-mEq tablet; some forms are in combination with potassium chloride2.2 mEq/100 kcal of energy/day PO; or 40--75 mg/kg PO q12hPotassium gluconateKaon; Tumil-K; genericPotassium source/*replacement therapy*2-mEq tablet; 500-mg tablet; Kaon elixir is 20 mg/15 mL elixirDog: 0.5 mEq/kg PO 12--24hCat: 2--8 mEq/day PO divided twice daily![](fx2.gif) Pralidoxime chloride (2-PAM)2-PAM; Protopam ChlorideCholinesterase re-activator/*adjunctive treatment in patients with organophosphate toxicosis*50 mg/mL injection20 mg/kg q8--12h (initial dose) IV slowly or IMPraziquantelDroncitAntiparasitic/treatment of cestodes(tapeworms)23-and 34-mg tablets; 56.8 mg/mL injectionDog: \<6.8 kg,7.5 mg/kg once; \>6.8 kg, 5 mg/kg IM, SC once; \<2.3 kg,7.5 mg/kgPO once; 2.7--4.5 kg,6.3 mg/kg PO once; \>5 kg,5 mg/kg PO onceCat: \<1.8 kg,6.3 mg/kg PO once; \>1.8 kg, 5 mg/kg PO once.*For Paragonimus*: 25 mg/kg PO q8h for 2--3 days) 5 mg/kg IM, SC![](fx2.gif) PrazosinMinipressAlpha-1 blocker/*adjunctive treatment of congestive heart failure; also hypertension and pulmonary hypertension (e.g., heartworm disease)*1-,2-, and 5-mg capsules0.5-and 2-mg/animal (1 mg/15 kg) PO q8--12h![](fx2.gif) PrednisoloneDelta-Cortef; many othersGlucocorticoid/*antiinflammatory and immunosuppressive*5-and 20-mg tabletsDog (cat often requires 2 × dog dose):*Antiinflammatory*: 0.5--1 mg/kg IV, IM, PO q12--24h initially; then taper to q48h*Immunosuppressive*:2.2--6.6 mg/kg/day IV, IM, PO initially; then taper to 2--4 mg/kg q48h*Replacement therapy*: 0.2--0.3 mg/kg/day PO *Shock, spinal trauma*: *See* Prednisolone sodium succinate![](fx2.gif) Prednisolone sodium succinateSolu-Delta-CortefGlucorticoid/*adjunctive therapy for endotoxic or septic shock*100-and 200-mg vials for injection (10 and 50 mg/mL)*Shock*: 5.5--11 mg/kg IV (repeat in 1,3,6, or 10 h)*CNS trauma*: 15--30 mg/kg IV; then taper to 1--2 mg/kg q12h![](fx2.gif) PrednisoneDeltasone; generic; Meticorten for injectionGlucocorticoid/*antiinflammatory and immunosuppressive*1-,2.5-,5-,10-,20-,25-, and 50-mg tablets; 1 mg/mL syrup (Liquid-Pred in 5% alcohol); 1 mg/mL oral solution (in 5% alcohol); 10 and 40 mg/mL prednisone suspension for injectionSame as for prednisolonePrimidoneMylepsin; NeurosynAnticonvulsant/*idiopathic epilepsy (not generally recommended)*50-and 250-mg tablets8--10 mg/kg PO q8--12h as initial dose, and then adjust via monitoring to 10--15 mg/kg q8hWARNING: May cause irreversible liver disease with prolonged administrationProcainamidePronestyl; genericAntiarrhythmic/*ventricular premature contractions (e.g., ventricular tachycardia)*250,375,500 mg/mL injectionDog: 10--30 mg/kg PO q6h (up to maximum dose of 40 mg/kg); 8--20 mg/kg IV, IM; 25--50 μg/kg/min IV infusionCat: 3--8 mg/kg IM, PO q6--8hProcarbazineMatulane; Natulan; NatulanarAntineoplastic/*component drug used in lymphoma protocols*50-mg capsulesUsed in combination with mechlorethamine and prednisolone; consult latest information on protocols for precise doseProchlorperazineCompazinePhenothiazine/*antiemetic*5-,10-, and 25-mg tablets (maleate); 5 mg/mL injection (edisylate)0.1--0.5 mg/kg IM, SC q6--8hProgesterone, repositol*See* Medroxyprogesterone acetatePromethazinePhenerganPhenothiazine/*antiemetic*6.25 and 25 mg/5 mL syrup;12.5-, 25-, and 50-mg tablets; 25 and 50 mg/mL injection0.2--0.4 mg/kg IV, IM, PO q6--8h (up to maximum dose of 1 mg/kg)Propantheline bromidePro-BanthineAntimuscarinic/*antidiarrheal; also used to treat urge incontinence associated with detrusor hyperreflexia; oral antiemetic effect*7.5-and 15-mg tabletsDog:*Urge incontinence*: 0.2 mg/kg PO q6--8h*Diarrhea:* 0.25 mg/kg PO three times daily for 2--3 days maxCat:*Urge incontinence*: 0.25--0.5 mg/kg PO once or twice daily*Chronic colitis*: 0.5 mg/kg PO two to three times dailyPropiopromazineTranvet; LargonAntiemetic, tranquilizer/*sedation, parenteral antiemetic*20 mg/mL injection1.1--4.4 mg/kg q12--24h*Propionibacterium acnes* (injection)ImmunoregulinImmunomodulator/*nonspecific immunostimulant used as adjunctive therapy in dogs with pyoderma and in retrovirus-positive cats*0.4 mg/mL in 5-and 50-mL vialsDog: 0.03--0.07 mL/kg IV twice weekly for 10 wk (NOTE: dose is mL/kg)Cat: 0.5 mL IV twice weekly for 2 wk; then one injection weekly for 20 wkNOTE: Treatment is NOT expected to convert retrovirus-*positive* cats to a retrovirus-*negative* status.![](fx2.gif) PropofolRapinovet; PropoFloShort-acting injectable anesthetic (hypnotic)/*induction or restraint for short-term procedures*1% (10 mg/mL) injection in 20-mL ampules6.6 mg/kg IV slowly over 60 sec (constant-rate IV infusions have been used at 2 mg/kg/h)![](fx2.gif) PropranololInderalBeta blocker/*antiarrhythmic*10-,20-,40-,60-,80-, and 90-mg tablets; 1 mg/mL injection; 4 and 8 mg/mL oral solutionDog: 20--60 μg/kg over 5--10 min IV; 0.2--1 mg/kg PO q8h (titrate dose to effect)Cat: 0.4--1.2 mg/kg (2.5--5 mg/cat) PO q8hPropylthiouracil (PTU)Propyl-Thyracil; genericAntithyroid/*alternative drug used in the management of feline hyperthyroidism*50-and 100-mg tabletsCat: 11 mg/kg PO q12hProstaglandin F~2~ alphaLutalyse; DinoprostProstaglandin/*open pyometra; pregnancy termination in dogs*5 mg/mL solution for injectionNOTE: Any use of this drug in dogs and cats is EXTRA-LABEL*Open pyometra*:Dog: 0.1--0.2 mg/kg SC once daily for 5 days;Cat: 0.1 mg/kg SC twice daily for 5 daysNOTE: Concurrent antibiotic therapy is recommended. SURGERY IS ALWAYS PREFERRED!*Abortion (within 30 days of the last unwanted breeding)*:Dog: 0.1 mg/kg SC q8h for 2 days; then 0.2 mg/kg SC q8h until abortion is confirmed by ultrasound.Pseudoephedrine (OTC)Sudafed; many others (some formulations have other ingredients)Adrenergic agonist/*urinary incontinence (generally only used when phenylpropanolamine is not available)*30-and 60-mg tablets; 120-mg capsule; 6 mg/mL syrup0.2--0.4 mg/kg (or 15--60 mg/dog) PO q8--12hPsylliumMetamucil; othersLaxative, stool softenerAvailable as powder 180 mg/mL paste and 50 mg/mL suspension1 tsp/5--10 kg (added to each meal)Pyrantel pamoate and tartrateNemex; StrongidAntiparasitic/*treatment of ascarids and hookworms*Dog: 5 mg/kg PO once; repeat in 7--10 daysCat: 20 mg/kg PO oncePyridostigmine bromideMestinon; RegonolCholinesterase inhibitor/*management of myasthenia gravis*12 mg/mL oral syrup; 60-mg tablet; 5 mg/mL injection*Antimyasthenic*: 0.02--0.04 mg/kg IV q2h; or 0.5--3 mg/kg PO q8--12h*Antidote (nondepolarizing muscle relaxant)*:0.15--0.3 mg/kg IM, IVPyrimethamineDaraprimFolic acid inhibitor/*treatment of toxoplasmosis and neosporosis*25-mg tabletDog: 1 mg/kg PO q24h for 14--21 days (5 days for *Neosporum caninum)*Cat: 0.5--1 mg/kg PO q24h for 14--28 daysQuinacrineLimited availability in the U.S.Antiprotozoal/*may be useful in management (not curing) of Giardia infections, leishmaniasis, and coccidiosis*100-mg tabletDog: 6.6 mg/kg PO q12h for 5 daysCat: 11 mg/kg PO q24h for 5 daysQuinidine gluconateQuiniglute; DuraquinAntiarrhythmic/*ventricular arrhythmias*324-mg tablets; 80 mg/mL injectionDog: 6--20 mg/kg IM q6h; 6--20 mg/kg PO q6--8h (of base)Quinidine sulfateCin-Quin; QuinoraAntiarrhythmic/*ventricular arrhythmias*100-,200-, and 300-mg tablets; 200-and 300-mg capsules; 20 mg/mL injectionDog: 6--20 mg/kg PO q6--8h (of base); 5--10 mg/kg IVQuinidine polygalacturonateCardioquinAntiarrhythmic/*ventricular arrhythmias*275-mg tabletDog: 6--20 mg/kg PO q6h (of quinidine base). NOTE: 275 mg quinidine polygalacturonate =167 mg quinidine base![](fx2.gif) RanitidineZantacH~2~ receptor antagonist/*treatment and prevention of gastric and duodenal ulcers*75-,150-, and 300-mg tablets; 150-and 300-mg capsules; 25 mg/mL injectionDog: 2 mg/kg IV, PO q8hCat:2.5 mg/kg IV q12h;3.5 mg/kg PO q12hRetinol*See* Vitamin A (Aquasol-A)Riboflavin*See* Vitamin B~2~RifampinRifadinAntibacterial (reported to have limited antifungal and antiviral activity)150-and 300-mg capsules10--20 mg/kg PO q24h![](fx2.gif) Ringer\'s solutionGenericFluid replacement250-,500-, and 1000-mL bags for infusion40--50 mg/kg/day IV, SC, IPSAMe (*S*-adenosyl-methionine)Denosyl-SD4Nucleotide-like molecule derived from the amino acid methionine/*adjunctive therapy in patients with chronic liver disease*Enteric coated tablets20 mg/kg PO dailySalicylate*See* AspirinSelamectinRevolutionAntiparasitic (ivermectin)/*multiple applications in dogs and cats*Various sizes of topical solutions available for dogs and catsSee manufacturer\'s dosing instructions for the specific condition being treatedSelegilineAnipryl (also known as deprenyl and L-deprenyl)MAO-B inhibitor/*canine cognitive dysfunction; reported use in treatment of canine hyperadrenocorticism (use in canine Cushing\'s is currently NOT recommended)*2-,5-,10-,15-, and 30-mg tabletsDog: Begin with 1 mg/kg PO q24h; if there is no response within 2 mo, increase dose to maximum of 2 mg/kg PO q24hCat: Dose not establishedSennaSenokotLaxativeGranules in concentrate, or syrupCat: syrup: 5 mL/cat q24h; granules: 1/2 teaspoon/cat q24h (with food)SertralineZoloft;Altruline; Anilar; othersSelective serotonin reuptake inhibitor/*management of certain behavior disorders in dogs*25-,50-, and 100-mg tablets; 20 mg/mL injectable in 60-mL vialsDog: 0.5--4.0 mg/kg q24hCat: 0.5--1.0 mg/kg q24h![](fx2.gif) Sodium bicarbonate (NaHCO~3~^−^) (OTC)Generic; e.g., baking soda, soda mintAlkalinizing agent/*management of acidosis and renal failure; also used to alkalinize urine when indicated*325-,520-, and 650-mg tablets; injection of various strengths (4.2% to 8.4%), and 1 mEq/mL*Acidosis*: 0.5--1 mEq/kg IV*Renal failure*: 10 mg/kg PO q8--12h*Alkalization of urine*: 50 mg/kg PO q8--12h (1 tsp is approximately 2 g)![](fx2.gif) Sodium chloride 0.9%GenericFluid replacement (isotonic)500-and 1000-mL infusion40--50 mL/kg/day IV, SC, IP![](fx2.gif) Sodium chloride 7.2%Generic (hypertonic)Fluid replacementInfusion2--8 mL/kg IVCAUTION: NOT a balanced electrolyte solutionSodium iodide 20%Iodopen; genericIodine replacement/*replacement for confirmed deficiencies*100 μg elemental iodide (118 μg sodium iodide)/mL injection20--40 mg/kg PO q8--12hSotalolBetapaceNonselective beta blocker (antiarrhythmic)/*ventricular tachycardia*80-,160-,240-mg tabletsDog: 1--2 mg/kg PO q12h (start with 40 mg/dog q12h; then increase to 80 mg if no response)Cat: 1--2 mg/kg PO q12hSpironolactoneAldactoneAldosterone antagonist/*K-sparing diuretic used in the treatment of congestive heart failure; generally used in patients that fail to respond to furosemide and ACE inhibitors*25-,50-, and 100-mg tablets2--4 mg/kg/day (or 1--2 mg/kg PO q12h)StanozololWinstrol-VAnabolic steroid/*adjunctive therapy for no one really knows what; has been used to treat anemia of chronic disease*50 mg/mL injection; 2-mg tabletDog: 2 mg/dog (or range of 1--4 mg/dog) PO q12h; 25--50 mg/dog/wk IMCat: 1 mg/cat PO q12h; 25 mg/cat/wk IMCAUTION: Use in anorexic patients can cause weight loss (catabolic effect?)SuccimerChemetHeavy metal chelator/*treatment of lead poisoning*100-mg capsule10 mg/kg PO q8h for 5 days; then 10 mg/kg PO q12h for 2 more wk![](fx2.gif) SucralfateCarafateAntiulcer treatment/*treatment of gastric and duodenal ulcers (may have preventive effect)*1-g tablet; 200 mg/mL oral suspensionDog: 0.5--1 g/dog PO q8--12hCat: 0.25 g/cat PO q8--12hSufentanilSufentaAnalgesic (potent opiate)/*adjunct to anesthesia or epidural anesthesia*50 μg/mL injection2 μg/kg IV (maximum dose is 5 μg/kg IV)SulfadiazineGeneric combined with trimethoprim in TribrissenAntibacterial500-mg tablet100 mg/kg IV PO (loading dose), followed by 50 mg/kg IV PO q12h (see also Trimethoprim)SulfadimethoxineAlbon; Bactrovet; genericAntibacterial125-,250-, and 500-mg tablets; 400 mg/mL injection; 50 mg/mL suspension55 mg/kg PO (loading dose), followed by 27.5 mg/kg PO q12h (see also Ormetoprim and Sulfadimethoxine)SulfamethazineMany brand name products (e.g., Sulmet)Antibacterial30-g bolus100 mg/kg PO (loading dose), followed by 50 mg/kg PO q12hSulfamethoxazoleGantanolAntibacterial50-mg tablet100 mg/kg PO (loading dose), followed by 50 mg/kg PO q12h (see also Bactrim, Septra)Sulfasalazine (sulfapyridine + mesalamine)Azulfidine (see also Mesalamine, Olsalazine)Antibacterial and antiinflammatory activity/*ulcerative colitis and other forms of inflammatory bowel disease in dogs*500-mg tablets; pediatric suspensionDog: 10--30 mg/kg PO q8--12hWARNING: Has been reported to cause keratoconjunctivitis sicca in dogs.SulfisoxazoleGantrisinAntibacterial500-mg tablet; 500 mg/5 mL syrup50 mg/kg PO q8h (*urinary tract infections*)TaurineGenericAmino acid/*taurine deficiency cardiomyopathies*Available in powderDog: 5.0 mg PO q12hCat: 2.50 mg/cat PO q12hTepoxalinZubrinNSAID/*management of pain associated with osteoarthritis in dogs*30-,50-,100-and 200-mg tabletsDog: 10--20 mg/kg PO on the first day; then 10 mg/kg PO once daily; thereafter as needed![](fx2.gif) TerbutalineBrethine; BicanylBeta agonist/*bronchodilator; use includes feline asthma*2.5-and 5-mg tablets; 1 mg/mL injection (equivalent to 0.82 mg/mL)Dog: 1.25--5 mg/dog PO q8hCat: 0.1--0.2 mg/kg PO q12h (or 0.625 mg/cat, ¼ of 2.5-mg tablet)Testosterone cypionate esterAndro-Cyp; Andronate; Depo-Testosterone; othersHormone/*replacement therapy; most commonly used for testosterone-responsive urinary incontinence in neutered male dogs/cats*100 and 200 mg/mL injection1--2 mg/kg IM q2--4wk (see also methyltestosterone)Testosterone propionate esterTestexHormone/*replacement therapy; most commonly used for testosterone-responsive urinary incontinence in neutered male dogs/cats*100 mg/mL injection0.5--1 mg/kg IM 2--3 times/wkTetracyclinePanmycinAntibacterial250-and 500-mg capsules; 100 mg/mL suspension15--20 mg/kg PO q8h; or 4.4--11 mg/kg IV, IM q8hThenium closylateCanoparAntiparasitic/*hookworms*500-mg tabletDog: \>4.5 kg,500 mg PO once and repeat in 2--3 wk; 2.5--4.5 kg,250 mg q12h for 1 day and repeat in 2--3 wksTheophyllineMany brand name and generic productsBronchodilator/*chronic bronchitis and feline asthma*100-,125-,200-,250-, and 300-mg tablets; 27 mg/5 mL oral solution or elixir; injection in 5% dextroseDog: 9 mg/kg PO q6--8hTheophylline, sustained-releaseTheo-Dur; Slo-bid; GyrocapsBronchodilator/*chronic bronchitis and feline asthma*100-,200-,300-, and 450-mg tablets (Theo-Dur); 50-to 200-mg capsules (Slo-bid)Dog: 20 mg/kg PO q12h (*Theo-Dur*); 30 mg/kg q12h (*Slo-bid*)Cat: 25 mg/kg PO q24h (at night) for *Theo-Dur* and *Slo-bid*ThiabendazoleOmnizole; Equizole; Tresaderm (topicalotic)Antiparasitic/*multiple applications for parasitic infections*2 or 4 g/oz (30 mL) suspension or liquidDog: 50 mg/kg q24h for 3 days and repeat in 1 mo;*Respiratory parasites*: 30--70 mg/kg PO q12hCat: *Strongyloides*: 125 mg/kg q24h for 3 daysThiacetarsamide sodiumCaparsolateArsenical/*formerly used to treat canine heartworm disease*NOT commercially availableThiamine*See* Vitamin B~1~Thioguanine (6-TG)GenericAntineoplastic/*lymphocytic or granulocytic leukemia*40-mg tabletDog: 40 mg/m^2^ PO q24hCat: 25 mg/m^2^ PO q24h for 1--5 daysThiopental sodiumPentothalShort-acting injectable anesthetic/*anesthesia induction or restraint for short procedures*Various size vials from 250 mg to 10 g (mix to desired concentration)Dog: 10--25 mg/kg IV (to effect)Cat: 5--10 mg/kg IV (to effect)ThiotepaGenericAntineoplastic/*lymphocytic or granulocytic leukemia*15-mg injection (usually in solution of 10 mg/mL)0.2--0.5 mg/m^2^/wk, or daily for 5--10 days (IM, intra-cavitary, or intra-tumor)Thyroid hormone*See* Levothyroxine sodium (T~4~) and Liothyronine (T~3~)Thyrotropin (thyroid-stimulating hormone \[TSH\])ThytroparHormone/*used to test for hypothyroidism (primarily in dogs)*10-U vialDog: Collect baseline sample, followed by 0.1 U/kg IV maximum (dose is 5 U); collect post-TSH sample at 6 hCat: Collect baseline sample, followed by 2.5 U/cat IM; collect a post-TSH sample 8--12 h laterTicarcillinTicar; TicillinAntibacterial6 g/50 mL vial; vials containing 1,3,6,20, and 30 g33--50 mg/kg IV, IM q4--6hTicarcillin + clavulanateTimentinAntibacterial3-g vial for injection33--50 mg/kg IV, IM q4--6hTiletamine + zolazepamTelazol; ZoletilGeneral anesthetic/*indicated for restraint and minor procedures of short duration in healthy dogs and cats*Sterile vial to which 5 mL of sterile water is added; provides the equivalent of 50 mg of tiletamine/mLDosage is based on combined mg of each drug:CAUTION: Limited shelf life following reconstitutionDog: 6.6--10 mg/kg deep IM (*restraint*); 10--13 mg/kg deep IM (*minor surgical procedures*)Do NOT exceed 26.4 mg/kg TOTAL DOSECat: 9.7--12 mg/kg deep IM (*restraint*) 10.6--12.5 mg/kg, deep IM (minor surgical procedures) 14.3--15.8 mg/kg deep IM (*anesthesia*)TobramycinNebcinAntibacterial40 mg/mL injection2--4 mg/kg IV, IM, SC q8h![](fx2.gif) TocainideTonocardOral antiarrhythmic/*used to manage patients with ventricular arrhythmias*400-and 600-mg tabletsDog: 15--20 mg/kg PO q8hCat: Dose not establishedTolazolineTolazineAlpha-adrenergic blocker/*reversal agent for xylazine*100 mg/mL in 100-mL multi-dose vials4 mg/kg by slow IV (approx 1 mL/sec)TriamcinoloneVetalog; Trimtabs; Aristocort; genericGlucocorticoid/*antiinflammatory (not generally used in the treatment of immunemediated disease)Veterinary* (Vetalog): 0.5-and 1.5-mg tablets*Antiinflammatory*: 0.5--1 mg/kg PO q12--24 h; then taper dose to 0.5--1 PO; taper dose to mg/kg q48h (however, manufacturer recommends doses of 0.11--0.22 mg/kg/day)*Human form*: 1-,2-,4-,8-, and 16-mg tablets; 10 mg/mL injectionTriamcinolone acetonideVetalogGlucocorticoid/*antiinflammatory (not generally used in the treatment of immune-mediated disease)*2 and 6 mg/mL suspension injection; 0.5-and 1.5-mg tablets0.1--0.2 mg/kg IM, SC; repeat in 7--10 days*Intralesional*: 1.2--1.8 mg, or 1 mg for every cm diameter of tumor q2wkTriamtereneDyreniumDiuretic/*K-sparing diuretic used as an alternative to spironolactone*50-and 100-mg capsules1--2 mg/kg PO q12hTrientine hydrochlorideSyprineOral copper chelating agent/*copper-associated hepatopathy; indicated in dogs that cannot tolerate penicillamine*250-mg capsulesDog: 10--15 mg/kg PO q12hTrifluoperazineStelazinePhenothiazine/*antiemetic*10 mg/mL oral solution; also as 1-,2-,5-, and 10-mg tablets; 2.0 mg/mL injection0.03 mg/kg IM q12hTriflupromazineVesprinPhenothiazine/*antiemetic*10 and 20 mg/mL injection0.1--0.3 mg/kg IM, PO q8--12hTriiodothyronine*See* LiothyronineTrimeprazine tartrate with prednisoloneTemaril-PPhenothiazine antihistamine + glucocorticoid combination/*antitussive and antipruritic Not generally recommended today*5 mg trimeprazine + 2-mg prednisolone (combined) tabletsDog: See manufacturer\'s recommendations regarding indications and doseTrimethoprim + sulfonamide (sulfadiazine or sulfamethoxazole)Tribrissen; othersAntibacterial30-,120-,240-,480-, and 960-mg tablets15 mg/kg PO q12h; or 30 mg/kg PO q12--24h. *For toxoplasma*: 30 mg/kg PO q12hTSH (thyroid-stimulating hormone)*See* ThyrotropinTylosinTylocine; Tylan; Tylosin tartrateAntibacterial/*has antiinflammatory effects in the bowel and is sometimes used to treat inflammatory bowel disease and chronic colitis*Available as soluble powder with 2.2 g tylosin per tsp (tablets available for dogs in Canada)Dog and cat: 7--15 mg/kg PO q12--24hDog (*for colitis*): 11 mg/kg q8h, with foodUrsodiol (ursodeoxycholic acid)ActigallBile acid/*adjunctive therapy in patients with chronic liver disease*300-mg capsule10--15 mg/kg PO q24hValproic acid, divalproexDepakene (valproic acid); Depakote (divalproex)Anticonvulsant/*uncommonly used alternative to conventional anticonvulsant therapyDepakote*:125-,250-, and 500-mg tabletsDog: 60--200 mg/kg PO q8h; or 25--105 mg/kg/day PO when administered with phenobarbital*Depakene*: 250-mg capsule; 50 mg/mL syrupCat: DO NOT USEVancomycinVancocin;VancoledAntibacterialVials for injection (0.5 to 10 g)Dog: 15 mg/kg q6--8h IV by CRICat: 12--15 mg/kg q8h IV by CRIVasopressin (ADH)PitressinHormone/*diagnostic test agent for diabetes insipidus (DI). NOT for therapeutic use (see Desmopressin)*20 (pressor) units/mL in 0.5-, 1.0-, and 10-mL vials (aqueous only) and 1-mL ampulesDog: *Test protocol for DI*: 2.5 mU/kg (aqueous vasopressin) IV over 1 hCat: 0.5 U/kg, IM (test protocol in cats is different from that in dogs)NOTE: test protocol entails patient preparation in advance of administering vasopressin![](fx2.gif) VerapamilCalan; IsoptinCalcium channel blocker/*supraventricular tachycardia and hypertension*40-,80-, and 120-mg tablets; 2.5 mg/mL injectionDog: 0.05 mg/kg, IV slowly (can repeat every 5 min) to a maximum cumulative dose: 0.15--0.2 mg/kg*For hypertension*: 1--5 mg/kg PO q8hCat: 0.025 mg/kg IV slowly (can repeat every 5 minutes) to a maximum cumulative dose of 0.15--0.2 mg/kgVinblastineVelbanVinca alkaloid/*antineoplastic*1 mg/mL injection2 mg/m^2^ IV (slow infusion) q7--14 days![](fx2.gif) VincristineOncobin;Vincasar; genericVinca alkaloid/*antineoplastic; also for the treatment of thrombocytopenia*1 mg/mL injection*Antitumor*: 0.5--0.75 mg/m^2^ IV q7--14 days (q7 days in cats, depending on protocol); for thrombocytopenia: 0.02 mg/kg IV, once weekly (alternatively,0.5--0.7 mg/m^2^ as an infusion over 4--6 h) each weekViokase*See* Pancreatic EnzymesVitamin A (retinoids)Aquasol AVitamin/*nutritional supplementation*Oral solution: 5000 U (1500 RE)/0.1-mL and 10,000-,25,000-, and 50,000-U tablets625--800 U/kg PO q24hVitamin B~1~ThiamineVitamin/*nutritional supplementation*250 μg/5 mL elixir; tablets of various sizes from 5 mg to 500 mg; 100 and 500 mg/mL injectionDog: 10--100 mg/dog/day POCat: 5--30 mg/cat/day PO (up to maximum dose of 50 mg/cat/day)Vitamin B~2~RiboflavinVitamin/*nutritional supplementation*Tablets of various sizes in increments of 10 to 250 mgDog: 10--20 mg/day POCat: 5--10 mg/day POVitamin B~12~CyanocobalaminVitamin/*nutritional supplementation*100 μg/mL injectionDog: 100--200 μg/day POCat: 50--100 μg/day POVitamin CAscorbic acidTablets of various sizes and injection100--500 mg/dayVitamin D analogDihydrotachysterol (DHT); HytakerolVitamin/*management of hypocalcemia associated with hypoparathyroidism or parathyroid gland surgery*0.125-mg tablet; 0.5 mg/mL oral liquid0.01 mg/kg/day PO*Acute treatment*: 0.02 mg/kg initially; then 0.01--0.03 mg/kg PO q24--48h thereafterthen 0.01--0.03 mg/kg PO q24--48h thereafterVitamin D~2~Ergocalciferol; Calciferol; DrisdolVitamin/*management of hypocalcemia associated with hypoparathyroidism or parathyroid gland surgery*400-U tablet (OTC); 50,000-U tablet (1.25 mg); 500,000 U/mL (12.5 mg/mL) injection4000 to 6000 U/kg/day PO (*initial*); 1000 to 2000 U/kg/day PO (*maintenance*)Vitamin D~3~1--25, dihydroxy vitamin D~3~Vitamin also considered a hormone/*management of hypocalcemia associated with hypoparathyroidism or parathyroid gland surgery; also used to supplement hypocalcemia of chronic renal failureSee* Vitamin D analog (Dihydrotachysterol \[DHT\])*Hypocalcemia*:0.030--0.06 μg/kg PO once daily *Chronic renal failure*: 0.025 μg/kg, PO once dailyVitamin E (may be combined with selenium)Alpha-tocopherol; Aquasol E; genericVitamin/*nutritional supplementation and adjunctive therapy in patients with chronic liver disease; may be combined with selenium as adjunctive therapy for patients with immune-mediated skin disease in dogs; efficacy in management of arthritic dogs is questionable*Wide variety of capsules, tablets, oral solution available (e.g., 1000 units per capsule)See manufacturer\'s recommendations for treatment indications and dose![](fx2.gif) Vitamin K~1~Phytonadione; phytomenadione; Aqua-MEPHYTON (injection); Mephyton (tablets); Veta-K~1~ (capsules)Antidote/*anticoagulant rodenticide toxicosis and in any disorder impacting formation of vitamin K--dependent coagulation factors*2 and 10 mg/mL injection; 5-mg tablet (Mephyton); 25-mg capsule (Veta-K~1~)*Rodenticide toxicosis:*2.5--5.0 mg/kg PO3--4 weeks for diphacinone or chlorphacinone toxicosis*Acute intoxication*: 5 mg/kg SQ in multiple locations with 25-gauge needleWarfarinCoumadin; genericAnticoagulant/*adjunctive treatment for and prevention of thromboemboli*1-,2-,2.5-,4-,5-,7.5-and 10-mg tabletsDog: 0.22 mg/kg PO q12h to prolong PT by 1.25 to 1.5 times normal*Pulmonary thromboemboli*: 0.2 mg/kg PO daily to prolong PT by 1.5 to 2.5 times normalCat:*Chronic treatment*: 0.1--0.2 mg/kg PO once daily to prolong PT by 2 to 2.5 times normal*Aortic embolus*: 0.06--0.1 mg/kg PO once daily![](fx2.gif) XylazineRompun; genericAlpha-2 adrenergic agonist/*sedative and analgesic (sometimes used as an emetic in cats)*20 and 100 mg/mL injectionDog and cat: 1.1 mg/kg IV; or 1.1 to 2.2 mg/kg IM or SCCat (*to induce emesis*): 0.4--0.5 mg/kg IV![](fx2.gif) YohimbineYobineAlpha-2 adrenergic antagonist/*reverse xylazine (and possibly amitraz)*2 mg/mL injection in 20-mL vials0.11 mg/kg IV slowlyZidovudine (AZT)RetrovirAntiretroviral agent/*adjunctive treatment of FeLV/FIV-positive cats*300-mg tablets; 100-mg capsules; 10 mg/mL syrup 10 mg/mL injectionCat: 5--15 mg/kg PO q12h; or 5 mg/kg PO q8h for 5 wk and then rest for 4 wkCAUTION: Significant bone marrow suppression (usually reversible with cessation of therapy) is expected; monitor CBC during therapyZolazepam*See* Tiletamine-zolazepam combination[^39][^40][^41]
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[^1]: All species listed except rabbits are seasonally polyestrous.

[^2]: Better source of vitamin C than lettuce.

[^3]: *AST,* aspartate aminotransferase; *BUN,* blood urea nitrogen; *RBCs,* red blood cells; *WBCs,* white blood cells.

[^4]: \*These are values found in healthy-appearing animals and can be used as guides but should not be interpreted as physiologic norms for the species listed.

[^5]: Values are for both sexes.

[^6]: *BUN,* blood urea nitrogen; *AST,* aspartate aminotransferase.

[^7]: Values for both sexes.

[^8]: Ferrets in right lateral recumbency; sedation with ketamine and xylazine.

[^9]: Presented in alphabetical order.

[^10]: 1 cc (or cubic centimeter) = 1 cm^3^ = 1 mL.

[^11]: *NR,* Not Generally Recommended.

[^12]: Because of the high susceptibility for infection in kittens, several authors have recommended FeLV vaccine be classified as *core* through the first year of life, then *non-core* thereafter.

[^13]: The Recombinant (Transdermal) FeLV vaccine and FIV vaccine were not licensed in 2000 when the latest iteration of the feline vaccine guidelines was published. The "Non-Core" classification is the author\'s recommendation.

[^14]: *MLV,* modified live virus.

[^15]: For any vaccine preceded by "+," see defining criteria.

[^16]: In some states or municipalities, annual rabies vaccination may be required.

[^17]: All intranasal *B. bronchiseptica* vaccines also contain parainfluenza virus; some also contain canine adenovirus-2.

[^18]: *MLV,* modified live virus.

[^19]: For any vaccine preceded by "+," see defining criteria.

[^20]: All intranasal *B. bronchiseptica* vaccines also contain parainfluenza virus; some also contain canine adenovirus-2.

[^21]: In some states or municipalities, annual rabies vaccination may be required.

[^22]: For any vaccine preceded by "+," see defining criteria.

[^23]: All intranasal *B. bronchiseptica* vaccines also contain parainfluenza virus; some also contain canine adenovirus-2.

[^24]: In some states or municipalities, annual rabies vaccination may be required.

[^25]: *MLV,* modified live virus.

[^26]: For any vaccine preceded by "+," see defining criteria.

[^27]: Although administration of rabies vaccine to cats may not be required by state or local statutes, it is recommended for all cats, regardless of risk.

[^28]: *MLV,* modified live virus.

[^29]: For any vaccine preceded by "+," see defining criteria.

[^30]: Although administration of rabies vaccine to cats may not be required by state or local statutes, it is recommended for all cats, regardless of risk.

[^31]: *MLV,* modified live virus.

[^32]: For any vaccine preceded by "+," see defining criteria.

[^33]: *Chlamydia psittaci* has been renamed *Chlamydophila felis* (the name on vaccine label may not reflect the new classification).

[^34]: Although administration of rabies vaccine to cats may not be required by state or local statutes, it is recommended for all cats, regardless of risk.

[^35]: Minimum age (or older) and revaccinated 1 year later.

[^36]: 1 month = 28 days.

[^37]: Intramuscularly.

[^38]: Subcutaneously.

[^39]: Note: Listings preceded by ![](fx2.gif) are for rapid reference and denote drug/dosage used in the emergency or critical care setting.

[^40]: Listings preceded by an ![](fx2.gif) are for rapid reference and denote drug/dosage used in the emergency or critical care setting.

[^41]: NOTE: Doses listed in this table are based on best available evidence at the time of table preparation; although considerable effort has been made to verify all dosages listed, it is prudent to verify treatment protocols and drug dosages whenever using a product for the first time. Adverse effects may be possible from virtually any of the drugs listed in this table. High-risk warnings and precautionary statements are listed. Veterinarians using this table are encouraged to check current literature, product label, and the manufacturer\'s disclosure for information regarding reported changes in efficacy or safety as well as any new treatment contraindications not identified at the time of preparation of these tables. When dosage listed does NOT stipulate Dog or Cat, drug may be administered to both dogs and cats at the dosage listed.

    *Abbreviations:* ACE, angiotensin-converting enzyme;ADH, antidiuretic hormone; CMI, cell-mediated immunity; CNS, central nervous system; CRI, constant-rate infusion; DIC, disseminated intravascular coagulation; FeLV, feline leukemia virus; FIV, feline immunodeficiency virus; GI, gastrointestinal; h, hour(s); IM, intramuscular; IP, intraperitoneal; IV, intravenous; kg, kilograms of body weight; m^2^, square meters of body surface area (commonly used in cancer chemotherapy protocols); MCV, mean corpuscular volume; mg, milligram(s); min, minute(s); mo, month(s); MOA-B, monoamine B; μg, microgram(s); NSAID, nonsteroidal antiinflammatory drug; OTC, over-the-counter (prescription not required); PO, per os (oral administration); PT, prothrombin time; q12h, interval between treatment (e.g., every 12 hours); SC, subcutaneous; U, units; wk, week(s).
